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Abstract 
 
The control of biofilm formation is a major concern for industrial, environmental, and 
public health. Undesirable biofilms can harbor different disease-causing pathogens and shorten 
the operational life of different equipment. On the other hand, beneficial biofilms are also used 
in various applications and managing its growth and activity can be desirable. Killing the biofilm 
does not usually incorporate the removal of the dead biofilm structure that is adhered to the 
surface. Therefore, the aim of this thesis is to control biofilm formation; to be able to remove, 
inhibit, and enhance biofilm formation. This thesis investigated the use of norspermidine, D-
amino acids, and selected enzymes for the control of biofilm formation. Biofilm was pre-grown 
in 96-well microtiter plates and the different treatments were applied for 24 h. Biofilm 
formation was quantified before and after treatments using crystal violet stain. The results 
obtained in this thesis showed that norspermidine had a dual effect on biofilms formation. A 
concentration of 1 mM norspermidine removed 39% of nonactive biofilm, while for active 
biofilm norspermidine enhanced the biofilm growth by 73%. D-amino acids can inhibit biofilm 
growth at a low concentration of 5 µM. The two D-amino acids used in this study, D-tryptophan 
(15 mM) and D-tyrosine (20 µM), removed 28% and 31% of biofilm, respectively. No clear 
synergetic effects were noticed from mixed D-amino acids treatment. The enzymes Savinase 
and Pectinex showed the highest biofilm removal among the different tested industrial 
enzymes. Savinase removed 68% and 84% while Pectinex removed 74% and 55% of biofilm 
formed by Bacillus species and Pseudomonas fluorescens, respectively. The optimized 
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enzymatic treatment containing both Savinase (19.6 and 23.7 U/mL) and Pectinase (63.8 and 
48.8 U/mL) showed the highest biofilm removal for Bacillus sp. biofilm at pH 6 and P. 
fluorescens at pH 8.  
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Chapter 1  - Introduction 
1.1 Research Background 
Nosocomial infections obtained at dental clinics are a major rising concern (Shatokhin, 
2010). There is a growing interest in the contamination of dental unit waterlines (DUWLs) in the 
dental community due to rising awareness of infection control. Large quantities of water are 
used daily in dental procedures for rinsing the mouth, cooling the instruments, and other 
procedures. This water is being supplied to the dental units from the municipal water network 
or in some other cases from a private water tank owned by the dental clinic (Pederson, 2002; 
Rowland and Voorheesville, 2003). One old practice was warming the water to reach body 
temperature for the comfort of the patient; this is not encouraged anymore because it provides 
a favorable environment that will increase the microbial contamination. Biofilms are formed by 
bacterial communities that adhere to surfaces where moisture and nutrients can be found. 
Dental unit’s water lines are one good example of an optimal environment for bacterial 
microorganisms to dwell (Rowland and Voorheesville, 2003). Noncoliform bacteria in 
recreational and drinking water cannot exceed 500 CFU/mL according to Safe Drinking Water 
Act standards.  However, untreated DUWLs can contain anywhere between 104 and 105 
CFU/mL, in fact, a study on DUWLs in a dental school revealed a value of 2×105 CFU/mL after 5 
days only from the first use of newly installed DUWLs (Barbeau et al., 1996). The fact that 
DUWLs are dramatically higher in bacterial load when compared with the municipal water 
network comes from four main factors that act together to provide an optimal environment for 
biofilms, these are nutrition, surface area to volume ratio, surface chemistry, and laminar flow 
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(Rowland and Voorheesville, 2003). Drinking water supplied by municipal water network usually 
contains minerals that deposit inside the DUWLs such as calcium carbonate (Mills, 2000). Free 
bacterial cells in the water will then adhere to the minerals and create biofilms, this is more 
promoted during the stagnation periods when dental units are turned off after working hours 
(Pederson, 2002).  
One of the main characteristics of biofilms is their higher resistance to antibiotic and other 
chemical treatments due to the protective shield provided by the biofilm matrix to the cells 
living underneath in what is called “the protective mode”, one study reported that biofilms can 
be up to 1000-fold more resistant to chemical treatments (Gilbert and McBain, 2001). Another 
characteristic of biofilms is the fact that they are multicellular communities that can contain 
different types of microorganisms (Coleman et al., 2010). One interesting characteristic of 
biofilm is quorum sensing, which is the cell-to-cell communication system used among bacteria 
living within the biofilm through signaling molecules, this communication system is used to 
coordinate the collective behavior of the biofilm community (Atkinson and Williams, 2009). 
Biofilms can vary in their thicknesses depending on the shear forces exerted from the 
surrounding flow, biofilm forming under higher shear conditions are denser and have less 
permeability and are much harder to remove (Stoodley, Boyle and Lappin-scott, 1999).   
Most of the bacterial microorganisms that dwell in DUWLs are harmless water bacteria, 
the remaining harmful pathogenic microorganisms are obtained from patients during dental 
procedures as a result of backflow in the suction devices. These pathogenic microorganisms can 
cause serious health problems to dental staff and patients, especially those who are 
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immunocompromised (Rowland and Voorheesville, 2003). A list of microorganisms that have 
been detected in DUWLs is presented in Table 1–1.  
Table 1–1. Microorganisms detected in DUWL (Rowland and Voorheesville, 2003). 
      
Acanthamoeba Klebsiella aerogenes Pseudomonas fluorescens 
Lactobacillus Klebsiella pneumoniae Pseudomonas maltophilia 
Legionella dumoffi Achmmobacter xyloxidans Pseudomonas pickettii 
Actinomyces Acinetobacter calcoaceticus Pseudomonas posimobilis 
Aeromonas Legionella pneumophila Pseudomonas putida 
Moraxella urethalis Brevindimonas vesicularis Pseudomonas testosteroni 
Alcaligenes faecalis Burkholderia cepacia Pseudomonas stutzeri 
Bacillus subtilis Burkholderia pickettii Pseudomonas vesicularis 
Bacteroides Alcaligenes dentrificans Psychrobacter phenylpyruvica 
Micrococcus luteus Myroides odoramm Seromonas salmonicida 
Morabella osloensis Streptococcus mitis Moraxella phenylpyruvica 
Serratia marcescens Flavobacterium odoratum Sphingomonas paucimobilis 
Candida Flavobacterium indologenes Staphylococcus capitus 
Cephalosporium Pasteurella haemolytica Staphylococcus cohnii 
Cladosporium Pasteurella multocida Staphylococcus saprophyticus 
Cloaca Pasteurella paucimobilis Staphylococcus wameri 
Enterococcus Pasteurella pneumotropica Streptococcus faecalis 
Nocardia Pseudomonas acidovorans Ochromobacterium anthropi 
Fusobacterium Pseudomonas aeruginosa Streptococcus salivarius 
Weillonella Pseudomonas cepacia Xanthomonas maltophilia 
      
   
 
Some of the alarming pathogens that have been detected in DUWLs are Legionella sp., 
aquatic nontuberculosis mycobacterium, and Pseudomonas aeruginosa. Legionella sp. can cause 
several diseases including the legionnaire’s disease, pontiac fever, and pneumonia (Bartram et 
al., 2007). Each year between 10,000 and 15,000 cases caused by Legionella are reported in the 
United States with mortality rates of 5 to 15% (Rowland and Voorheesville, 2003). Aquatic 
nontuberculosis mycobacterium can cause respiratory diseases and are associated with wound 
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infections (Griffith et al., 2007). Different types of infections can be caused by Pseudomonas 
aeruginosa, in addition to pneumonia especially in individuals that suffer from cystic fibrosis 
(Young and Armstrong, 1972).  Gram-negative bacteria are the most common microorganisms 
found in DUWLs and they are associated with endotoxins, which can lead to serious immune 
reactions. Endotoxins have been reported in DUWLs with concentrations up to 500 endotoxin 
units/mL and up to this day, there is no legislation on the standard levels of endotoxins in water 
(Rowland and Voorheesville, 2003). Documented cases of infections that were related to 
contaminated DUWLs are not abundant, in two cases patients with immunocompromised 
conditions acquired wound infections caused by Pseudomonas aeruginosa, and both patients 
completely recovered (Mills, 2000). In one other case, a dentist lost his life to Legionnaire’s 
pneumonia caused by aerosols from DUWLs contaminated with Legionella dumoffii (Atlas and 
Williams, 1995).    
Although several organizations and governmental agencies provided guidelines for the 
water used in dental clinics, there are no regulations or laws that set water quality standards 
for water used in dental clinics.  In 1993, the Center for Disease Control and Prevention 
published their guidelines with three main relevant recommendations, the use of backflow 
prevention valves (later proven not to be effective due to negative pressure), if the treatment is 
associated with cutting bone sterile solutions should be used, and flushing the DUWLs for 20 to 
30 sec between different patients and for several minutes at the end of each day (Kohn et al., 
2003). In 1996, following the results of a study on hemodialysis that found rapid colonization 
occurs in fluids containing more than 200 CFU/mL heterotrophic bacteria; the American Dental 
Association recommended that water used in dental treatments should not contain more than 
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200 CFU/mL heterotrophic bacteria (Depaola et al., 2002).  The American Public Health 
Association (APHA) are alert to DUWLs associated problems, they encouraged the CDC to 
perform studies on the DUWLs associated health effects. It is worth mentioning that none of 
the aforementioned recommendations was directed towards prevention or control of biofilms 
in DUWLs.  
Common cleaning procedures used to clean DUWLs can be summarised in four main 
methods: drying or flushing DUWLs, chemical agents, filtration devices, and the use of 
autoclavable or disposable water delivery systems (Rowland and Voorheesville, 2003). Drying 
the DUWLs will not reduce the microorganism load in the DUWLs and had no effect on biofilms. 
While flushing the DUWLs can reduce the microorganisms count in the DUWLs temporarily until 
the microorganisms repopulate again, the process has no effect on biofilms in DUWLs 
(Kettering et al., 2002). Flushing the DUWLs between consecutive treatments can discharge 
microorganisms acquired during treatments from patients and help in preventing cross-
contamination between patients (Cobb et al., 2002; Fiehn and Larsen, 2002). The most applied 
method is the use of chemical agents to kill the microorganisms in DUWLs. Treatments are 
applied either by the shock-treatment in intermittent periods at high concentrations or as a 
continuous low concentration treatment. Dental units that use the shock treatment method 
must have their own water reservoir, the germicidal treatment is applied for a certain period of 
time and that is followed by a complete system flush with sterile water, in this way the 
germicidal treatment is completely removed from the DUWLs before treating the patients 
(Rowland and Voorheesville, 2003). Although the microorganisms that survive the germicidal 
treatment will repopulate again between the treatments. These germicidal treatments have 
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negative effects on the DUWLs components and can impose toxicity risks on the staff due to 
the harsh chemicals that are used in their manufacture (Rowland and Voorheesville, 2003). In 
the continuous treatment, the germicidal treatment is applied at low concentrations, since 
these germicidal treatments are continuously present in DUWLs, the chemicals used must be 
chosen carefully as they must not impose any health effects on patients (Rowland and 
Voorheesville, 2003). Moreover, these germicidal agents can also damage the DUWLs 
components and they can interfere with the bonding agents used in dental treatments. One 
common used germicidal agent is sodium hypochlorite (bleach). Other effective germicidal 
agents used are sodium fluoride, hydrogen peroxide, and commercial mouth rinses (Wirthlin 
and Marshall, 2001; Kettering et al., 2002; Tuttlebee et al., 2002; Rowland and Voorheesville, 
2003).   
The only method that can lower the microorganisms count to 200 CFU/mL or even 
lower is filtration. Filters used are usually 0.22 µM pore size. The locations of the filters are 
usually chosen to be as close as possible to the endpoint of the DUWLs (i.e. just before the 
handpiece or the sonicator). The limitations on using filters can be summarised by DUWLs 
clogging, biofouling, and no control on the release of the harmful endotoxins (Mills, 2000).  
New research is now focused on developing novel methods for reducing the 
microorganisms count and biofilm control in DUWLs. Germiphene corporation, the industrial 
partner in this project, is a privately owned Canadian company located in Brantford, Ontario. 
Germiphene is licensed by FDA and Health Canada. They are specialized in developing and 
manufacturing medical devices, infection control products, and dental pharmaceuticals with a 
special interest in the dental market. Germiphene started to implement a new development 
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plan to improve a number of its current products to become more environmentally friendly. 
One of their many products is a biofilm control product called Gobble, which has been in the 
dental market for many years. In their product, Germiphene developed a new “out of the box” 
method for the reduction of pathogenic microorganisms count and biofilm control in DUWLs. It 
is a fact that biofilms are going to grow inside the DUWLs for the many reasons mentioned 
previously, and since that is inevitable, a beneficial biofilm will be grown, using the 
heterotrophic, cannibalistic, and yet non-pathogenic microorganism, that microorganism is a 
gram-positive Bacillus species. Biofilms by Bacillus sp. will form inside the DUWLs and they will 
cannibalize the pathogenic microorganisms they will get in contact with using self-secreted 
toxins or antibiotics. Researchers discovered this phenomenon during a study on natural matrix 
inducers. In their study, they co-cultured a Bacillus strain that contained a reporter for matrix 
gene expression with other similar soil microorganisms. Although there were a variety of 
bacterial microorganisms tested in the soil samples they used, the majority of matrix inducing 
microorganisms were found to be Bacillus species (Liu et al., 2010; Shank et al., 2011; Vlamakis 
et al., 2013). 
1.2 Problem Description and Motivation 
Dental clinics sanitation relies on chemical disinfectants to lower the microorganisms count 
in their DUWLs, the presence of pathogenic biofilms in the DUWLs will make that extremely 
hard to achieve (Barbeau, Bokum and Gauthier, 1998; Rowland and Voorheesville, 2003). 
Pathogenic biofilms formation in dental units has been reported by several researchers. 
Biofilms can form in tanks, pipes, tubing, sinks, suction hoses, hand pieces, air and water 
syringes, and ultrasonic scalers (Barbeau, Bokum and Gauthier, 1998; Coleman et al., 2009, 
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2010). Pathogenic biofilms can incorporate different mixtures of microorganisms such as 
bacteria, viruses, fungi, algae, amoebae and protozoa (Coleman et al., 2010; Vasickova et al., 
2010). The biofilm extracellular matrix and the outer layers of cells form a shield that protects 
the microorganisms living underneath, consequently resulting in a biofilm community that is 
more resistant to disinfectants, antibiotics, and detergents. It has been reported that bacteria 
are one thousand-fold more resistant when they live within a biofilm community (Barbeau, 
Bokum and Gauthier, 1998; Coleman et al., 2010). In dental clinics, pathogenic biofilms are 
responsible for high contamination levels in water used for invasive procedures (Barbeau et al., 
1996; Barbeau, Bokum and Gauthier, 1998). Pathogens released from the biofilms can be 
passed around with aerosols from dental tools such as the hand piece (Barbeau, Bokum and 
Gauthier, 1998; Pederson, 2002). Moreover, wet dental devices such as the evacuation system 
(suctioning apparatus and saliva ejectors) are bases of cross-contamination among the patients 
due to tubing backflow (Barbeau, Bokum and Gauthier, 1998). These dental instruments are 
used to drain blood, saliva, tissue, and restoration debris that result from dental procedures 
(Barbeau, Bokum and Gauthier, 1998). The evacuation system consists of a filter, plastic tubing, 
and a mouth piece. Although the mouth piece is disposable, the filter and plastic tubing are not 
and can be easily contaminated with pathogens.  Since the evacuation system is not regularly 
cleaned or disinfected, clearly not between consecutive patients, they can become a source of 
cross-contamination among patients (Barbeau, Bokum and Gauthier, 1998). One other concern 
from biofilm growth in dental settings is the interference with the mechanical functions of the 
dental devices and the clogging of tubes and pipes. Based on the aforementioned biofilm 
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growth control is a major concern for dental clinics hygiene and dental devices industry 
(Barbeau et al., 1996). 
 
Figure 1-1. Schematic for biofilm formation in dental unit water lines (DUWLs) and the use of 
amalgam separators for the remove of amalgam from the wastewater.  
Amalgam separators are a specialized type of filters used to recover amalgam waste from 
the liquids removed from patient’s mouth during procedures involving amalgam containing 
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fillings.  Without these separators amalgam will travel through the DUWLs to the vacuum lines 
and end of in the wastewater discharged to the municipal sewer system. The main problem 
occurs from mercury that is being released from the amalgam. The amount of mercury in the 
sludge of a wastewater treatment plant as well as the amount being discharge in wastewater 
are regulated by Canadian Environmental Protection Act, 1999.  
Germiphene developed a product for cleaning DUWLs known commercially as Gobble. 
Gobble utilizes a beneficial biofilm formed from the non-pathogenic Bacillus Species to cover 
the inner walls of the DUWLs. This beneficial biofilm is safe for human consumption and will 
prevent the formation of pathogenic biofilm. It is useful to enhance the formation of such 
beneficial biofilm especially with new commissioned DUWLs. However, some dental clinics have 
been experiencing excessive shedding of biofilm. These biofilm aggregates that peel from the 
inner walls of the DUWLs have been travelling through the DUWLs and accumulating in the 
amalgam separator. This accumulation of biofilm aggregates in the amalgam separator requires 
a more frequent replacement of the filter. These filters are expensive to replace. Also, the 
proper disposal of the amalgam filter is expensive and must be contracted to a specialized 
company that carries a certificate of approval to handle biohazard and hazardous wastes. The 
ability to better control biofilm growth could therefore lead to developing an overall better 
product.      
 It must be emphasised here that the aim of this research is not to kill the biofilm nor 
completely remove it, but control its formation in the DUWLs. In this thesis, the term “control”, 
as in control biofilm formation, implies the ability to either enhance, inhibit, or remove biofilm 
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formation. There is abundant of previous knowledge that can be employed in this research to 
find effective methods to control biofilm formation.  
1.3 Research Objectives 
1.3.1  General Research Objective 
The general objective of this thesis is to thoroughly investigate the capability of different 
suggested treatments for controlling biofilm formations. To be able to inhibit, enhance, and 
most importantly eradicate biofilm formation.  
The main problem faced from the presence of biofilm in DUWLs is the physical barrier 
provided by the biofilm extracellular structure. This structure provides a diffusion barrier that 
harbors different pathogens from chemical treatments, and it interferes with the physical 
properties of the dental devices. The intention of this work is not to kill biofilms or the 
microorganisms living within the biofilm community, as by doing so, the biofilm structure 
“skeleton” remains intact and can facilitate the attachment of new microorganisms, and the 
biofilm cycle continues building on the extracellular structure causing more problems. 
1.3.2 Specific Research Objectives 
1.3.2.1  Investigate Biofilm Control Using Norspermidine 
There is current apparent controversy in the literature on the interaction of norspermidine 
with biofilms. It has been reported that norspermidine is self-produced in mature biofilm 
formed by Bacillus subtilis to trigger biofilm disassembly (Kolodkin-Gal et al., 2012). While other 
researchers reported that norspermidine is not self-produced by Bacillus subtilis and when 
added to biofilms it enhanced growth (Hobley et al., 2014). Moreover, to the best knowledge of 
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the authors, present literature is lacking for quantitative studies that investigate the interaction 
of norspermidine with biofilms. Therefore, it was deemed necessary to further investigate the 
interaction between norspermidine and biofilms, and whether norspermidine can be used to 
dismember biofilm formation or not. 
1.3.2.2 Investigate Biofilm Control Using Amino Acids 
Previous researchers have reported that four D-amino acids (D-tyrosine, D-tryptophan, D-
methionine, and D-leucine) are self-produced in late stages of biofilms formed by Bacillus 
subtilis to trigger biofilm disassembly (Kolodkin-Gal et al., 2010). To the best knowledge of the 
authors, no quantitative studies that investigated biofilm removal using D-amino acids exist 
today. Hence, it was considered important to further investigate the removal of biofilms using 
D-amino acids, and if any synergetic effects can be noticed for combined treatments that can 
lead to optimization experiments. 
1.3.2.3 Investigate Biofilm Control Using Enzymes 
Enzymatic treatments are being suggested as relatively new method for biofilm removal 
due to their environmentally friendly nature, high efficiency, and low cost (Cortés, Bonilla and 
Sinisterra, 2011; Taraszkiewicz et al., 2013; Meireles et al., 2016). There exists today abundant 
information in the literature on different types of enzymes that are being used in different 
applications. To the best of the author's knowledge, current published work related to the use 
of enzymes for biofilm removal lacks a comprehensive approach to the problem. Most of the 
published studies deal with a specific type of microorganism, enzyme(s), and substratum 
(Johansen and Falholt, 1997; Loiselle and Anderson, 2003; Molobela, Cloete and Beukes, 2010; 
Marcato-Romain et al., 2012). The diversity in the biofilm-forming microorganisms is coupled 
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with diversity in biofilms constituents (Branda et al., 2001; Morikawa et al., 2006; Molobela, 
Cloete and Beukes, 2010), which should be accounted for in the selection of proper enzymatic 
treatments (Molobela, Cloete and Beukes, 2010). Although biofilms are complex in their 
composition, the two main constituents of biofilms reportedly are polysaccharides and proteins 
(Branda et al., 2001; Morikawa et al., 2006; Molobela, Cloete and Beukes, 2010). Therefore, it 
was considered important to further investigate the available enzymes that can target those 
two constituents and degrade them. The published literature will be revisited for the selection 
of specific enzymes that have been reported to degrade biofilms by targeting the 
polysaccharides and proteins constituents (polysaccharide-degrading enzymes and proteases). 
The selected enzymes will be further investigated to select the most effective in biofilm 
removal. 
1.3.2.4 Optimization of Biofilm Removal Using Enzymatic Treatments 
The use of enzymatic treatments as anti-biofilm agents have proven to be successful 
(Taraszkiewicz et al., 2013; Thallinger et al., 2013; Meireles et al., 2016). Enzymes present a 
more green, efficient, and affordable alternative to chemical treatments used to eradicate 
biofilms (Cordeiro, Hippius and Werner, 2011; Cortés, Bonilla and Sinisterra, 2011; Srey, Jahid 
and Ha, 2013). To obtain a higher biofilm removal efficiency, previous researchers have 
recommended the use of anti-biofilm enzymatic treatments consisting from mixtures of 
different enzymes targeting different substrate types (Augustin, Ali-Vehmas and Atroshi, 2004; 
Cordeiro, Hippius and Werner, 2011; Torres et al., 2011). To the best knowledge of the authors, 
no such studies exist in the literature. Consequently, it was considered vital to conduct a “first 
of its kind” optimization study for the use of proteases and polysaccharide-degrading enzymes 
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for biofilm removal. The top two of each, proteases and polysaccharide-degrading enzymes, 
that will show the highest biofilm removal efficiency in the preceding objective (Section 1.3.2.3) 
will be further utilized in the optimization study. 
1.4 Thesis Overview 
This thesis contains four chapters. The first chapter is the introduction which presents the 
research background, the problem description and motivation, research objectives (general and 
specific), and the thesis overview. The second chapter is the literature review which will provide 
the reader with the related background information on bacteria and biofilms, biofilm life cycle, 
bacterial strains used (Bacillus species and Pseudomonas fluorescens), factors governing biofilm 
formation, polyamines, amino acids, and enzymes. The third chapter is the experimental results 
where the methodology used and results obtained are presented and discussed. The fourth 
chapter is the summary and conclusions of the thesis. 
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Figure 1-2. Overview of the procedure used for evaluating the efficiency of the different biofilm 
control agents tested in this thesis. Fixed (killed) biofilm is treated with methanol to preserve 
biofilm formation at a certain stage to be quantified at a later stage. 
This thesis investigated different biofilm control agents. Each biofilm control agent 
investigated in the subsections of chapter three had a specific preparation procedure and 
application method and unique results. Nevertheless, the assessment of the effectiveness of 
each different biofilm control agent tested was done following the flow chart presented in 
Figure 1-2. 
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Chapter 2 - Literature Review 
2.1  Preface 
This thesis aims to investigate different potential biofilm control agents and their ability to 
control biofilm formation. Therefore, a literature review was prepared to provide the reader 
with the relevant background information on bacteria, biofilm, and biofilm control agents. The 
literature review presented in this chapter is divided into seven subsections (subsections 2.2-
2.7) reviewing the major related topics covered in this thesis. Section 2.2 will provide 
information on bacteria and biofilms, Section 2.3 will provide information on biofilms life cycle, 
Section 2.4 will provide information on the bacterial strains used in this research, Section 2.5 
will provide information on the factors governing biofilm formation, Section 2.6 will provide 
information on polyamines and the previous work that used them for biofilm control, Section 
2.6 will provide information on amino acids and their related previous research as biofilm 
control agents, and finally Section 2.8 will provide information on enzymes and their use as 
biofilm control agents.  
2.2  Bacteria and Biofilms 
Bacterial microorganisms are single-celled living beings, also known as prokaryotes, which 
have been considered to be “simple” when compared to other multicellular organisms. 
Relatively recent studies have shown that these simple microorganisms can perform complex 
processes and behaviors. Few examples of that can be the spore formation of Bacillus subtilis, 
and bacterial biofilms which are both used by bacteria as survival mechanisms (Karatan and 
Watnick, 2009). In the spore formation, vegetative cells will generate multiple internal and 
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external signals to produce a new morphological shape that can adapt to harsh environments. 
When free planktonic bacterial cells find them self in a favorable environment (i.e. abundant 
nutrients, surface area) they tend to form biofilms, and once the surrounding environment 
becomes less favorable they will disassemble their biofilms and return to their free planktonic 
form and start a new quest to find another favorable location to start a new biofilm, and so on 
the cycle continues (Karatan and Watnick, 2009; Romero and Kolter, 2011). While in the biofilm 
formation bacterial cells aggregate and get attached together to form a protective layer that 
shelters the cells underneath it, by doing that bacteria have evolved to tolerate low 
concentrations of antibiotics and antimicrobials that they could not have survived in their free 
individual cell form (O’Toole, Kaplan and Kolter, 2000; O’Toole and Stewart, 2005).  Biofilms are 
defined as complex multicellular communities that form by bacterial aggregation on abiotic and 
biotic surfaces. Bacterial cells in a biofilm are connected together by an extracellular matrix, 
which consists of exopolysaccharides and amyloid protein fibers, and sometimes DNA, with the 
exopolysaccharides and proteins being the main constituent (Hall-Stoodley, Costerton and 
Stoodley, 2004; Bryers, 2008; Coleman et al., 2010; Molobela, Cloete and Beukes, 2010). Biofilm 
formation is part of the life cycle of bacteria and is vital for its survival, biofilms provide the 
bacterial cells located underneath is with a protective shield from surfactants and antibiotics, in 
addition to the optimum positioning of the bacteria to access nutrients (Costerton et al., 1987; 
Cava et al., 2011).  Biofilms have a complex architectural shape that contains channels for the 
flow of food and nutrient within and throughout their community. Moreover, there is an 
interdependent relationship among the biofilm members including communications between 
different species through different signalling compound (Rowland and Voorheesville, 2003). 
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Biofilms are complex and hard to characterise, in example, it was found that in dental units 
water lines only 4% of bacterial cells within a biofilm community are cultivable with the rest 
being non-cultivable or dead (Depaola et al., 2002). 
In aquatic systems, bacteria tend to form biofilms at interfaces with abiotic and biotic 
surfaces. Biofilms can adhere to solid surfaces in the liquid-solid interface, they can also form 
floating biofilms called pellicles in the liquid-air interface of static cultures (Hall-Stoodley, 
Costerton and Stoodley, 2004; Bryers, 2008; Cava et al., 2011; Kolodkin-Gal et al., 2012). Biofilm 
formation starts after the initial layer of colonies are attached to the surface through the 
reversible and weak van der Waals forces. More attachment sites will become available for the 
free microorganisms on the initial biofilm layer and the attachment becomes more permanent 
due to other cell attachment methods. Consequently, biofilm growth is promoted and the 
protective extracellular matrix secretion is initiated (Coleman et al., 2010). 
2.3  Biofilms Life Cycle 
Biofilms go through different stages in their life cycle which can be summarised in: free 
planktonic cells, Initial attachment, early biofilm, mature biofilm, biofilm disassembly, and 
return into its original planktonic form (Palmer and White, 1997; O’Toole, Kaplan and Kolter, 
2000).  Environmental stress is the main reason for biofilms formation with the availability of 
nutrients being the main driving force; some other environmental factors can trigger biofilm 
initiation such as temperature, pH, iron, and oxygen with all these factors being microorganism 
specific (O’Toole, Kaplan and Kolter, 2000). Planktonic cells are transferred from the liquid 
media to the surface boundary by physical forces or by bacterial movement through their 
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flagella. If the environmental condition promotes biofilm formation, planktonic cells will be 
induced to attach to the surface and they will change from motile cells into non-motile. This 
attachment is governed by different environmental factors such as surface structure, 
temperature and pressure. When bacterial cells are attached to each other the term cohesion is 
used, while the term adhesion is used when bacterial cells are attached to a surface (Garrett, 
Bhakoo and Zhang, 2008). External physical forces affect the bacterial adhesion to surfaces. 
These forces are: Electrostatic interactions, Van der Waals forces, steric interactions, all 
together known as the DVLO (Derjaguin, Verwey, Landau and Overbek) (Coleman et al., 2010). 
After initial adhesion of the bacteria to the surface some bacterial cells will become 
permanently adsorbed to the surface and form the initial attached biofilm layer. The initially 
attached cells will divide and facilitate the cohesion of additional free planktonic cells that will 
get attached to the initial layer (Coleman et al., 2010). Consequently, new bacterial cells will 
grow sideward and outward to form a mushroom like shape. Bacterial cells are connected 
together and to the surface by the exopolysaccharides and protein fibers (O’Toole, Kaplan and 
Kolter, 2000), forming the early biofilm which will grow and adapt to the surrounding 
environment that will develop into a mature biofilm. Bacterial cells at this point are 
characterised with and increased synthesis of exopolysaccharides, higher antimicrobial 
resistance, UV light tolerance, and formation of bacterial spore cells (Habash and Reid, 1999; 
O’Toole, Kaplan and Kolter, 2000; Rowland and Voorheesville, 2003; Garrett, Bhakoo and 
Zhang, 2008; Coleman et al., 2010; Vlamakis et al., 2013). At late stages of the mature biofilm, 
bacterial cells will start the secretion of small molecules such as polyamines and D-amino acids. 
These small molecules will target the protein fibers and the exopolysaccharides that connect 
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the bacterial cells in the biofilm, initiating the biofilm disassembly and the release of planktonic 
cells and bacterial spores as a survival mechanism. Released planktonic cells and spores will 
migrate to find another favorable location and initiate a new biofilm community (Kolodkin-Gal 
et al., 2010, 2012). 
 
Figure 2-1. Biofilm life cycle for Bacillus subtilis, modified from (Cava et al., 2011). 
 
2.4  Bacterial Strains 
2.4.1 Bacillus Species 
The Bacillus species (sp.) strain used is known commercially as Unizyme 20X CSB 20 NF 
SPORE, and it was obtained from the industrial partner (Germiphene Inc.). Many researchers 
have employed Bacillus bacteria in different research studies, which made it a model 
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microorganism for understanding biofilm development (K P Lemon et al., 2008).  Bacillus sp. is a 
rod-shaped, motile, gram-positive, spore-forming, biofilm forming, and non-pathogenic 
bacteria that are well known for their ability to highly compete with other types of 
microorganisms as a response to nutrients depletion and increased population densities. 
Bacillus sp. are usually found in terrestrial (soil and vegetation) and aquatic environments, this 
ability to adapt to a wide range of environments makes it clear why this bacterial species is 
abundant in the environment. They grow in the mesophilic temperature range with an optimal 
temperature of growth ranging between 25 to 37 oC (Grossman, 1995; Maglott et al., 2007; 
Earl, Losick and Kolter, 2008).  
The cell wall of Bacillus sp. bacteria has a rigid structure, made of a polymer composed of 
sugars and amino acids known as peptidoglycan also known as murein in bacteria. Bacillus sp. 
uses its flagella to swarm around. (Schaechter, Ingraham and Neidhardt, 2006). Bacillus cells 
can produce toxins (enzymes) that kill different species they encounter in a mixed culture (Liu 
et al., 2010). 
It had been conceived previously that Bacillus sp. are strictly aerobic bacteria, which means 
that oxygen is required for their growth. However, later studies have shown that they can grow 
in anaerobic conditions. Nitrite and nitrates are used as electron acceptors in the absence of 
oxygen during the cell respiration (Nakano and Zuber, 1994; Marino et al., 2001). 
Bacillus sp. forms biofilms on the surface of plants roots (Earl, Losick and Kolter, 2008), 
evidence exist that this is a favorable association for the plants and it promotes plant growth 
due to the following reasons: (a) it activates the plant immune system making the plants ready 
28 
 
to overcome other harmful pathogens; (b) their biofilms will overgrow and kill other potential 
pathogens that can affect the plant health; (c) they make key nutrients to the plants 
(phosphorus and nitrogen) more readily available to the plant (Cazorla et al., 2007; Nagórska, 
Bikowski and Obuchowski, 2007; Earl, Losick and Kolter, 2008). In animals, Bacillus subtilis is 
considered to have beneficial effects when ingested by maintaining a healthy bacterial 
community in their gastrointestinal tract (Hong, Duc and Cutting, 2005). Several popular 
fermented food products in Japan such as fermented soybeans contain Bacillus subtilis, these 
types of food have been thought to carry many health benefits (Inatsu et al., 2006). Other 
industrial uses of Bacillus subtilis in the manufacturing of many types of enzymes such as 
xylanase, lipase, protease, amylase (Westers, Westers and Quax, 2004).  
2.4.2 Pseudomonas Fluorescens 
The Pseudomonas fluorescens strain used in this research was purchased from DSMZ in 
Germany, it is known commercially as Pseudomonas fluorescens (Migula 1895) DSM no. 50090, 
Type strain. Pseudomonas fluorescens is considered a model microorganism for studying 
biofilms (Rossignol et al., 2008).  Pseudomonas fluorescens is a gram-negative, rod-shaped, non-
spore forming, motile (via flagella), biofilm forming, non-pathogenic bacteria (Rossignol et al., 
2008; Scales et al., 2014). They are considered obligate aerobes, but they can survive in 
anaerobic conditions by using nitrate as an electron acceptor during cellular respiration. It 
grows in mesophilic temperatures (Optimal temp. 25 to 30 oC) (Donnarumma et al., 2010), due 
to its ability to resist a wide range of antibiotics and disinfectants and its high adaptation, this 
bacterium is largely reported in many locations in the environment and in hospitals (Spiers, 
Buckling and Rainey, 2000; Rossignol et al., 2008; Scales et al., 2014). Previous research has 
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reported that Pseudomonas fluorescens biofilms are mainly composed of proteins (Molobela, 
Cloete and Beukes, 2010). Previous researchers showed that when compared with biofilms 
formed by other pathogenic gram-negative microorganisms (Staphylococcus aureus, 
Pseudomonas aeruginosa, and Staphylococcus epidermidis), Pseudomonas fluorescens biofilms 
has shown the highest resistance to treatments, which makes their biofilm the worst case 
scenario for biofilm removal (Johansen and Falholt, 1997). 
2.5  Factors Governing Biofilm Formation 
2.5.1 The Effect of Nutrients 
Bacteria require a source of energy and raw materials to grow. Bacterial cells that can 
obtain energy from sunlight are called Autotrophs (self-feeding); while bacterial cells that 
obtain energy from oxidizing inorganic and organic materials are called heterotrophs (other-
feeding). The heterotrophs are the most common types in humans and medical applications 
(Todar, 2012).  For a bacterial cell to generate energy and carry on biosynthesis the surrounding 
environment must provide all the required substances. These substances that are utilized for 
bacterial growth are usually referred to as nutrients. Bacterial cells grown in laboratories are 
always grown in a culture media that provides them with all the essential nutrients for growth 
and development (Todar, 2012). Major elements required for bacterial growth are the same 
elements used in the composition of the bacterial cell itself and those are: C, H, N, O, P, S, Ca, 
Mn, K, Mg, Fe and some trace concentrations of Mo, Co, Zn, Cu. These molecules have 
structural or functional roles in the bacterial cells and are usually found in inorganic 
compounds, water, and other molecules. Trace concentration of metals are required by certain 
bacterial cells and their presence is not necessary in the culture medium, they work as co-
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factors for enzymatic reactions in the cells (Todar, 2012). It must be stated that nutrients are 
bacteria-specific and what one bacterial cell can utilize for energy another bacterial cell may not 
be able to utilize, since some metabolizing enzymes may not be present or the fact that these 
molecules cannot be transported through the cell wall membrane of that specific bacteria 
(Todar, 2012).  
Bacterial cells in a biofilm cannot utilize the available energy source in its surrounding 
environment without being able to transport it into the biofilm cells. Usually, nutrients are 
dissolved and must be able first to diffuse through the mass transfer boundary layer this is 
known as the external mass transfer, following that the nutrients need to diffuse through the 
biofilm matrix and this is known as the internal mass transfer to finally reach the bacterial cells. 
The decrease in the thickness of the boundary layer is reversely correlated with the nutrients 
diffusion rate (Characklis and Marshall, 1990; Ghannoum and O’Toole, 2004). 
2.5.2 The Effect of Temperature 
The ideal temperature for bacterial growth and development is related to the rate of 
nutrients intake, a higher rate will result in a rapid biofilm formation (Stepanovic et al., 2003). 
The metabolism of nutrients is dependent on the usage of enzymes, based on that the rate of 
biofilm formation and development of biochemical and physiological systems depends on the 
availability and reaction rates of enzymes (Garrett, Bhakoo and Zhang, 2008). Optimal growth 
of bacterial cells and their biofilms requires ideal temperatures, and consequently when 
temperatures deviate from the ideal temperature that reduces their growth efficiency. Due to 
reduction in the reaction rates of the bacterial enzymes, and the change in the physical 
properties in the surrounding environment to the cells (Garrett, Bhakoo and Zhang, 2008).  
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A study by Fletcher et al. (Fletcher, 1977) investigated how the attachment of cells in the 
stationary phase is affected by temperature in the marine Pseudomonad, results showed that 
temperature and cell adhesive properties are proportional to each other. That was related to 
the reduction in the bacterial surface polymers and the reduction in surface area at lower 
temperatures. On the other hand, a study by Herald et al. (Herald and Zottola, 1988) observed 
that the bacterial cell flagella counts is temperature dependent, several flagellas were noticed 
at 10 oC, whilst two or three flagellas were noticed at 21 oC, and only one flagella was observed 
at 35 oC. Based on that, initial interactions between the bacterial cells and the attachment 
surface will increase at lower temperature, which likely will increase the chances of initial 
attachment of bacterial cells. Moreover, at lower temperatures there are more uniform 
properties of the exopolysaccharides which in turn enhances the bacterial cells attachment. It 
was also found that the use of high temperatures (80 to 90 oC) have negative effects on biofilm 
removal due to the “baking effects”. Results showed that high temperatures are not effective 
for biofilm removal; in fact, high temperatures increased the adherent nature of the biofilms to 
the attachment surface (Marion-Ferey et al., 2003). 
2.5.3 The Effect of pH 
The manipulation of the pH is common for detergents and disinfectants used to kill bacteria 
due to its direct effect on bacterial growth (Garrett, Bhakoo and Zhang, 2008). Bacterial cells 
possess proton pumps in their membrane that are used to expel protons from the cytoplasm to 
generate the proton motor force, which is used to regulate the cytoplasm pH (Rowland and 
Voorheesville, 2003; Garrett, Bhakoo and Zhang, 2008).  A sudden change in external pH can 
cause influx of protons into the cytoplasm and that is problematic to the bacterial cells (Booth, 
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1985). Large variations in the pH of the surrounding environment of a bacterial cell can have 
fatal effects on it.  Bacterial cells overcome the changes in pH by adjusting the synthesis and 
activity of proteins in cellular processes (Olson, 1993). Researchers have shown that a gradual 
decrease in pH will increase the bacterial cell survival when compared to a sudden drop in pH 
(Li et al., 2001). 
Although bacterial cells can adapt with gradual changes in pH, some cellular activities 
cannot adapt with pH changes. An example on that will be the excretion of the 
exopolysaccharides. An optimum pH value for exopolysaccharides secretion is species 
dependent; usually for most bacteria it is in the neutral range (Oliveira et al., 1994).   
2.5.4 The Effect of Flow Dynamics 
The common testing methods used for biofilm control usually employ the use of microtiter 
plates (6, 12, and 96 well) in static conditions (Kolodkin-Gal et al., 2010; Cava et al., 2011; 
Brandenburg et al., 2013; Leiman et al., 2013), the use of microtiter plates has been evaluated 
previously and found to be appropriate for testing biofilm control agents (Stiefel et al., 2016). 
Biofilm forming in static conditions are different from biofilms forming in a dynamic fluid 
system.  One example on biofilm formation inside tubes and pipes is the biofilm formation 
inside DUWLs. Flow inside DUWLs is described to be laminar, flow velocity near the inner 
DUWLs wall approaches zero due to friction, which dramatically reduce the shear forces 
exerted on the biofilm developing on the inner walls of the DUWLs. This in fact reduces the 
chances of biofilm dislodging from the inner wall of DUWLs (Rowland and Voorheesville, 2003). 
A higher flow velocity is usually associated with higher shear forces exerted on the biofilm 
inside the DUWLs. Fluid dynamics has direct effects on biofilm formation; a biofilm will form in 
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different shapes with specific characteristics depending on the fluid dynamics under which it 
formed (Stoodley, Boyle and Lappin-scott, 1999; Buckingham-Meyer, Goeres and Hamilton, 
2007). It had been reported that when flow was turned off biofilm thickness increased 38% in 
comparison to biofilm grown at 1.5 m s-1 flow velocity (Stoodley, Boyle and Lappin-scott, 1999). 
Biofilms forming under higher shear forces are denser, more strongly attached to the surface, 
have lower profile thickness, and have lower internal diffusivity when compared with biofilms 
formed in static conditions or under lower shear conditions (Vieira, Melo and Pinheiro, 1993; 
Pereira et al., 2002).      
When compared to municipal water network, DUWLs represent an ideal environment for 
biofilm growth for many reasons other than the abundance of nutrients. Flow rates inside 
DUWLs can be as low as 2 mL min-1 or as high as 100 mL min-1 and it turns into static conditions 
over night and when the dental units are not in use (Rowland and Voorheesville, 2003). This 
flow is considered to be very low when compared to flow rates of 5000 mL min-1 in usual 
municipal water networks (Swift, 1999; Pederson, 2002). Another factor is the surface area to 
volume ratio. Normally DUWLs have an inner diameter ranging between 1/16 and 1/8 inch. The 
inner diameter of DUWLs has an inverse relationship with the area available for bacterial 
attachment and growth, as the inner diameter of the DUWLs decrease the surface area to 
volume ratio will increase dramatically (Pederson, 2002). 
2.5.5 The Effect of Surface Type  
Previous literature has presented the effect of surface physical and chemical 
characteristics on bacterial adhesion to surfaces. Surface roughness is being used over a large 
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scale of measurements. The surface patterns that have been reported to reduce biofilm 
formation was in the scale of the bacterial cells (i.e. between 1 and 2 µm) (Graham et al., 2013).   
In a previous study by Graham et al. 2013, the attachment of Escherichia coli (E. coli) 
was evaluated on surfaces related to medical applications made from titanium, silicon and, 
glass. The researchers reported that the attachment of E. coli on the different surfaces was 
proportional to wettability of the surfaces quantified by measuring the surface contact angle 
using deionized water droplets. Interestingly the researchers reported that the inherent surface 
roughness did not correlate with the attachment of E. coli cells. The same researchers 
evaluated the effect of engineered surface roughness on the attachment of E. coli. Different 
topographical features were formed from silicon surfaces and tested at static and microfluidic 
flow conditions for E. coli attachment, the highest attachment observed was on un-patterned 
flat surfaces, while linear patterned surfaces showed less bacterial attachment. They also 
reported that surfaces containing holes further reduced attachment of E. coli when compared 
to surfaces with linear patterns. The authors concluded that the shape of the surface features, 
spacing, size have high effect on the cell-surface interactions which should be considered in the 
design of anti-biofilm surfaces (Graham et al., 2013). 
Previous studies have shown that surfaces that are formed from repetitive microscale 
patterns can reduce bacterial attachment to surfaces (Whitehead and Verran, 2006). A study by 
Schumacher et al. 2007 suggested that the use of microscale biometric patterns that are similar 
to ones on shark skin reduced bacterial attachment to surfaces significantly lower than similarly 
sized different patterns.  The same researchers reported that engineered surfaces with spacings 
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that are equal to the size of the individual bacterial cells significantly enhanced the attachment 
of bacterial cells to surfaces (Schumacher et al., 2007). 
Other research focused on different coatings that can be used to reduce bacterial 
attachment to surfaces such as immobilized enzymes (Cordeiro, Hippius and Werner, 2011), 
this method was not seen effective for the use in dental treatments as enzymes can be 
denatured due to different chemical treatment that can pass through DUWLs. Other research 
focused on the use of active coatings that have bactericidal effects (such as copper) to prevent 
biofilm formation on surfaces (Zeiger et al., 2014), these treatments have shown to be 
ineffective in DUWLs applications due to physical degradation by debris released from dental 
treatments passing through the DUWLs. More information can be found in the review by Tuson 
et al. 2013 on surface modifications and the interactions between bacteria and surfaces (Tuson 
and Weibel, 2013).   
The research that focuses on modifying surfaces to reduce bacterial attachment can 
produce very useful results that can be used by the different manufacturers of dental and 
medical equipment. On the other hand, this method is not applicable for the removal of pre-
existing biofilm from surfaces.     
2.6  Polyamines 
Polyamines are organic compounds that have two or more amino groups. Polyamines are 
found naturally in all types of bacteria and in most animal cells, they are considered to be 
important growth factors in microorganisms. In microorganisms, they are made from 
putrescene, while in mammals they are made from arginine (Lawrence, 2004). Polyamines are 
important for the growth and development of cells; it is no surprise they occur in high 
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concentrations in milk and other dairy products, they can also be found in other food products 
such as: fish, meat, fruits, and nuts. In addition to the polyamines that exist in nature, there are 
many other synthetic industrial polyamines (Lawrence, 2004). There is an increased interest in 
polyamines due to their high distribution among most living cells and their high concentrations 
especially in rapidly growing tissue (Tabor and Tabor, 1984).  
The life span of biofilms formed by Bacillus subtilis is limited. After three days of incubation 
in a biofilm growth medium at 22 oC the biofilm matures, and after eight days the biofilm 
disassembles and start releasing the free planktonic cells (Kolodkin-Gal et al., 2010; Romero et 
al., 2011). It was previously found by Kolodkin-Gal et al. (2010) that an eight day old bacillus 
subtilis culture contained factors that inhibited the formation of pellicles when mixed with fresh 
cultures, these factors were mixtures of D-amino acids (Kolodkin-Gal et al., 2010). Following the 
same procedure, the same researchers announced the discovery of a new biofilm disassembly 
factor that was found in the eight-day Bacillus subtilis biofilm growth medium, this factor is the 
polyamine norspermidine, which was found at concentrations ranging between 50 and 80 µM 
in the eight-day biofilm growth media culture which makes that the minimum required 
concentration for pellicle formation inhibition. Furthermore, norspermidine was present in the 
three day biofilm growth media culture only at a lower concentration of less than 1 µM and 
that concentration had no inhibition effects on pellicle formation (Kolodkin-Gal et al., 2012). 
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Figure 2-2. Specificity in structural activity of polyamines with exopolysaccharides, modified 
from (Kolodkin-Gal et al., 2012). 
There is evidence of direct interaction between norspermidine and the exopolysaccharides, 
this interaction was specific to norspermidine that other similar polyamines such as spermidine 
that only have one extra methylene group did not show any biofilm inhibiting activity at 
concentration as high as 2 mM. Moreover, Bacillus subtilis mutant cells that could not produce 
norspermidine and D-amino acids formed long living pellicles. In their research paper Kolodkin-
Gal et al. 2012 presented data showing extreme reduction in the average diameter of the 
exopolysaccharides aggregates before and after the addition of norspermidine (570 nm and 85 
nm respectively) similar results were obtained from norspermine. Using molecular modeling 
(Figure 2-2) the researchers suggested that the amines in norspermidine and other polyamines 
that are similar in structure and charge ("three methylene groups flanked by two positively 
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charged amino groups") interacts with the negatively charged residues (i.e. uronic acid) or the 
neutral sugars with polar groups (i.e. poly-N-acetyglucosamine) that exist in the secondary 
structure of the exopolysaccharides. They hypothesised that norspermidine interacts directly 
with the exopolysaccharides within the biofilm community. This interaction disrupts the biofilm 
formation and diminishes the pre-existing biofilm and causes it to collapse in biofilms 
communities from Bacillus subtilis, Staphylococcus aureus, and Escherichia coli (Kolodkin-Gal et 
al., 2012).  
A later study by Hobley et al. 2014, revisited the findings of Kolodkin-Gal et al. 2012. In 
contrast, they found that norspermidine can not naturally exist in biofilms formed by Bacillus 
subtilis, therefore norspermidine is not self-produced by Bacillus subtilis. They also found that 
the gene responsible to produce norspermidine in V. cholera was missing in Bacillus subtilis 
genome. The researchers suggested that norspermidine does not have a native role in the 
physiology of Bacillus subtilis biofilms. Moreover, the researchers stated that spermidine has an 
essential role in robust biofilm formation from Bacillus subtilis and norspermidine can 
substitute spermidine efficiently for that role. Moreover, results showed that biofilm formation 
from Bacillus subtilis wild type was inhibited by norspermidine at a minimum concentration in 
the range of 250 to 300 µM. Pellicle formation was completely inhibited at a minimum 
concentration of 500 µM. When norspermidine concentrations were lower than 250 µM, 
biofilm formation was enhanced (Hobley et al., 2014). 
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2.7  Amino Acids 
The word chirality is used to describe objects when their mirror reflected image cannot be 
superimposed on their original image. One good example on that is the human hand, which in 
fact where the word was derived from in Greek. The term enantiomers have been used to refer 
to the two mirror images of a chiral molecule. Although enantiomers share almost the same 
physical properties (i.e. molecular weight, solubility…), they have different interactions when 
they are subjected to plane-polarized light. The common basis of chirality in molecules is a 
carbon atom that is bonded to four groups; this carbon atom is called the chiral center or 
stereocenter (Cava et al., 2011). The arrangement of the atoms bonded to the chiral center in 
three-dimension is used to describe the chirality of a molecule. For amino acids and sugars the 
D or L are the nomenclature used to describe their chirality (Meierhenrich, 2008). The 
structures of D- and L- enantiomers of Tyrosine are presented in Figure 2-3. 
 
Figure 2-3. Chirality of Tyrosine. 
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Unlike chemical synthesis that can usually produce both enantiomers, enzymes show 
clear substrate selectivity, and based on that biochemical processes usually use and produce 
particular enantiomers. One good example on that is the fact that L-amino acids are the 
building blocks of proteins in the ribosomal synthesis, at the same time D-amino acids cannot 
be utilized into proteins though ribosomal synthesis. Another example on that are the 
enantiomers of alanine. While L-alanine is considered to be a germinant, and in the presence of 
L-alanine and other nutrients bacterial spores can reactivate their metabolism and grow again, 
it was discovered that D-alanine is a strong inhibitor of Bacillus spore germination (Hills, 1949). 
Following that discovery researchers have shown that Bacillus bacteria uses D-alanine as an 
auto inhibitor for spore germination at spore densities that are considered high when 
compared to available nutrients. This is considered a survival mechanism in Bacillus bacteria to 
prevent premature germination of bacterial spores in low nutrient environments and high 
spore density which will lead to cell death due to rapid consumption of available nutrients 
(Halvorson and Spiegelman, 1952; McKevitt et al., 2007). 
Among the different enantiomers of amino acids, the L-amino acids are the most common and 
naturally existing in nature and in many living organisms. L-amino acids are utilized for the 
manufacture of D-amino acids. The process of changing the L- amino acid to its D-amino acid 
enantiomer is called racemases; within racemases the stereochemistry of the chiral α-carbon 
atom is changed (Tanner, 2002). 
Bacteria show great resistance to chemical, biological, and physical assaults. Mostly, due to the 
existence of the peptidoglycan cell wall, this is also known as the murein, which is located 
outside of the cytoplasmic membrane of most bacteria (Park, 1996; Holtje, 1998; Nanninga, 
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1998). The peptidoglycan cell wall is a flexible strong polymer that has a net-like shape, it is 
composed of linear glycan strands formed from disaccharide chains and cross linked by short 
polypeptides (Cava et al., 2011). The peptidoglycan cell wall provides the bacterial cell with 
many benefits such as: protecting the contents of the bacterial cell, strength to hold its shape, 
resists the osmotic pressure, provides a framework structure to anchor cell envelop 
components (Holtje, 1998; Young, 2006; Dramsi et al., 2008; Vollmer, Blanot and de Pedro, 
2008). One interesting feature of the peptidoglycan cell wall composition is the D-amino acids 
that are present in the polypeptides (Nagata et al., 1998). These D-amino acids help in forming 
the structure of the peptidoglycan cell wall and provide resilience to the known proteases (Cava 
et al., 2011). The most common D-amino acids found in peptidoglycan cell wall are D-alanine 
and D-glutamate. However, the peptidoglycan cell wall of other bacteria incorporate other D-
amino acids such as D-serine in Staphylococcus aureus (vancomysin-resistant bacteria), and D-
aspartate in Enterococcus and Lactococcus (Sieradzki and Tomasz, 1996; de Jonge, Gage, and 
Xu, 2002; Reynolds and Courvalin, 2005; Bellais et al., 2006; Veiga et al., 2006). These 
incorporations are thought to increase the bacterial resistance to antibacterial agents (de 
Lencastre, Oliveira and Tomasz, 2007).    
 Previous researchers have concluded that D-amino acids are self-produced by Bacillus subtilis 
to disassemble their biofilms in the stationary phase of their life cycle (Kolodkin-Gal et al., 
2010). This is triggered when nutrients are limited and the products of metabolic waste have 
accumulated, which makes it more favorable to escape into the free planktonic cells form.  In 
specific, D-tyrosine, D-tryptophan, D-leucine, and D-methionine have shown capabilities in 
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biofilm growth inhibition in both solid and liquid mediums (Lam et al., 2009; Kolodkin-Gal et al., 
2010; Leiman et al., 2013).   
  A study by Kolodkin-Gal et al. 2010 reported the existence of self-produced D-amino 
acids in mature biofilm growth medium (6 to 8 days old). In their experiments, they showed 
that a minimum concentration of 3µM, 5 mM, 8.5 mM, and 2 mM for D-tyrosine, D-tryptophan, 
D-leucine, and D-methionine respectively must be used to inhibit biofilm formation by Bacillus 
subtilis. Moreover, a mixture of the aforementioned D-amino acids with a concentration of 10 
nM for each D-amino acid was potent and had synergetic results that dismembered the pre-
existing biofilms. They also suggested that amyloid protein TasA fibers that connects the 
bacterial cells within the biofilm are anchored to the cell wall, when D-amino acids are 
introduced to the biofilm they incorporate them self into the cell wall by replacing the pre-
existing D-alanine, and consequently the protein fibers are disengaged from their anchors 
which causes the biofilm to disassemble (Kolodkin-Gal et al., 2010). They also stated that the 
corresponding L-amino acids had no effects on Bacillus subtilis biofilm disassembly, and that the 
presence of D-alanine will mitigate the inhibitory effects of the aforementioned D-amino acids. 
They also found similar results when same treatments were tested on biofilms from 
Pseudomonas aeruginosa (Kolodkin-Gal et al., 2010). However, the direct interaction between 
the D-amino acids and the protein amyloid fibers is not the only mean by which biofilm 
disassembly is promoted by D-amino acids. The same researchers stated that D-amino acids 
dispersed biofilms from bacterial species that are not known to have amyloid protein fibers in 
their biofilm matrix such as Staphylococcus aureus and Pseudomonas aeruginosa.  
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Another study by Leiman et al. 2013 stated that D-tyrosine, D-tryptophan, D-leucine, 
and D-methionine can inhibit Bacillus subtilis biofilms. They suggested that the major inhibitory 
effect of the mentioned D-amino acids on biofilm growth arises from their interference with 
protein synthesis by their misincorporation into the protein synthesis. They also stated that D-
tyrosine in specific is a metabolic inhibitor for Bacillus subtilis. It was also proposed that the 
presence of L-amino acids will mitigate the inhibitory effects of the D-amino acids on Bacillus 
subtilis biofilm. They also said that a mixture of the four amino acids at a concentration of 10 
nM each was not sufficient for Bacillus subtilis biofilm inhibition, and a higher concentration 
(500 nM) is required for such inhibitory effects. They also suggested that the presence of D-
alanine did not counter the effects of the four D-amino acids in contrast to the presence of L-
tyrosine which countered the effects of the D-amino acids (Leiman et al., 2013). This contradicts 
what was presented by Kolodkin-Gal et al. 2010. 
Brandenburg et al. 2013 conducted a study that aimed to study the effects of amino 
acids on biofilm formation and motility of Pseudomonas aeruginosa. Results obtained showed 
that only D-tryptophan and D-tyrosine possessed inhibitory effects with D-tryptophan being 
most effective, while D-methionine and D-leucine interestingly increased biofilm growth. 
Moreover, at a concentration of 10 mM both tryptophan isoforms (D and L) were effective in 
biofilm inhibition with the L-tryptophan being more effective than D-tryptophan (86% and 71% 
at 24 hr respectively). A mixture with an equimolar ratio of both tryptophan isoforms (total 
concentration of 10 mM tryptophan) resulted in higher inhibitory effects (93% at 24 hr). They 
hypothesised that tryptophan enhances bacterial cell swimming motility (~40%) by increasing 
the flagellar activity of bacterial cells, which results in biofilm growth inhibition and 
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disassembly. Since bacterial cells that were under flagellar arrest before introducing tryptophan 
will prefer to detach from the biofilm (Brandenburg et al., 2013). These results contradict what 
was presented in the previously mentioned two studies. 
In summary, D-amino acids can inhibit biofilm formation and disperse pre-existing biofilms 
through different mechanisms which can be characterised by the following: (i) misincorporation 
of D-amino acids into the cell wall by replacing the D-alanine in the polypeptide chains, and 
consequently the amyloid protein fibers are disengaged from their anchors, (ii) D-amino acids 
can interfere with protein synthesis by their misincorporation into the protein synthesis, (iii) D-
amino acids increase the flagellar activity of bacterial cells and promote free planktonic cells 
form. The fact that D-amino acids can be used to control biofilm formation is significantly 
promising due to the lack of toxicity and the favorable pharmacokinetic properties of D-amino 
acids (Jayaraman and Wood, 2008). 
2.8  Enzymes 
Enzymes are biological catalyst made from amino acids strings, they accelerate chemical 
reactions by lowering their activation energy, similar to other catalyst, enzymes do not get 
consumed within the reactions they catalyze (Berg, Tymoczko and Stryer, 2002). Enzymes have 
a limitless number of possible applications such as but not limited to cellular metabolism, 
detergents, food industry, animal feed, textiles, drugs, pulp, personal care, baking, and paper 
(Kirk, Borchert and Fuglsang, 2002). There is a current interest in enzymes to be used as anti-
biofilm agents, this was after their reported promising results in the removal of biofilm from 
industrial surfaces (Taraszkiewicz et al., 2013; Thallinger et al., 2013; Meireles et al., 2016). 
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Previous research have described enzymes as affordable, efficient, and echo-friendly 
alternative to the chemicals that have been used in eradicating biofilms (Cordeiro, Hippius and 
Werner, 2011; Cortés, Bonilla and Sinisterra, 2011; Srey, Jahid and Ha, 2013). Enzymes have 
been approved by regulatory agencies, and there has been no side effects reported from using 
enzymes for cleaning surfaces and in industry (Schmidt, 2012; Meireles et al., 2016).   
Enzymes mitigate biofilm formation by breaking the extracellular matrix components and 
weakening its structural integrity (Molobela, Cloete and Beukes, 2010). There are different 
factors that affect enzymes efficiency such as the substrate type and concentration, enzyme 
concentration, pH, temperature, cofactors or inhibitors, and presence or absence of activators 
(Madhumathi, 2007; Meireles et al., 2016). The enzymes used to mitigate biofilm related 
problems has been categorised into anti-quorum sensing, oxidative enzymes, polysaccharide 
degrading enzymes, and proteolytic enzymes (Thallinger et al., 2013).   
Quorum sensing is the intercellular communication system used by bacterial cells in 
communities with high cell density (i.e. a Biofilm), it is used among bacterial cells to regulate 
many of their physiological activities including biofilm formation(Pearson, Van Delden and 
Iglewski, 1999; Meireles et al., 2016). This communication system operates through the release, 
and detection of small self-produced molecules (autoinducers) used as signalling molecules 
among different bacterial cells within the biofilm community (LaSarre and Federle, 2013). Anti-
quorum sensing enzymes such as lactonases and AHL acylase can prevent the signaling 
molecules from binding to their target (transcriptional regulators), this is done by the 
hydrolyses of the transcriptional regulators and/or the hydrolyses of the signalling molecule 
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respectively, eventually preventing them from bonding (Thallinger et al., 2013). More 
information about quorum sensing can be found in previous work (Kalia, 2015).  
Oxidative enzymes such as xanthine oxidase, deoxyribonuclease, and lipoxygenases can 
produce superoxide anions that are used to destroy invading pathogens, it can also disperse 
biofilms by targeting the DNA in the extracellular matrix of the biofilm (Valko et al., 2007; 
Thallinger et al., 2013; Okshevsky and Meyer, 2015a). This is similar to the defence system used 
in the human body defence system against pathogens (Thallinger et al., 2013). Further 
information can be found on oxidative enzymes in many previous valuable studies (Hall-
Stoodley et al., 2008; Thomas et al., 2008; Okshevsky and Meyer, 2015b). 
Proteases (proteolytic enzymes) are enzymes that hydrolyse peptide bonds in proteins, they 
contain a range of enzymes that vary in their mechanisms and targeted substrates (Hedstrom, 
2002). There are two major groups of proteases, exopeptidases are proteases that hydrolyse 
the peptide bond at the C-terminal and the N-terminal (i.e. Aminopeptidase and 
Carboxypeptidase), and endopeptidases are proteases that hydrolyse the peptide bond at the 
inner regions within the molecule (i.e. Savinase, Protamex, Subtilisin A, and Trypsin) (Obayashi 
and Suzuki, 2005). Previous researchers have reported promising results on the use of Savinase 
as an anti-biofilm agent (C Leroy et al., 2008; Molobela, Cloete and Beukes, 2010).  
A study by Marcato-Romain et al. 2012 investigated the effectiveness of different enzymes in 
reducing biofilm formation in paper industry. The extracellular matrix material (found to be 
mainly composed from proteins) was extracted from six industrial biofilms and treated with 
different enzymes (glycosidases, lipases, and proteases) at varying concentrations and contact 
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time. Only proteases were found to be effective in biofilm reduction, in specific, Savinase was 
found to be the most effective in biofilm reduction which exceeded 80% (Marcato-Romain et 
al., 2012).  
Protamex is an enzyme introduced first in fisheries for its ability to hydrolyse proteins 
(Dumay et al., 2009; Nguyen et al., 2011; Minh, 2015). To this date, no previous studied could 
be found on the use of Protamex as an anti-biofilm agent. Due to its wide use for protein 
hydrolysis in the fish industry, It was considered in this work as a potential anti-biofilm removal 
agent. 
A study by Cordeiro et al. 2011 has investigated the effect of immobilized enzymes on 
the initial attachment of Staphylococcus epidermidis and Pseudomonas aeruginosa on 
poly(ethylene-alt-maleic) anhydride copolymer surfaces. The enzymes Subtilisin A and Cellulase 
were immobilized by covalent bonding on the surfaces, and test control were prepared by using 
heat-inactivated enzymes on the surfaces. The tested surfaces were submerged in a suspension 
containing bacterial culture (106 CFU/mL) and incubated at 37oC for 24 hrs. The surfaces are 
then washed and the remaining attached cells were plated in serial dilutions for viable cell 
count quantification.  The immobilized Subtilisin A reduced the attachment of P. aeruginosa by 
44%, no effect on the attachment of S. epidermidis was noticed. The authors concluded that 
different biomolecules are involved in the initial attachment step among different bacterial 
strains which requires a wide spectrum of enzymes coatings to control biofilm attachment to 
surfaces (Cordeiro, Hippius and Werner, 2011).   
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Chaignon et al. 2007 investigated the use of the protease Trypsin for removing biofilms 
from different bacterial species (S. epidermidis RP62A, S. epidermidis 444, S. epidermidis 5, S. 
lugdunensis 47, S. aureus 383, S. lugdunensis 18a). The biofilms were grown in 96-well 
microtiter plates and then treated with Trypsin (100 μL) at 1 mg mL−1 in 20 mM Tris buffer (pH 
7.5) for 2 h. Biofilms were measured indirectly using safranin stain (5%) and quantified via 
absorbance measurements at optical density of 492 nm. Their results showed that Trypsin was 
able to remove more than 70% of biofilms formed by S. lugdunensis 47, S. epidermidis 444, S. 
aureus 383, S. lugdunensis 18a. In contrary, Trypsin hand no effect on biofilm formed by S. 
epidermidis 5 and S. epidermidis RP62A., the authors hypothesised that this was due to their 
biofilm composition being rich in polysaccharides, which is not a suitable substrate for Trypsin.  
The authors stated that the removal of the polysaccharide-rich biofilm formed by S. epidermidis 
444 using Trypsin was a result of the interdependent roll of proteins and polysaccharides in the 
structural integrity of biofilms formed by this strain of bacteria (Chaignon et al., 2007). In a 
similar study by Rohde et al. 2007, 98% of pre-grown biofilms from Staphylococcus epidermidis 
and Staphylococcus aureus were removed using Trypsin (100 µg/mL applied for 16 hrs at 37oC) 
(Rohde et al., 2007). 
Polysaccharides and polysaccharide-degrading enzymes are naturally abundant, with 
bacteria being the main source for polysaccharide-degrading enzymes, these enzymes are used 
by bacteria to takedown host defences in nature (Jedrzejas, 2000).   There are two main types 
of polysaccharide-degrading enzymes lyases and hydrolases. Lyases enzymes degrade 
polysaccharides using the β-elimination process that is based on the mechanism of proton 
donation and acceptance, more information can be found in previous research (Jedrzejas and 
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Chantalat, 2000). Hydrolases enzymes degrade polysaccharides by the hydrolysis of the 
glycosidic bonds between the building blocks of the sugar, some of the hydrolases enzymes use 
the mechanism of direct-displacement where a water molecule replaces the leaving group from 
the substrate (Jedrzejas, 2000). The polysaccharide-degrading enzyme Cellulase is vastly used as 
an anti-biofilm enzyme for the removal and prevention o biofilms (Loiselle and Anderson, 2003; 
Cordeiro, Hippius and Werner, 2011). 
Cordeiro et al. 2011 reported that Cellulase was effective in reducing the attachment of 
S. epidermidis by 67%, while it had no effect on biofilms formed by P. aeruginosa, the 
researchers followed the same procedure explained previously for subtilisin A (Cordeiro, 
Hippius and Werner, 2011). 
A study by Loiselle et al. 2003 investigated the use of Cellulase for inhibiting biofilm 
formed by P. aeruginosa. The biofilm was gown on a glass slide for four days inside a flow 
chamber. Biofilm formation was quantified using viable cell counts (CFU) and by biomass areal 
density (mg cm-2). The biofilm tested was grown in the presence of Cellulase at different 
concentrations and pH values. Controls were prepared using deactivated Cellulase. The results 
presented showed that Cellulase could partially inhibit biofilm. The highest biofilm areal density 
removal achieved using Cellulase was 88% at concentration of 75.2 U mL-1 at pH 5. While viable 
cell counts was reduced 60% at concentration of 9.4 U mL-1 and pH 5, no effect of 
concentration increase was noticed for viable cell counts (Loiselle and Anderson, 2003).  
Pectinases are heterogenous mixtures of enzymes that hydrolyse pectic substances, 
they are abundant in plants and microorganisms (Jayani, Saxena and Gupta, 2005). 
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Pectic compounds are polysaccharides that are negatively charged, acidic, macromolecules that 
have high molecular weight, they are abundantly found in the plant kingdom (Jayani, Saxena 
and Gupta, 2005).Pectinases have an important role in the plant kingdom in the degradation of 
the plant cell wall (Ward and Moo-Young, 1989). They also have an important role at plant 
maturation in softening the plant tissue (Sakai, 1992), they also have an ecological role in the 
degradation and recycling of plant waste material (Lang and Dörnenburg, 2000).  
A study by Johansen et al. 1997 investigated the use of Pectinex as an anti-biofilm agent 
on biofilms formed by Staphylococcus aureus ATCC 25923, Pseudomonas fluorescens AH2, and 
Pseudomonas aeruginosa ATCC 10148. Discs made from steel and polypropylene were vertically 
immerged in growth medium and the biofilm was allowed to form on both sides of the discs 
while stirring continuously at 200 rounds per minute for four days at 26oC. The loosely attached 
cells were then removed by washing the discs using phosphate buffer (pH 7), following to that, 
the discs were incubated in different concentrations of Pectinex prepared in phosphate buffer 
for 15 min, static, at 20 oC. Control samples were prepared using phosphate buffer solution 
containing no Pectinex. The biofilm removal was assessed using the total number of cells and 
the number of respiring cells, which were quantified using fluorescence microscopy. The 
presented results showed that Pectinex was successful in removing biofilms formed by all 
tested bacterial strains. The cell number for P. aeruginosa and S. aureus were reduced by two 
log reductions, while the cell number count for P. fluorescens was reduced one log reduction, at 
a Pectinex concentration of 180 PSU mL-1 (Johansen and Falholt, 1997).  
The first obstacle to overcome in biofilm removal is the extracellular matrix which 
shields and covers the bacterial cells living within the biofilm community. Due to the abundance 
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of available enzymes, the different biofilm composition among different bacterial strains, and 
the substrate specificity of enzymes (Simões, Simões and Vieira, 2010), it is important to 
investigate and compare the ability of different available enzymes to remove biofilms. Although 
biofilms have a complex composition, they are composed mainly from polysaccharides and 
proteins, which makes polysaccharide-degrading enzymes and proteases the most suitable 
enzymes for their removal, this due to their substrate compatibility (Meyer, 2003). Hence, 
polysaccharide-degrading enzymes and proteases will be investigated in this work.  
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Chapter 3 - Experimental Work 
 
3.1  Preface 
The results of the experimental work conducted in this thesis are presented in Chapter 
Chapter 3. The experimental work is presented in four subsections (subsections 3.2-3.5), each 
subsection represents a separate contribution. Each subsection was directed toward one of the 
four specific research objectives presented previously in Sections (1.3.2.1-1.3.2.4). 
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3.2  Biofilm Control Using Norspermidine 
Bilal Al-Bataina, Erin Johnson, and Lars Rehmann 
Department of Chemical and Biochemical Engineering, Western University 
1151 Richmond St., London, Ontario, Canada, N6A 5B9 
 
3.2.1. Preface 
Section 3.2 presents the experimental work conducted to fulfill the specific objective 
presented in Section 1.3.2.1. The work presented in this section provides a possible explanation 
for the apparent contradiction in previous work presented by different researchers on the role 
of norspermidine in removing biofilm. Based on the results presented in Section 3.2 
norspermidine can remove nonactive biofilms, and enhance the growth of active biofilms. The 
apparent controversy in previous published research was attributed to the different viable state 
of the treated biofilm. Section 3.2 provides quantitative information on biofilm removal and 
biofilm growth enhancement using norspermidine. 
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3.2.2. Introduction 
When free planktonic bacterial cells find a surface in a favorable environment they tend 
to colonize it by forming  biofilms (Henrici, 1933; Torres et al., 2012; Daniel et al., 2016). While 
in biofilm formation, bacterial cells aggregate to form a protective layer that shelters the cells 
underneath. In doing so, bacteria have evolved to tolerate low concentrations of antibiotics and 
antimicrobials (O’Toole, Kaplan and Kolter, 2000; O’Toole and Stewart, 2005). Bacterial cells in a 
biofilm are connected together by an extracellular matrix, which consists of polysaccharides, 
protein fibers, and in some cases DNA, with the exopolysaccharides and proteins being the 
main constituent (Donlan, 2002; Hall-Stoodley, Costerton and Stoodley, 2004; Molobela, Cloete 
and Beukes, 2010; Daniel et al., 2016). Biofilm formation, a vital part of the bacteria life cycle,  
in harsh environments,  also positions  the bacteria to access nutrients (Costerton et al., 1987; 
DeBeer, Stoodley and Lewandowski, 1994).  Biofilms have a complex architectural shape that 
contains channels for the flow of nutrients within and throughout their community (DeBeer, 
Stoodley and Lewandowski, 1994). Naturally occurring biofilms are difficult to fully characterize, 
for example only 4% of the bacterial cells living in biofilm communities in dental units water 
lines (DUWL) are cultivable, with the rest being non-cultivable or dead (Barbeau et al., 1996; 
Barbeau, Bokum and Gauthier, 1998). Biofilms can adhere to solid surfaces at the liquid-solid 
interface and can also form floating biofilms called pellicles in the liquid-air interface of static 
cultures (Bryers, 2008; Cava et al., 2011; Kolodkin-Gal et al., 2012). Biofilm formation in medical 
and industrial settings have been problematic, this is due to the adverse effects of the 
pathogens they can potentially harbor on public health (Rowland and Voorheesville, 2003), and 
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due to their negative interference with the mechanical functions of industrial settings (Torres et 
al., 2012). 
The typical ‘life cycle’ of a biofilm can be summarized in five main cyclical stages: free 
planktonic cells, initial attachment, early biofilm, mature biofilm, biofilm disassembly. After 
biofilm disassembly, many bacteria return to their original free planktonic form (Palmer and 
White, 1997; O’Toole, Kaplan and Kolter, 2000). Environmental stress promotes biofilms 
formation with the availability of nutrients being the main driving force; some other 
environmental factors can affect biofilm formation such as temperature, pH, iron, and oxygen 
with all these factors being microorganism specific (O’Toole, Kaplan and Kolter, 2000).  At late 
stages of the mature biofilm, bacterial cells have been reported to secrete small molecules such 
as polyamines and D-amino acids. These molecules have been reported to target the 
exopolysaccharides and protein fibers in the extracellular matrix that connect the bacterial cells 
in the biofilm, initiating the biofilm disassembly and the release of planktonic cells and bacterial 
spores as a survival mechanism. Released planktonic cells and spores will migrate to find 
another favorable location and initiate a new biofilm community (Kolodkin-Gal et al., 2010, 
2012).  
Controlled studies are typically undertaken with single species biofilms. The timeline of 
such lab experiment can differ substantially from natural biofilms (Jahid et al., 2015). The life 
span of biofilms formed by Bacillus subtilis in lab studies is in the order of days (Kolodkin-Gal et 
al., 2010, 2012; Hobley et al., 2014), while biofilms in natural environments can form over 
longer durations (Jahid et al., 2015). In lab studies biofilms of B. subtilis can matures in three 
days, and after eight days it disassembles and start releasing the free planktonic cells (Kolodkin-
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Gal et al., 2010; Romero et al., 2011). Biofilms formed over longer durations exhibited some 
variations from biofilms formed over short durations (i.e. higher tolerance to harsh 
environments) (Jiang et al., 2017) .  
Polyamines are believed to function as growth factors in microorganisms, thus they are found 
naturally in all types of bacteria and in most animal cells (Tabor and Tabor, 1984). There has 
been  an increased  interest in the recent years in polyamines due to their debated role in 
biofilm formation (Hobley et al., 2014; Nesse, Berg and Vestby, 2015; Cardile et al., 2017).  
There exists today some high-profile controversy among researchers on the interactions 
between the polyamine norspermidine and biofilms formed by B. subtilis. It was initially 
identified as an agent involved in biofilm disassembly in a highly-cited study, which was later 
retracted (Kolodkin-Gal et al., 2012). While other researchers proposed norspermidine to play 
an essential role in the formation of a robust biofilm of the same organism (Hobley et al., 2014). 
There is a lack of quantitative studies on the interaction between norspermidine and biofilm 
formation. It was therefore the objective of this study to clarify the effects of norspermidine on 
Bacillus sp. biofilm formation by investigating its effect on biofilms of different viable states.  
3.2.3. Experimental Procedures 
3.2.3.1. Materials 
3.2.3.1.1 Macronutrients Concentrate 
To prepare 100 mL macronutrients, 100 mL DI-Water, 1.9 g MgCl2, 1.03 g CaCl2.2H2O, 0.1 g 
MnCl2.4H2O, 0.1 g FeCl2.4H2O, 0.0014 g ZnCl2, sterile filter. 
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3.2.3.1.2 Amino Acids and Thiamine Concentrate 
To prepare 100 mL, 100 mL DI-Water, 0.5 g L-tryptophan, 0.5 g L-phenylalanine, 0.5 g L-
threonine, 0.006 g Thiamine-HCL, sterile filter. 
3.2.3.1.3 10X Tbase 
To prepare 250 mL, 4.95 g (NH4)2SO4 (0.15M ammonium sulphate), 34.84 g K2HPO4 (0.8M 
potassium phosphate dibasic), 14.97 g KH2PO4 (0.44M potassium phosphate monobasic), 2.5 g 
Trisodium citrate (34 mM sodium citrate), add DI-Water to bring the total volume to 250 mL, 
autoclaved for 20 min. 
3.2.3.1.4 Biofilm Growth Media 1 (BGM1) 
To prepare 1 L, 900 mL of DI-Water, 10 g tryptone, 10 g NaCl, 5 g yeast extract, 0.04 g D-
glucose), 0.012 g MgSO4, and finally add 10 mL of 10X Tbase, autoclave for 20 min. 
3.2.3.1.5 Biofilm Growth Media 2 (BGM2) 
To prepare 1L, 0.871 g K2HPO4, 20.9 g MOPS free acid, 2 mL of 10M KOH, 5 g glycerol, 5 g 
glutamic acid, bring volume to 1L using DI-Water, sterile filter the mixture, remove 1 mL from 
the mixture and add 1 mL micronutrients concentrate, remove 1 mL from the mixture and add 
1 mL amino acids and thiamine concentrate. 
3.2.3.1.6 Wash Buffer (Sterile) 
To prepare 1 L, 900 mL DI-Water, 1 ml of 1M MgSO4, 100 mL of the 10X Tbase solution, 
autoclave for 20 min. 
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3.2.3.1.7 Crystal Violet Stain 
To prepare 1 L of 0.1 % (w/v) crystal violet stain, 1 gm of crystal violet powder, 1 L of wash 
buffer. Stir the mix until the crystal violet dissolve completely. 
3.2.3.1.8 Sodium Phosphate Buffer (SPB) 
To prepare sodium phosphate buffer at pH 7.6, first prepare 60 mM of Na2HPO4.7H2O solution 
by dissolving 16.1 g in 1 L DI-Water, then prepare 60 mM of NaH2PO4.H2O solution by dissolving 
8.28 g in 1L DI-Water. Mix the two solutions until the desired pH is obtained (the desired pH 
was obtained by mixing 12.5 mL of 60 mM Na2HPO4.7H2O to 1 mL of 60 mM NaH2PO4.H2O). 
3.2.3.2. Methods 
3.2.3.1.9 Bacterial Strain 
The bacterium used in this research is a Bacillus sp. known commercially as Unizyme 20X CSB 20 
NF SPORE, obtained from Germiphene Inc. Brantford, Ontario, Canada. 
3.2.3.1.10 Seed Culture Preparation (sterile procedure) 
Four milliliters of Bacillus sp. spore suspension are poured into a small vial. Using a pipette 1 mL 
of the poured spore suspension is transferred into a sterile microcentrifuge vial, centrifuge at 
10,000 rounds per minute for 60 seconds. At this point, bacterial spores should be visible to the 
naked eye as a white precipitated powder in the bottom of the vial.  The supernatant is 
removed and 1 mL wash buffer is added. The vial is then mixed using a vortex until the bacterial 
spores are completely dissolved, following that the sample is centrifuged again, pour off the 
supernatant, another 1 mL of wash buffer is added, vortex again, centrifuge, pour off 
supernatant. Now the spore suspension is washed two times using the wash buffer. One 
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milliliter of biofilm growth media is added to the vial containing the washed Bacillus sp. spores 
and the sample is mixed using a vortex until completely dissolved.  Half a milliliter of the 
Bacillus sp. washed spores and re-suspended in biofilm growth media is added into a sterile 125 
mL flask with a cover that contains 20 mL of biofilm growth media and a stir bar. The mixture is 
then placed on the magnetic stirrer at 300 rounds per minute inside a 37 oC humidified 
incubator oven for 270 min until optical density at 600 nm is between 1 and 1.6 when Milli-Q 
water is used as blank. 
3.2.3.1.11 Inoculating the Microtiter Plates with Seed Culture (sterile procedure) 
Biofilm was grown in microtiter plates, a common method used in biofilm related studies 
(Kolodkin-Gal et al., 2012; Hobley et al., 2014; Liu et al., 2015). A 200-mL glass petri dish with a 
flat bottom is filled with biofilm growth media (each plate requires 10 mL) and a stir bar. The 
prepared Bacillus sp. seed culture is then diluted in a 1:100 ratio in biofilm growth media. The 
petri dish is then placed on a magnetic stirrer at 300 rpm. It should be assured that no bubbles 
are formed, if that happens the rpm should be lowered until no more bubbles are formed. A 
multichannel pipette is then used to transfer 100 µL from the petri dish while stirring into wells 
in the microplates. Also, 100 µL of sterile biofilm growth media are transferred into control 
wells. Each plate is then covered with a sterile thin film (25 µm) to seal it and reduce 
evaporation, one hole is poked in the center of each well using a 22-gauge sterile needle. 
Separate needles should be used for each of the inoculated wells and control wells to ensure no 
cross contamination will occur. The microplates are then incubated at 37 oC humidified oven in 
static conditions for 32 h. Following that, plates are washed with wash buffer. 
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3.2.3.1.12 Washing Microtiter Plates with Buffer Solution 
The thin film placed on the microplate is removed and then the microplate is placed in the 
Tecan Hydroflex Plate Washer. Each well in the plate is filled with 100 µL of wash buffer 
solution using the drip mode and then wash buffer is aspirated. This will remove the remaining 
media and free cells (Stepanović et al., 2000). The device must be calibrated not to touch the 
sides or the bottom of the wells. Following that 150 µL of wash buffer solution is dispensed and 
aspirated same as the previous step, the process is repeated for a total of three times. Finally, 
the microtiter plate is gently flicked and the face of the microtiter plate is turned facing down 
on a paper towel to release any excess liquid. 
3.2.3.1.13 Fixing Biofilm Growth 
This step in performed to fix initial biofilm growth that will be compared with the biofilm 
remaining in other wells after applying treatment to them. Fixed biofilms are assumed to be 
nonactive or dead. This process is repeated at the end of the treatment duration to treated 
wells and prior to biofilm quantification. Using a multichannel micropipette, the volume of 200 
µL of methanol (99%) are dispensed into desired wells. The microtiter plate is then covered 
with aluminum foil to prevent evaporation. After 20 min, the methanol is removed using the 
multichannel micropipette. Plates are then left to air dry at room temperature (Stepanović et 
al., 2000; Kwasny and Opperman, 2010). 
3.2.3.1.14 Applying Treatments 
After the thin film is removed and the wells are washed with the buffer solution. Treatment is 
applied by dispensing 125 µL of treatment solution into desired wells using the multichannel 
micropipette. The microtiter plates are then covered with thin film and holes are poked in the 
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center of each well using the 22-gauge sterile needle as described previously. The microtiter 
plates are then incubated in a humidified oven with the temperature set at 37 oC for the 
decided treatment duration. 
3.2.3.1.15 Total Biofilm Quantification Using Crystal Violet Stain 
  Crystal violet binding assay has been used in abundant by researchers to quantify biofilms 
formation from gram-positive bacteria such as Bacillus Subtilis (O’Toole, Kaplan and Kolter, 
2000; Kolodkin-Gal et al., 2010, 2012; Brandenburg et al., 2013). This method was initially 
described by Christensen et al. 1985, which was followed with many improvements to increase 
its accuracy and to allow biofilm quantification in the microtiter plate wells (Stepanović et al., 
2000).Crystal violet is a basic dye that binds to the exopolysaccharides and negatively charged 
surface molecules and stains them with a violet color, following that crystal violet can be easily 
resolubilized using an acetic acid solution(Li, Yan and Xu, 2003; Negri et al., 2010). Due to the 
fact that crystal violet binds to both dead and alive cells in addition to the extracellular matrix, 
this method remains not suitable for evaluating the ability to kill biofilm cells or to measure 
disinfectants efficiencies on biofilms (Li, Yan and Xu, 2003).  
To quantify biofilm formation in the microtiter plates, 150 µL of 0.1 % (W/V) crystal violet is 
dispensed into each well using the multichannel micropipette. The microtiter plate is covered 
to prevent evaporation and incubated at room temperature for 60 min (Stepanović et al., 2000; 
Kwasny and Opperman, 2010). Microtiter plates are washed 4 times by dispensing 200 µL DI-
water in drip mode and aspirating using the Tecan Hydroflex plate washer (washing the plates 4 
times have proven to produce a washing waste liquid that is free of stain). Microtiter plates are 
then left to air dry at room temperature. The crystal violet is then resolubilized by dispensing 
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200 µl 30% acetic acid into each well using the multichannel micropipette (Stepanović et al., 
2000). The microtiter plates are then covered and incubated without shaking at room 
temperature for 20 min. Using the multichannel pipette, transfer 100 µL from each well to new 
hard polystyrene plate with the clear flat bottom for quantification. Absorbance at OD 570 nm 
is measured using a TECAN infinite M200 Pro plate reader (Stepanović et al., 2000). The mean 
OD 570 nm value for the media only controls is subtracted from the OD 570 nm of the treated 
wells, this represents the environmental noise in the measurements.  
3.2.3.1.16 Biofilm Viability Using Fluorescein Diacetate 
Biofilm viability following treatment will be measured using the fluorescein diacetate (FDA) 
method. The FDA method has been used by several researchers for viability measurements 
(Clarke et al., 2001; Wanandy et al., 2005; Armour, Powell and Boyce, 2008).  A stock solution 
of FDA is prepared with a concentration of 10 mg mL-1 FDA in acetone. FDA Stock solution 
samples are then stored in the freezer at -80 oC. 
The prepared FDA stock solution samples are taken out from the -80 oC freezer. The FDA stock 
solution is then diluted (1:50) using sodium phosphate buffer (60 mM, pH 7.6), this will result in 
a 0.2 mg mL-1 FDA concentration. Using a multichannel pipette, 100 μL of the sodium 
phosphate buffer (60 mM, pH 7.6) is dispensed into each tested well. The diluted FDA stock 
solution is vortexed and then 100 μL is dispensed into each tested well (FDA concentration in 
each well is now 0.1 mg mL-1). Microplates are covered with thin film and a single hole is poked 
at the center of each tested well. The microplates are then covered with foil for darkness and 
incubate at 37 oC for 1 h with shaking at 150 rpm. Transfer 100 μL from each well to a rigid flat 
bottom black fluorescent plate for reading. All fluorescence measurements were quantified 
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using M1000 Plate Reader (λ excitation = 405 nm, λ emission = 520 nm, top mode, optimal gain, and 
no lid). The response of the assay is enhanced by norspermidine addition; hence a washing step 
was introduced prior to the addition of FDA. The effectiveness of the washing was verified 
experimentally (data not shown).  
3.2.3.1.17 HPLC analysis 
The supernatant in the microtiter plates was collected following the formation of biofilms 
amended with different concentrations of norspermidine. Samples collected and prepared 
standards were benzoylated using the procedure explained in Morgan (1998) (Morgan, 1998). 
In the benzoylation process, a benzene ring is attached to the polyamine to be able to detect it 
using the HPLC system. The HPLC analysis utilized an Agilent 1260 Infinity instrument equipped 
with an autosampler and an Agilent 1260 Infinity Diode Array Detector (DAD) for UV-detection 
set at 229 nm. The column used was a ZORBAX 300SB-C18 (4.6 x 250mm, 5µm). The sample run 
duration was 10 min, isocratic with 45% acetonitrile in water, sample injection volume of 40 µL, 
flow rate of 0.8 mL/min, and the column temperature was 25 oC. 
3.2.4. Results 
3.2.4.1. Biofilm Formations in Different Microtiter Plates are Comparable 
All biofilm studies were conducted by cultivating Bacillus sp. in microtiter plates based 
on a modified method (Stepanović et al., 2000; Branda et al., 2001; Kwasny and Opperman, 
2010). Reproducibility of biofilm growth and removal within the envisioned parameter space is 
crucial.  It was therefore evaluated first, in order to validate comparisons between different 
wells within the same microtiter plate and between different microplates prepared from the 
same batch. Biofilm growth was quantified in 80 wells per plate in three separate plates 
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following a 32 h incubation time. A one-way ANOVA test was performed for inter-plate 
comparison of biofilm formation after 32 h incubation time. The results showed no significant 
difference (p-value = 0.34) among the three plates.  The average biofilm formations in the three 
plates (based on 80 wells/plate) with a 95-per-cent confidence interval were 1.66 ±0.041, 1.69 
±0.037, and 1.71 ±0.043 Absorbance Units (based on crystal violet staining assay), respectively. 
The standard deviation between the three different plates’ averages was found to be 0.022.  
3.2.4.2. Biofilm Formation Increased for Active Biofilms in the Presence of Norspermidine, 
Crystal Violet Staining. 
 
Figure 3-1.  Biofilm Formation Increased Following the Addition of Norspermidine to Active 
Biofilm. 
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To investigate the effects of norspermidine on active biofilm, microtiter plates were 
inoculated with Bacillus sp. and the biofilm was grown for 32 h at 37oC. Following that, the 
plates were washed to remove existing media and one column (8 wells) was inactivated and 
fixed using methanol (the fixed column represent initial biofilm growth) (Stepanović et al., 
2000). The remaining wells in the microtiter plates were then filled with 150 µL fresh media 
(BGM2, only promoting slow biofilm formation compared to BGM1) and different 
concentrations of norspermidine and incubated at 37oC for an additional 24 hrs. At the end of 
the treatment time, the amount of biofilm was quantified. 
The results of the quantification (crystal violet staining analysis, Figure 3-1) show that additional 
biofilm formation occurred (denoted with 0 mM norspermidine in Figure 3-1) when compared 
to the biofilm that was fixated after 32 h. The amount of biofilm increased with increasing the 
amount of norspermidine in the medium, up to 73% at 1 mM norspermidine. 
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3.2.4.3. Biofilm Formation Decreased for Nonactive Biofilms in the Presence of 
Norspermidine, Crystal Violet Staining. 
 
Figure 3-2. Biofilm Formation Decreased Following the Addition of Norspermidine to Fixed 
Biofilm. 
The effects of norspermidine on non-active biofilm was investigated in a similar way as 
described above, only that all wells were inactivated with methanol. Quantification of the 
biofilm after incubation in the presence of norspermidine (crystal violet staining) is shown in 
Figure 3-2. Under the employed conditions, a slight decrease was observed in the amount of 
quantifiable biofilm for the control wells without norspermidine, while this effect was 
substantially increased with increasing concentrations of norspermidine. Up to 39% removal 
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was achieved for the norspermidine concentration of 1 mM on fixed, non-active biofilm (Figure 
3-2). 
3.2.4.4. Norspermidine in Growth Media was Consumed When Added to Active Biofilms 
 
Figure 3-3. Norspermidine Concentration following 24 h Norspermidine Treatment Decreased 
with Active Biofilm, But Not for Nonactive Biofilm. Error bars represent 95% confidence interval 
(n=12). 
In order to understand the nature of the interaction between norspermidine and the 
biofilm, the supernatant remaining in the microtiter plates following the 24 h treatment was 
collected and analyzed for remaining norspermidine via HPLC (Morgan, 1998). It can be seen 
from Figure 3-3 that the amount of supplemented norspermidine was reduced in the active 
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biofilm samples. Residual norspermidine could be detected, however, the more biofilm was 
formed (Figure 3-1), the more norspermidine was reduced (Figure 3-3). This effect was not 
observed in the presence of inactive biofilm (fixed), where the norspermidine concentration 
after incubation is similar to the initially available amount. 
3.2.4.5. Verification of Previous Results with Secondary Activity Assay (FDA testing) 
The biofilm quantification via crystal violet staining, does not discriminate between 
living or dead cells. The observed increase in biofilm formation in the presence of 
norspermidine was therefore further investigated through the fluorescein diacetate (FDA) 
viability assay. 
 
Figure 3-4. Norspermidine Addition Enhanced Biofilm Viability. 
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The intra-plate reproducibility of the FDA testing was evaluated to validate the 
comparison between the different treatments within the same microtiter plate. Biofilm grown 
within the same microtiter plate under the same conditions was tested using the FDA method. 
A one-way ANOVA test was performed for intra-plate comparison of biofilm viability. The 
results showed no significant difference (p-value = 0.19) among the ten-tested columns (each 
column contain 8 wells) within the same microtiter plate (data not shown).   
Following the growth of biofilms for 32 h, norspermidine treatment was applied with different 
concentrations for 24 h.  The biofilm grown in the microtiter plates was washed five times using 
sodium phosphate buffer saline, this was to assure that norspermidine was not left behind, 
interfering with the FDA test results. Following that, the enzymatic activity of the biofilm was 
measured using the FDA viability test and the results are presented in  Figure 3-4. Biofilm 
treated with higher concentration of norspermidine showed higher enzymatic activity with a 
significant difference between concentrations of 0 and 1 mM norspermidine. The data follows 
the same trend as the data generated through total biomass quantification via crystal violet 
staining (Figure 3-1), hence verifying via a different detection mechanism. 
3.2.5. Discussion 
 The effect of increased norspermidine concentrations on active biofilm was associated 
with an increase in biofilm formation (Figure 3-1). No inhibitory effects were detected for 
norspermidine concentrations on biofilm formation, up to 1 mM. These results appear to be in 
contradiction with findings reported by Kolodkin-Gal et al. (2012), showing that an inhibitory 
effect of norspermidine on biofilm formation at concentrations as low as 0.05-0.08 mM. While 
the results of this study partially agreed with Hobley et al. (2014) whom found that the addition 
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of norspermidine at concentrations 0.01- 0.025 mM resulted in more robust biofilm formation, 
they also reported inhibitory effects on biofilm formation at concentrations higher than 0.25-
0.30 mM, which was not observed here. The results obtained in Figure 3-1 suggests that 
norspermidine addition can be beneficial in situations where rapid biofilm growth is favored. 
Norspermidine can also be utilized in other applications were biofilm formation is beneficial 
(i.e. plant biocontrol agents, inhibitor of mild steel corrosion, bioreactor, and bioremediation) 
(Morikawa, 2006), for more information please refer to Morikawa (2006). 
Naturally occurring polyamines, such as, spermidine and spermine, are reported in higher 
concentrations in fast growing tissues and are involved in the process that controls cellular 
growth in prokaryotic cells such as bacteria (Tabor and Tabor, 1984; Rodriguez-Garay, Phillips 
and Kuehn, 1989). Polyamines modulate membrane fusion and protect the functionality and 
structural integrity of the bacterial organisms (Meers et al., 1986; Marton and Morris, 1987). 
Since the shorter polyamine, norspermidine can replace the essential role of spermidine in the 
formation of robust biofilms (Burrell et al., 2010; Hobley et al., 2014), this provides a possible 
explanation for the increase in biofilm formation associated with the increase of norspermidine 
concentration (Figure 3-1). The biological utilization of norspermidine in different cellular 
processes offers a possible explanation for the increase in biofilm formation, which was 
associated with the depletion of norspermidine concertation in the supernatant extracted from 
the microtiter plate wells containing actively growing biofilms (Figure 3-3), and an increase in 
viability of the biofilm (Figure 3-4). 
Previous researchers have referred to norspermidine as a biofilm disassembly agent that 
prevents biofilm formation and disassembles pre-existing biofilm (Kolodkin-Gal et al., 2012; 
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Böttcher et al., 2013; Oppenheimer-Shaanan, Steinberg and Kolodkin-Gal, 2013). This apparent 
contradiction can likely be contributed to the different vital stages of the biofilms in question.  
This study clearly shows that norspermidine accelerates biofilm dissolution when its biological 
activities were artificially stopped by fixing the biofilm using methanol.  The results of the 
interactions between norspermidine and the pre-existing nonactive biofilm are the direct 
opposite of the results found with the active biofilm.  Since the biofilm was no longer actively 
growing, the interaction between the added norspermidine concentrations and the nonactive 
(fixed) biofilm was of a pure chemical nature and it is assumed that no biological process take 
place. When the concentration of added norspermidine increased, the pre-existing nonactive 
(fixed) biofilm removal increased (Figure 3-2). It is reported that norspermidine targets the 
exopolysaccharides component in the biofilm. Norspermidine binds to the negatively charged 
groups (i.e. uronic acid) or to the neutral sugars with polar groups (i.e. poly-N-
acetylglucosamine) in the secondary structure of the exopolysaccharides through Coulombic 
attraction and hydrogen bonding (Kolodkin-Gal et al., 2012; Oppenheimer-Shaanan, Steinberg 
and Kolodkin-Gal, 2013). These interactions between polyamines and biofilms are structure and 
charge specific; only polyamines with three methylene groups and flanked by two amino groups 
that are positively charged were successful in dismembering the biofilms (i.e. norspermidine, 
norspermine, …etc) (Kolodkin-Gal et al., 2012). The aforementioned mechanism provides a 
possible explanation for the removal of the pre-existing nonactive (fixed) biofilm noticed in 
Figure 3-2 following the addition of norspermidine. 
88 
 
3.2.6. Conclusions  
Based on these results, with regards to biofilm formation and disassembly, it could be 
concluded that norspermidine can serve two functions. When norspermidine was added to an 
active biofilm, the biofilm formation increased due to the biological utilization of 
norspermidine, with no inhibition of biofilm formation at concentrations as high as 1 mM. On 
the other hand, when norspermidine was added to a pre-existing nonactive (fixed or dead) 
biofilm, biofilm formation was disassembled due to chemical interactions between 
norspermidine and the exopolysaccharides part of the biofilm. The results obtained in this 
research emphasizes that when it comes to investigating and testing of biofilm removal agents, 
the biological activity of the biofilm must be carefully considered. The interaction between the 
biofilm and norspermidine was dependent on its biological activity. When added to an active 
biofilm, biological process dominated the chemical interaction between norspermidine and the 
exopolysaccharides, which resulted in the increase of biofilm formation (Figure 3-1). The 
chemical interaction between the exopolysaccharides and norspermidine were likely not 
significant until the biological processes had ceased (after fixing the biofilm with methanol) and 
this resulted in the disassembly of the pre-existing nonactive biofilm (Figure 3-2) due to the 
interactions between norspermidine and the exopolysaccharides in the pre-existing biofilm. The 
fluorescein diacetate testing results also supported these findings. 
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3.3.1. Preface 
Section 3.3 presents the experimental work performed to fulfill the specific objective 
presented in Section 1.3.2.2. The presented results in Section 3.3 provided a quantitative 
evaluation of biofilm removal using D-amino acids. The results obtained in Section 3.3 suggests 
that D-amino acids have limited biofilm removal capabilities, while they were found to be more 
suitable for inhibiting biofilm growth. No clear synergetic effects were noticed from the 
combined treatment. 
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3.3.2. Introduction 
Biofilms are multicellular communities formed by bacterial aggregation on surfaces. The 
bacterial cells within the biofilm are connected together by an extracellular matrix consisting of 
exopolysaccharides, protein fibers, and DNA (Costerton, Stewart and Greenberg, 1999; Donlan, 
2002; Hall-Stoodley, Costerton and Stoodley, 2004). The formation of biofilms is vital for 
bacterial survival and a natural part of their life cycle, they protect the bacterial cells living 
within from harsh environments, they also provide optimal positioning for the bacterial cells 
living within to access nutrients (DeBeer, Stoodley and Lewandowski, 1994; Costerton, Stewart 
and Greenberg, 1999). Bacterial cells in aquatic systems can form biofilms on both biotic and 
abiotic surfaces. They can adhere to solid surfaces at the liquid-solid interface, and they can 
form floating biofilms known as pellicles at the liquid-air interface (Hall-Stoodley, Costerton and 
Stoodley, 2004; Bryers, 2008; Cava et al., 2011). The main driving force for biofilm formation is 
the availability of nutrients. Environmental stress promotes biofilm formation, factors such as 
temperature, pH, iron, and oxygen affects biofilm formation, although they are microorganism 
specific (O’Toole, Kaplan and Kolter, 2000). The architectural shape of biofilms is complex, it 
contains channels  for the flow of nutrients within and through their community (DeBeer, 
Stoodley and Lewandowski, 1994). In addition to connecting the bacterial cells together, the 
extracellular matrix connects the bacterial cells to the surface, this will form the initial biofilm 
which will grow to a mature biofilm and adapt to its surrounding environment. The bacterial 
cells within the biofilm at this point are characterised by an increase synthesis of 
exopolysaccharides, UV light tolerance, higher antimicrobial resistance, and formation of 
bacterial spores (Habash and Reid, 1999; O’Toole, Kaplan and Kolter, 2000; Hall-Stoodley and 
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Stoodley, 2002; Rowland and Voorheesville, 2003; Garrett, Bhakoo and Zhang, 2008; Coleman 
et al., 2010; Vlamakis et al., 2013).  
One example of problematic biofilms is the potential pathogenic biofilm that form in dental 
settings. Several researchers have reported the formation of pathogenic biofilms in dental 
settings. Biofilms can form in sinks, tanks, suction hoses, tubing, pipes, handpieces, air and 
water syringes, and ultrasonic scalers (Barbeau, Bokum and Gauthier, 1998; Coleman et al., 
2009, 2010). Different pathogenic microorganisms (viruses, bacteria, algae, and fugai) can be 
found inside biofilms (Coleman et al., 2010; Vasickova et al., 2010). Pathogenic biofilms are 
responsible for high contamination levels in water used for invasive procedures in dental clincs 
(Barbeau et al., 1996; Barbeau, Bokum and Gauthier, 1998).  In dental clinics, cross-
contamination among different patients with pathogens released from biofilms can occur 
through aerosols from dental tools, and from tubing backflow in wet dental devices such as the 
evacuation system. These dental tools are used to drain blood, tissue, saliva, and other debris 
from dental procedures (Barbeau, Bokum and Gauthier, 1998).  Biofilm growth inside dental 
settings can have adverse effects on dental equipment by interfering with their mechanical 
functions, and clogging tubes and pipes. Based on the aforementioned, it is a major concern to 
control biofilm formation in dental clinics to protect both the patients and the dental settings 
(Barbeau et al., 1996).   
When the biofilm is mature, bacterial cells will secrete small molecules such as amino acids 
and polyamines. These small molecules will target the exopolysaccharides and protein fibers in 
the extracellular matrix, which initiates the biofilm disassembly and the release of bacterial 
spores and free planktonic cells (Kolodkin-Gal et al., 2010, 2012). Biofilms formed from Bacillus 
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subtilis mature after three days incubation in biofilm growth medium at 22 oC, and after eight 
days the biofilm disassembles and release free planktonic cells (Kolodkin-Gal et al., 2010; 
Romero et al., 2011).     
Bacteria has high resistance to physical, biological, and chemical assaults, this is due to their 
peptidoglycan call wall (also known as the murein), in most bacteria it is located outside the 
cytoplasmic membrane (Park, 1996; Holtje, 1998; Nanninga, 1998).  The peptidoglycan cell wall 
is a strong and flexible polymer with a net-like shape, composed from short polypeptides 
(proteins) that cross link linear glycan strands (formed from disaccharide chains) (Cava et al., 
2011). The peptidoglycan cell wall has many benefits such as protecting the contents of the 
bacterial cell, resists osmotic pressure, holds the bacterial cell shape, and provides a framework 
to anchor the components of the cell envelop (Holtje, 1998; Young, 2006; Dramsi et al., 2008; 
Vollmer, Blanot and de Pedro, 2008). One interesting fact about the polypeptides in the 
peptidoglycan cell wall is that they contain D-amino acids (Nagata et al., 1998). These D-amino 
acids help forming the structure of peptidoglycan cell wall and provide it with resilience to 
different proteases (Cava et al., 2011). The two most common D-amino acids found in the 
peptidoglycan cell wall are D-alanine and D-glutamate, other D-amino acids have been reported 
also such as D-serine and D-asp (Sieradzki and Tomasz, 1996; Reynolds and Courvalin, 2005; 
Bellais et al., 2006; Veiga et al., 2006). Their incorporation into the peptidoglycan cell wall is 
believed to increase its resistance to antibacterial agents (de Lencastre, Oliveira and Tomasz, 
2007). 
Previous researchers presented evidence that D-amino acids are produced by Bacillus 
subtilis to dismember their own biofilms at a late stage of the biofilm life cycle (Kolodkin-Gal et 
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al., 2010). The release of D-amino acids is triggered by the accumulation of metabolic waste 
and the low concentration of nutrients, at this point it is more favourable for the bacteria to 
dismember its biofilm, and release free planktonic cells that will migrate to a new favorable 
location to establish a new biofilm (Karatan and Watnick, 2009).  The D-amino acids D-tyrosine, 
D-leucine, D-tryptophan, and D-methionine have shown promising results in biofilm growth 
inhibition (Lam et al., 2009; Kolodkin-Gal et al., 2010; Leiman et al., 2013). The probability that 
D-amino acids can be used to control biofilm formation is significantly promising due to the lack 
of toxicity and the favorable pharmacokinetic properties of D-amino acids (Jayaraman and 
Wood, 2008). 
Kolodkin-Gal et al. 2010, have reported self produced D-amino acids in the growth medium 
of mature biofilms. The results of their study showed that to inhibit biofilm formation by 
Bacillus subtilis a minimum concentration of 2 mM, 8.5 mM, 5 mM, and 3 µM is required for D-
methionine, D-leucine, D-tryptophan, and D-tyrosine respectively. Their results also showed 
that a mixture of the four mentioned D-amino acids was potent to biofilm growth and can 
dismember pre-existing biofilms. The researchers suggested that the D-amino acids will be 
miss-incorporated into the cell wall and disengage the biofilm. They reported that the 
corresponding L-amino acids did not have any effect on Bacillus subtilis biofilm disassembly. It 
was also reported that D-alanine did mitigate the inhibitory effects of the four mentioned D-
amino acids. Similar results were obtained, by the same researchers, when the treatments were 
tested on biofilms of Pseudomonas aeruginosa. The researchers also suggested that the 
interaction between the D-amino acids and the protein amyloid fibers is not the only way by 
which D-amino acids disassemble biofilms. As they found that D-amino acids were successful in 
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dispersing biofilms from bacterial species that are not known to have amyloid protein fibers 
such as Pseudomonas aeruginosa (Kolodkin-Gal et al., 2010).    
Another study by Leiman et al. 2013 stated that D-leucine, D-tryptophan, D-tyrosine, and D-
methionine can inhibit biofilms formed by Bacillus subtilis. The minimum reported 
concentrations required to inhibit biofilm formation for D-leucine, D-tryptophan, and D-
tyrosine were 8.5 mM, 5 mM, and 6 µM respectively, while no information was provided for D-
methionine. The researchers suggested that the four mentioned D-amino acids interfere with 
protein synthesis by their misincorporation into the process, which results in the inhibition of 
the biofilm growth. The researchers stated that D-tyrosine is a metabolic inhibitor for Bacillus 
subtilis. It was also suggested that the inhibitory effects of the D-amino acids on Bacillus subtilis 
biofilm can be mitigated in the presence of L-amino acids. They also reported that a mixture of 
the four D-amino acids at a concentration higher than that obtained by Kolodkin-Gal et al. 2010 
was required to inhibit biofilm formation. The results they obtained also showed that the 
inhibitory effects of the four D-amino acids on biofilm formation were not countered in the 
presence of D-alanine. Moreover, they found that the presence of L-tyrosine did counter the 
inhibitory effects of the four D-amino acids (Leiman et al., 2013). These results contradict the 
findings of Kolodkin-Gal et al. 2010.  
Brandenburg et al. 2013, investigated the effects of amino acids on the formation and motility 
of biofilms produced by Pseudomonas aeruginosa. The results obtained in their study showed 
that only D-tyrosine and D-tryptophan had inhibitory effects at concentrations of 2.5 mM for 
each, with the latter being most effective. The biofilm growth was enhanced with the addition 
of D-methionine with concentrations between 2.5 and 10 mM. The addition of D-leucine with 
102 
 
concentrations between 2.5 and 10 mM had no significant effect on biofilm formation. 
Moreover, at a concentration of 10 mM, both D-tryptophan and L-tryptophan were found to be 
effective in inhibiting biofilm growth, with L-tryptophan being more effective than D-
tryptophan in inhibiting biofilm formation (86% and 71% respectively). A mixture containing an 
equimolar ratio of both tryptophan isoforms with a total concentration of 10 mM tryptophan 
had higher inhibitory effects (93% at 24 hr), which contradicts what was reported by the two 
previously mentioned studies. The researchers hypothesised that tryptophan enhances the 
swimming motility (~40%) of bacterial cells by enhancing the flagellar activity of the bacterial 
cells which will prefer to detach from the biofilm and swim freely, consequently resulting in the 
inhibition of biofilm growth and promoting biofilm disassembly (Brandenburg et al., 2013).  
Even though previous research has provided abundant information on the interactions 
between D-amino acids and biofilms, there is a lack of quantitative studies on the ability of D-
amino acids to remove pre-exiting biofilms. In this research, the effects of D-amino acids on 
biofilm formation and the dispersion of pre-existing biofilm will be further investigated. 
3.3.3. Experimental Procedures 
3.3.3.1. Materials 
3.3.3.1.1. Amino Acids and Thiamine Concentrate 
200 mL DI-Water, 0.012 g Thiamine-HCL, 1 g L-tryptophan, 1 g L-threonine, 1 g L-phenylalanine, 
the mixture was sterile filtered. 
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3.3.3.1.2. Macronutrients Concentrate 
200 mL DI-Water, 0.2 g MnCl2.4H2O, 0.2 g FeCl2.4H2O, 0.0028 g ZnCl2, 3.8 g MgCl2, 2.06 g 
CaCl2.2H2O, the mixture was sterile filtered. 
3.3.3.1.3. 10X Tbase 
116 mL of DI-Water, 1.25 g Trisodium citrate (34 mM sodium citrate), 2.48 g (NH4)2SO4 (0.15M 
ammonium sulphate), 7.49 g KH2PO4 (0.44M potassium phosphate monobasic), 17.42 g K2HPO4 
(0.8M potassium phosphate dibasic), the mixture was autoclaved for 20 min. 
3.3.3.1.4. Biofilm Growth Media 1 (BGM1) 
225 mL of DI-Water, 2.5 mL of 10X Tbase, 2.5 g tryptone, 0.01 g D-glucose, 2.5 g NaCl, 1.25 g 
yeast extract, 0.003 g MgSO4, the mixture was autoclaved for 20 min. 
3.3.3.1.5. Biofilm Growth Media 2 (BGM2) 
1 mL of 10M KOH, 0.44 g K2HPO4, 10.45 g MOPS free acid, 2.5 g glycerol, 2.5 g glutamic acid, 0.5 
mL amino acids and thiamine concentrate, 0.5 mL micronutrients concentrate, brought to a 
volume of 500 mL using DI-Water, the mixture is sterile filtered. 
3.3.3.1.6. Wash Buffer (Sterile) 
225 mL DI-Water, 25 mL of 10X Tbase, 0.25 ml of 1M MgSO4, the mixture was autoclaved for 20 
min. 
3.3.3.1.7. Treatments Preparation 
Treatments containing different concentrations of D-amino acids were prepared by dissolving 
appropriate amounts of the different D-amino acids in BGM2.   
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3.3.3.2. Methods 
3.3.3.2.1. Bacterial Strain 
The Bacillus sp. mixture used in this research is known commercially as Unizyme 20X CSB 20 NF 
SPORE, and it was provided by Germiphene Inc. 
3.3.3.2.2. Washing Bacillus sp. Spores 
Bacillus sp. spore suspension was washed three times. The washing procedure was performed 
by centrifugation at 10,000 rounds per minute for 1 min, the supernatant was removed and the 
spore concentrate was resuspended in 1 mL wash buffer using a vortex, this process was 
repeated twice, in the third time the resuspension was in 1 mL BGM1. This results in 1 mL 
washed Bacillus sp. spores.  
3.3.3.2.3. Seed Culture Preparation  
A glass flask (150 mL) containing 20mL BGM1 was then inoculated with 0.5 mL of the washed 
Bacillus sp. spores. The glass flask was then incubated at 37oC, stirring at 300 rounds per 
minute, inside a humidified incubator for approximately 270 min until the optical density 
measured at 600 nm was between 1 and 1.6. 
3.3.3.2.4. Inoculating the Microtiter Plates  
The Bacillus sp. seed culture was diluted in BGM1 (1:100), while stirring, 100 µL were 
transferred into each well in the microtiter plates. Controls were prepared by transferring 100 
µL of sterile BGM1 into the designated control wells. To reduce evaporation from wells, 
microtiter plates were covered with a sterile thin film, a single hole was poked in the thin film at 
the center of each well using a sterile needle (22-gage) for aeration. The microtiter plates were 
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incubated in static conditions inside a humidified oven at 37 oC for 32 hrs. At the end of the 
incubation time, the microtiter plates are washed three times with the wash buffer using the 
Tecan Hydroflex Plate Washer. 
3.3.3.2.5. Fixing Biofilm Growth 
Fixed biofilms are presumed to be dead or nonactive. This procedure is performed at two 
stages, first to the designated wells for initial growth to quantify the initial biofilm growth 
following the 32 hrs incubation, second to the designated treated wells in the microtiter plates 
to be able to quantify biofilm formation following the 24 hrs application of treatments 
(explained below).  The BGM1 was removed using the Tecan Hydroflex Plate Washer, and each 
well was incubated with 200µL methanol for 20 min. Microtiter plates are then placed on the 
bench top to air dry completely at room temperature (Stepanović et al., 2000; Kwasny and 
Opperman, 2010). 
3.3.3.2.6. Applying Treatments 
After the initial biofilm growth, the microtiter plates are washed and treatments were applied 
to the designated wells by dispensing 125 µL of treatment solutions into wells. The microtiter 
plates were then incubated for 24 hrs in the humidified oven with the same conditions 
described above.  
3.3.3.2.7. Total Biofilm Quantification Using Crystal Violet Stain 
The crystal violet binding assay is a method commonly used to quantify biofilms (O’Toole, 
Kaplan and Kolter, 2000; Kolodkin-Gal et al., 2010, 2012; Brandenburg et al., 2013; Zhang and 
Hu, 2013). To quantify the biofilm, 150 µL of 0.1 % (W/V) crystal violet was transferred into 
106 
 
each well in the microtiter plates, plates are covered using aluminum foil and incubated on 
bench top for 1 hr  (Stepanović et al., 2000; Kwasny and Opperman, 2010). Subsequently, the 
microtiter plates were washed 4 times using the Tecan Hydroflex plate washer by dispensing 
200 µL DI-Water in drip mode and aspirating, previous work showed that 4 times was sufficient 
for removing all excess (nonbinding) crystal violet stain. The microtiter plates are then left on 
bench top to air dry completely. The biofilm-binding crystal violet was then resolubilized by 
transferring 200 µL of 30% acetic acid into each well (Stepanović et al., 2000), the microtier 
plates are then covered with aluminum foil on bench top for 20 min at room temperature. 
Subsequently,100 µL from each well were transferred to clear flat bottom polystyrene plates 
for absorbance quantification at OD 570 nm using the plate reader (TECAN infinite M200 Pro).  
3.3.4. Results 
All treatments in this section were delivered to the biofilm in a solution that contained 
BGM2. When the treatment was only containing BGM2 without any D-amino acids, it was 
termed as zero concentration. Following the 32-hr incubation time, the designated wells for 
initial biofilm growth were treated with methanol, and it is termed as Fixed. Methanol 
treatment was done to kill the biofilm and preserve its initial growth to be used as a benchmark 
to compare it later with the treated biofilm and to be further used for biofilm removal 
calculations. This will allow to evaluate the effectiveness of the D-amino acid treatments in 
biofilm removal.  
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Figure 3-5.The effect of D-tyrosine on Bacillus sp. biofilm formation. 
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Figure 3-6. The effect of D-tryptophan on Bacillus sp. biofilm formation.  
It can be seen from Figure 3-5 and Figure 3-6 that D-tyrosine and D-tryptophan at 
concentrations of 5 mM and higher inhibited biofilm formation. The pre-existing biofilm was 
dispersed at concentrations of 10 mM and higher for both D-tyrosine and D-tryptophan. The 
increase in the concentration of both D-tyrosine and D-tryptophan was proportional with the 
amount of biofilm dispersion. For D-tyrosine and D-tryptophan, a concentration less than 5 mM 
did not show any significant inhibitory effects on biofilm formation. The maximum biofilm 
removal using D-tyrosine at 20 µM and D-tryptophan at 15 mM was 31% and 28% respectively.   
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Figure 3-7. The effect of D-methionine on Bacillus sp. biofilm formation. 
110 
 
 
Figure 3-8. The effect of D-leucine on Bacillus sp. biofilm formation. 
D-methionine and D-leucine were successful in inhibiting biofilm formation (Figure 3-7 
and Figure 3-8, respectively) at concentrations of 5 mM and higher. However, no significant 
reduction in the pre-existing biofilm was noticed. Moreover, the increase in their concentration 
did not seem to have any significant effect on biofilm control. No significant effects on biofilm 
formation were noticed for concentrations of 1 mM for both D-methionine and D-leucine. 
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Figure 3-9. The effect of D-amino acids mixture on Bacillus sp. biofilm formation. D-tyrosine 
concentration is in the units of µM while the remaining D-amino acids are in the units of mM. 
The results of D-amino acid mixture are presented in Figure 3-9. Results show that the 
D-amino acid mixture was successful in inhibiting biofilm formation for minimum 
concentrations of 5.  Significant reduction in the pre-existing biofilm was noticed for 
concentrations of 10 mM and higher of each. Moreover, the increase in the mixture 
concentration had a significant effect on biofilm control. Apparently, the D-amino acids mixture 
was the most effective treatment for biofilm control, the highest biofilm removal was 39% at 
concentrations of 20. No significant effect was noticed on the biofilm removal for 
concentrations less than 5. 
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3.3.5. Discussion 
Biofilm control do not require the development of treatments that can only kill biofilms 
without removing them. The desired treatments for biofilm control will have the ability to 
enhance, inhibit, or disperse biofilm formation. The results obtained (Figure 3-5) showed that 
D-tyrosine could inhibit biofilm formation at a concentration of 5 µM. The other three D-amino 
acids (D-tryptophan, D-methionine, and D-leucine) were also all successful in inhibiting biofilm 
formation, only at a higher concentration of 5 mM for each (Figure 3-6, Figure 3-7, and Figure 
3-8, respectively). Lower concentrations did not show any inhibitory effects on biofilm 
formation. This inhibition in biofilm formation was obtained through different mechanisms. 
Bacterial cells are connected within the biofilm by the amyloid protein fibers that anchor to the 
D-alanine in the peptidoglycan cell wall of the bacterial cell, when D-amino acids are present 
they can incorporate themselves into the cell wall by replacing the pre-existing D-alanine.  This 
incorporation disengages the protein fibers from the cell wall and consequently causing the 
inhibition of biofilm formation and the pre-existing biofilm to disperse (Kolodkin-Gal et al., 
2010). The D-amino acids tested can also be miss-incorporated into the protein synthesis, which 
results in the inhibition of the biofilm formation (Leiman et al., 2013). Although all four D-amino 
acids investigated in this research showed inhibitory effects on biofilm formation, only D-
tyrosine and D-tryptophan showed the ability to remove pre-existing biofilms.  
It is hypothesised that D-tyrosine inhibits biofilm formation and disperses the pre-
existing biofilm by two mechanisms; first by the miss-incorporation of D-tyrosine into the cell 
wall by replacing the D-alanine in the cell wall, and its consequent disengagement of attached 
cells and preventing new cells to attach, due to lack of attachment sites.  Second due to 
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metabolic inhibition associated with D-tyrosine (Champney and Jensen, 1969), which inhibit 
biofilm formation due to lack of access to nutrients, and disperse the pre-existing biofilm due to 
the unfavorable environment surrounding it, as cells prefer to return to its free planktonic form 
(Karatan and Watnick, 2009).  
D-tryptophan also showed inhibition of biofilm formation and dispersed pre-existing 
biofilms. One mechanism was the miss-incorporation of D-tryptophan into the cell wall as 
explained previously. The other mechanism is the significant increase in swimming motility, D-
tryptophan has been reported to significantly increase the swimming motility of bacterial cells 
(Brandenburg et al., 2013), and cells may favor the detachment from the biofilm (Boles, 
Thoendel and Singh, 2005), consequently dispersing pre-existing biofilm.  Since flagellar arrest is 
important for biofilm formation an increase in flagellar activity will inhibit biofilm formation, 
and disperse pre-existing biofilms (O’Toole and Kolter, 1998; Brandenburg et al., 2013). The 
results obtained for D-tryptophan was agreeing with the results obtained by Kolodkin-Gal et al. 
2010 and Leiman et al. 2013. 
 The minimum concentration of D-leucine required to inhibit biofilm formation (5 mM) 
was lower than that obtained by Kolodkin-Gal et al. 2010 and Leiman et al. 2013 (8.5 mM for 
both previous studies). While the minimum concentration of D-tyrosine required to inhibit 
biofilm formation (5 µM) was higher than that obtained by Kolodkin-Gal et al. 2010 (3 µM) and 
less than that obtained by Leiman et al. 2013 (6 µM). Although some differences existed in the 
minimum concentration required for the inhibition of biofilm formation, these differences 
remain limited. The minimum concentration of D-methionine to inhibit biofilm formation was 5 
mM, this concentration was higher than that reported by Kolodkin-Gal et al. 2010 (2 mM). 
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The results for the combined treatment (Figure 3-9) suggests that for complete 
inhibition of biofilm formation a minimum concentration of 5 µM of D-tyrosine and 5 mM each 
for the other three D-amino acids was required to inhibit biofilm formation. The treatment with 
a lower concentration of 1 µM of D-tyrosine and 1 mM of the three other D-amino acids 
showed limited biofilm inhibition, this can be seen when compared with both the treatment 
containing no D-amino acids (0) and the fixed biofilm. The removal of the pre-existing biofilm 
was not noticed for combined treatments with concentrations less than 5 µM for D-tyrosine 
and 5 mM for each of the other three D-amino acids. The amount of biofilm dispersed was 
proportional to the concentration of the D-amino acids until it levels at concentrations between 
15 and 20 mM. 
The minimum concentration required for biofilm inhibition and dispersal obtained in 
this research was higher than that reported by previous researchers. Kolodkin-Gal et al. 2010 
reported that a mixture of the four mentioned D-amino acids with a concentration of 10 nM of 
each D-amino acid was potent to the biofilm growth, and it was successful in dismembering 
part of the pre-existing biofilms. Following that, Leiman et al. 2013 also reported that a mixture 
of the four D-amino acids at a concentration of 10 nM of each was not able to inhibit biofilm 
formation, but rather a higher concentration of 500 nM was required to achieve inhibitory 
effects. 
By comparing the results obtained in Figure 3-5 and Figure 3-6 for D-tyrosine and D-
tryptophan respectively, with the results obtained from the D-amino acids mixture presented in 
Figure 3-9 , no clear synergetic effects can be seen from combining D-amino acids in a mixed 
treatments. The mixed treatment was more effective in removing pre-existing biofilm (39%) 
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when compared with the biofilm removal achieved by D-tyrosine (31%) and D-tryptophan 
(28%), this is hypothesised to be a result of combining the effects of D-tyrosine and D-
tryptophan in the mixed treatment containing the four different D-amino acids.  
3.3.6. Conclusions  
The results obtained suggests that the D-amino acids investigated in this research can 
be utilized to inhibit growth of pre-existing Bacillus sp. biofilm. The use of D-tyrosine and D-
tryptophan did result to some extent in partial removal of pre-exiting Bacillus sp. biofilm. The D-
amino acid mixture although removed pre-existing Bacillus sp. biofilm, it did not show clear 
synergetic effects from combining the amino acids into a mixed treatment. Therefore, the use 
of D-amino acids can be seen beneficial for inhibiting Bacillus sp. biofilm formation, but showed 
limited abilities in removing Bacillus sp. pre-existing biofilms. Since no clear synergetic effects 
were detected for the combined treatments, it is not recommended to conduct any 
optimization studies on biofilm removal using D-amino acids. 
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3.4.1. Preface 
Section 3.4 presents the experimental work conducted to fulfill the specific objective 
presented in Section 1.3.2.3. A comprehensive approach was used in the selection of relevant 
enzymes and evaluate their ability to remove biofilms of different compositions. The results 
presented in Section 3.4 suggests that the protease Savinase and the polysaccharide-degrading 
enzyme Pectinex had the highest biofilm removal capabilities among the different tested 
enzymes. The results obtained in Section 3.4 along with previous recommendations from other 
researchers suggests promising results from the optimization of biofilm removal using an 
enzymatic treatment containing proteases and polysaccharide-degrading enzymes. 
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3.4.2. Introduction 
Biofilms are multicellular heterogenous communities formed by the aggregation of 
bacteria on surfaces. Cells within a biofilm community are encased and connected together by 
an extracellular matrix that consists mainly from exopolysaccharides and protein fibers 
(Costerton, Stewart and Greenberg, 1999; Donlan, 2002; Hall-Stoodley, Costerton and Stoodley, 
2004). The extracellular matrix encases the biofilm community, it connects the bacterial cells 
together and to the surface. Bacterial cells living in a biofilm are characterised by an increased 
synthesis of extracellular matrix, UV light tolerance, the formation of free planktonic cells, the 
formation of bacterial spores, and higher antibacterial resistance, (Habash and Reid, 1999; 
O’Toole, Kaplan and Kolter, 2000; Hall-Stoodley and Stoodley, 2002; Garrett, Bhakoo and 
Zhang, 2008; Vlamakis et al., 2013).  
Removal of biofilms using chemical treatments was found to be a challenging process 
(Ntsama-Essomba et al., 1997; Vickery, Pajkos and Cossart, 2004). Chemical treatments cannot 
penetrate the biofilm due to the reaction-diffusion barrier it forms between the chemicals and 
the bacterial cells living within the biofilm (Gilbert and McBain, 2001). This fact makes biofilm 
communities highly resistant to disinfectants, antibiotics, and biocides.  Bacteria living in a 
biofilm formation was found to be between 100 and 1000-fold more resistant to chemical 
treatments than bacteria living in free planktonic form (Gilbert and McBain, 2001).  
Depending on the bacterial strain and other extrinsic factors (gaseous levels, nutrients 
fluctuations, and fluid shear) the extracellular matrix composition can vary (Simões, Simões and 
Vieira, 2010). The composition of the biofilm can contain all or some of the following: 
phospholipids, carbohydrates, glycoproteins, lipids, nucleic acids, polysaccharides, and amyloid 
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proteins (Branda et al., 2005; Flemming and Wingender, 2010; Hobley et al., 2015). Regardless 
of the different biofilm components, the main two components are the polysaccharides and 
proteins (Sutherland, 2001; Marvasi, Visscher and Casillas Martinez, 2010; Molobela, Cloete and 
Beukes, 2010). 
Bacillus sp. is considered a model microorganism for biofilm related studies and it was 
employed by different researchers in their studies (K. P. Lemon et al., 2008). Bacillus sp. is a 
gram-positive, biofilm forming, and non-pathogenic bacteria. Bacillus sp. can adapt in a wide 
range of conditions and is usually found in terrestrial and aquatic environments (Grossman, 
1995; Maglott et al., 2007; Earl, Losick and Kolter, 2008).  The major component of the 
extracellular structural matrix in biofilms formed by Bacillus sp. is the polysaccharides (Branda 
et al., 2001; Morikawa et al., 2006). Another model bacterium for biofilm related studies is the 
gram-negative, biofilm forming, and non-pathogenic Pseudomonas fluorescens (Rossignol et al., 
2008). Due to its high adaptation and its ability to resist a wide range of disinfectants and 
antibiotics this bacterium is ubiquitous in the environment and hospitals (Spiers, Buckling and 
Rainey, 2000; Rossignol et al., 2008). It has been reported that biofilms formed by 
Pseudomonas fluorescens are mainly composed of proteins (Molobela, Cloete and Beukes, 
2010). Currently, there is an increased interest in the use of enzymes as anti-biofilm agents, this 
came following their successful use in removing biofilms from industrial surfaces (Taraszkiewicz 
et al., 2013; Thallinger et al., 2013; Meireles et al., 2016). Enzymes have been described as 
efficient, affordable, and greener alternative than the harmful and ineffective chemicals used in 
diminishing problems associated with biofilm formation (Cordeiro, Hippius and Werner, 2011; 
Cortés, Bonilla and Sinisterra, 2011; Srey, Jahid and Ha, 2013). There is no evidence of any side 
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effects from using enzymes in the industry and the use of enzymes for cleaning surfaces was 
approved by regulatory agencies (Schmidt, 2012; Meireles et al., 2016).  Biofilms can be 
degraded by enzymes through different routes, enzymes can degrade the extracellular matrix 
encasing the biofilm, degrade the components of the biofilm, interfere with quorum sensing, 
cause cells lysis, and catalyse the production of antimicrobials (Donlan, 2002; Augustin, Ali-
Vehmas and Atroshi, 2004; Simões, Simões and Vieira, 2010; Werner, 2011; Thallinger et al., 
2013). Enzymes weaken the structural integrity of the biofilm by breaking the components of 
the extracellular matrix (Molobela, Cloete and Beukes, 2010). Regardless of the different modes 
of action, for an enzyme to degrade a biofilm the first line of defence it will face is the 
extracellular matrix that covers and shields the bacterial cells in biofilm community. Enzymes 
used to remove biofilms are divided into four groups and those are oxidative enzymes, anti-
quorum sensing, proteolytic enzymes such as proteases, and polysaccharide-degrading 
enzymes (Thallinger et al., 2013).  
Proteases are a class of proteolytic enzymes that can hydrolyse proteins. This class of 
enzymes contain a wide range of enzymes that are different in their target substrates and 
mechanisms (Hedstrom, 2002).  
Previous research has shown that proteases have been successful in degrading proteins 
in pipelines (Augustin, Ali-Vehmas and Atroshi, 2004). Different researchers reported that 
Savinase was successful in preventing and removing biofilm formations (C Leroy et al., 2008; 
Molobela, Cloete and Beukes, 2010). Leroy et al. 2008 compared the efficiency of different 
commercial enzymes (seven polysaccharide-degrading, four proteases, and one lipase) to 
eradicate biofilms formed by the marine bacterial strain Pseudoalteromonas sp. D41. The 
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biofilm was grown in a 96-well microtiter plate for 24 h using sterile seawater at 20 oC. The 
biofilm biomass was quantified by using fluorescent dye DAPI (4[prime]6-diamidino-2-
phenylindole). The results presented suggested that Savinase was the most efficient enzyme in 
removing and preventing biofilms (50% reduction of pre-existing biofilms after a 24 hrs 
treatment at a concentration of 1.7 mg mL-1, and up to 100% reduction in bacterial adhesion). 
The authors concluded that depending on the type of enzyme and the used concentrations 
enzymes might remove biofilms or inversely enhance their formation (C Leroy et al., 2008).  
Protamex was used by previous researchers for the hydrolyses of peptide bonds from 
different sources such as Yellowfin Tuna, Sardine heads, and Soybean (Dumay et al., 2009; 
Nguyen et al., 2011; Minh, 2015).  Cordeiro et al. 2011 investigated the effect of immobilized 
subtilisin A on the initial attachment of Pseudomonas aeruginosa and Staphylococcus 
epidermidis. The tested enzymes (Subtilisin A and Cellulase) were immobilized on a 
poly(ethylene-alt-maleic) anhydride copolymer films by covalent binding. Test controls were 
prepared using heat to inactivate enzymes. Test slides and controls were submerged in 
bacterial suspension (106 CFU/mL) and incubated in sterile conditions for 24 hrs at 37oC. After 
incubation, the test samples were washed to remove loosely attached bacteria by immersion 
into a saline solution, the cells that remained attached after the wash step were plated in serial 
dilutions for quantification of viable cell count. By comparing the active and inactive surfaces, 
the immobilized subtilisin A had no effect on the attachment of S. epidermidis but reduced the 
attachment of P. aeruginosa by 44%. The authors concluded that the initial steps of attachment 
for different bacteria involves different biomolecules, which requires a broad spectrum of 
enzymatic coatings to control biofilm(Cordeiro, Hippius and Werner, 2011). A study by Tasso et 
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al. 2009 investigated the control of biofilm by targeting the adhesives used by microorganisms 
to attach to surfaces. The researchers used the protease Subtilisin A by covalently attaching it 
to tested surfaces at different concentrations. The immobilized enzymatic coating was tested 
for its effect on the adhesion strength and settlement of two major species (green alga Ulva 
linza, and the diatom Navicula perminuta). The researchers reported that the immobilized 
Subtilisin A was effective in reducing the adhesion strength and settlement of the tested 
microorganisms  (Tasso et al., 2009). 
The protease Trypsin is substrate-specific for the peptide bonds of arginine and lysine 
(Chaignon et al., 2007). A study by Chaignon et al. 2007 evaluated the ability of trypsin to 
remove biofilms formed by S. epidermidis RP62A, S. epidermidis 5, S. epidermidis 444, S. 
lugdunensis 47, S. lugdunensis 18a, S. aureus 383 in 96-well microtiter plates. The pre-grown 
biofilms of the different bacterial species were treated with 100 μL of trypsin at 1 mg mL−1 in 20 
mM Tris buffer, and pH 7.5 for 2 h. Biofilms were stained using 5% safranin and quantified by 
measuring absorbance at 492 nm. Results obtained showed that Trypsin treatment removed 
more than 70% of biofilm formed by S. epidermidis 444, S. lugdunensis 47, S. lugdunensis 18a, S. 
aureus 383. While no effect of trypsin was noticed for biofilm formed by S. epidermidis RP62A, 
S. epidermidis 5. The authors stated that Trypsin had no effect on biofilms formed by S. 
epidermidis RP62A and S. epidermidis 5 due to their polysaccharide-rich composition. The 
authors also hypothesised that the removal of biofilms formed by S. epidermidis 444 
(polysaccharide rich biofilm) by Trypsin was due to the important role of proteins and 
polysaccharide as well in the stability of the biofilm formed by this bacterial strain (Chaignon et 
al., 2007). In a study by Rohde et al. 2007, Trypsin was used to remove pre-grown biofilm from 
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Staphylococcus epidermidis and Staphylococcus aureus. Biofilm was cultivated in 96-well 
microtiter plates, and a treatment containing Trypsin (100 µg/mL) was applied for 16 hrs at 
37oC. The Trypsin treatment removed more than 98% of the biofilm formed in the microtiter 
plates from both tested bacterial species (Rohde et al., 2007). 
Polysaccharides molecules and their degrading enzymes are abundant in nature, with 
many of these polysaccharide-degrading enzymes produced by bacteria, which in turn utilizes 
these enzymes in their invasions to bypass host defences (Jedrzejas, 2000). The polysaccharide 
degrading enzyme Cellulase arises among the different enzymes used as a common choice of 
enzymatic treatments for prevention and removal of bacterial biofilms (Cordeiro, Hippius and 
Werner, 2011).  Following the same procedure discussed previously for Subtilisin A, and by 
comparing results for active and inactive layers of enzymes, Cordeiro et al. 2011, reported that 
Cellulase, in contrary to Subtilisin A, did not affect the attachment of P. aeruginosa and reduced 
the attachment of S. epidermidis by 67%. (Cordeiro, Hippius and Werner, 2011). Loiselle et al. 
2003 conducted a study to investigate the ability of Cellulase to inhibit biofilm formation by 
Pseudomonas aeruginosa. Biofilm was formed on glass slides in a flow chamber for 4 days. 
Biofilm formation was assessed by quantifying the biomass areal density (mg cm-2) and by 
viable cell count (CFU). Biofilm was grown in the presence of different Cellulase concentrations 
at pH 7 and 5. The test controls were prepared using deactivated Cellulase. The results reported 
suggests that Cellulase was successful in partially inhibiting CFU formation and biomass by P. 
aeruginosa. Areal densities were reduced by 36% and 58% for Cellulase concentrations of 9.4 
and 37.6 Unit mL-1 at pH 7. While areal density was decreased by 60% and 88% for Cellulase 
concentrations of 9.4 and 75.2 Unit mL-1 at pH 5. Viable cell counts decreased by 60% and 57% 
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at pH 5 and 7 for Cellulase concentration of 9.4 Unit mL-1. The increase of Cellulase 
concentration did not have any effect of viable cell counts (CFU) at the tested pH values 
(Loiselle and Anderson, 2003). 
Pectinases (pectinolytic enzymes) are heterogeneous mixtures of enzymes that are 
abundant in plants and microorganisms for their ability to hydrolyze pectic substances (Jayani, 
Saxena and Gupta, 2005). Pectic compounds are polysaccharides that are negatively charged, 
acidic, high molecular weight macromolecules that are abundant in the plant kingdom (Jayani, 
Saxena and Gupta, 2005). Pectinases play an important role in the plant kingdom as they 
contribute in the plant cell wall degradation (Ward and Moo-Young, 1989). They also contribute 
in softening plant tissue at maturation and storage (Sakai, 1992), and have an important 
ecological role in the decomposition and recycle of plant waste materials (Lang and 
Dörnenburg, 2000).  
Pectinases have shown promising results as an anti-biofilm enzyme (Johansen and Falholt, 
1997). In their study, Johansen et al. 1997, evaluated the use of Pectinex on biofilms formed 
from Staphylococcus aureus ATCC 25923, Pseudomonas aeruginosa ATCC 10148, and 
Pseudomonas fluorescens AH2.  Sterile discs made from steel and polypropylene were 
immerged vertically in a steel tank containing growth medium and biofilm was allowed to 
develop on both sides of the discs at 26oC for 4 days with stirring (200 rpm). The discs were 
then rinsed to remove loosely attached cells using phosphate buffer (pH 7) prior to incubating 
them with Pectinex in phosphate buffer for 15 min at 20 oC static. Phosphate buffer solution 
(sterile) was used as a control. The total and respiring number of bacterial cells in the biofilm 
was determined using fluorescence microscopy. From the results presented Pectinex was 
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effective in removing biofilms formed by all tested species. Almost two log reductions in the cell 
number for S. aureus and P. aeruginosa, and one log reduction in the cell number for P. 
fluorescens was achieved with Pectinex concentration of 180 PSU mL-1 (Johansen and Falholt, 
1997).  
Due to the complexity of the different biofilm compositions among different bacterial 
species, and the abundant available enzymes in the market coupled with the enzymatic 
substrate specificity (Simões, Simões and Vieira, 2010), it is of vital importance to evaluate and 
compare the available related enzymes for their ability to remove biofilms. Although different 
biofilms compositions are described as complex, the to main components of biofilms are 
polysaccharides and proteins, hence, the most related enzymatic treatments recommended for 
degrading different biofilms are the proteases and the polysaccharide-degrading enzymes 
(Meyer, 2003). Far to the authors knowledge, the efficiency of the industrial enzymatic 
mixtures CellicCTec2, CellicHTec2, and Protamex have never been evaluated for biofilm 
removal. 
In this research, the efficiency of commercially available polysaccharide-degrading 
enzymes (Carezyme, CellicCTec2, CellicHTec2, and Pectinex) and proteolytic enzymes (Savinase, 
Protamex, Trypsin, and Subtilisin A) in the removal of pre-grown biofilms of different 
compositions formed by Bacillus sp. and Pseudomonas fluorescens will be evaluated and 
compared. 
 
 
131 
 
3.4.3. Experimental Procedures 
3.4.3.1.  Materials 
3.4.3.1.1. 10X Tbase 
To 232 mL DI-Water, add 2.5 g Trisodium citrate (34 mM sodium citrate), 4.95 g (NH4)2SO4 
(0.15M ammonium sulphate), 14.97 g KH2PO4 (0.44M potassium phosphate monobasic), 34.84 
g K2HPO4 (0.8M potassium phosphate dibasic), autoclave for 20 min. 
3.4.3.1.2. Biofilm Growth Media for Bacillus species. 
 To 900 mL of DI-Water, add 10 g tryptone, 5 g yeast extract, 10 g NaCl, 0.04 g D-glucose), 
10 mL of 10X Tbase, 0.012 g MgSO4, autoclave for 20 min. 
3.4.3.1.3. Biofilm Growth Media for Pseudomonas fluorescens. 
To 1000 mL of DI-Water, add 20 g peptone, 1.5 g K2HPO4, 1.5 g MgSO4.7H2O, 10 gm glycerol, 
autoclave for 20 min. 
3.4.3.1.4. Wash Buffer (Sterile) 
900 mL DI-Water, 1 ml of 1M MgSO4, 100 mL of the 10X Tbase solutions, autoclaved for 20 
min. 
3.4.3.1.5. Sodium Acetate Buffer for Polysaccharide-degrading enzymes (pH 4) 
410 mL of 0.2 M acetic acid solution, 2.45 g sodium acetate trihydrate, bring final volume to 
1 L using DI-Water, autoclave for 20 min.  
3.4.3.1.6. Sodium Phosphate Buffer for Proteases (pH 8) 
To 1000 mL of DI-Water, add 0.74 g Sodium Phosphate monobasic monohydrate, 25.23 g 
sodium phosphate dibasic heptahydrate, autoclave 20 min. 
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3.4.3.2.  Methods 
3.4.3.2.1. Bacterial Strains 
The Bacillus species strain used in this research was obtained from Germiphene Inc. It is 
known commercially as Unizyme 20X CSB 20 NF SPORE. The Pseudomonas fluorescens strain 
used in this research is known as Pseudomonas fluorescens Migula 1895 (DSM No. 50090, type 
strain), and was obtained from DSMZ in Germany.  
3.4.3.2.2. Seed Culture Preparation  
For Bacillus sp., one mL of the spore suspension was washed via centrifuge at 10,000 
rounds per minute for 60 seconds and then re-suspended in 1 mL wash buffer (repeated three 
times), this was followed by resuspension in 1 mL biofilm growth medium. A 150mL glass flask 
containing 20mL medium was then inoculated with 0.5 mL of the resuspended cells at 300 
rounds per minute inside a 37 oC humidified incubator oven for approximately 270 min until the 
optical density at 600 nm was between 1 and 1.6 (using DI-Water as blank).  
For P. fluorescens strain, the culture was revived in growth media and samples of 1 mL 
size were sampled and preserved with 20% glycerol in -80oC freezer. Prior to each experiment 
the frozen samples were revived in growth media until optical density measured at 600 nm was 
between 1 and 1.6 (using DI-Water as blank).  
3.4.3.2.3. Inoculating the Microtiter Plates and Biofilm Growth  
The prepared seed culture for each of the two strains was diluted in a 1:100 ratio in the 
designated biofilm growth media, and each well in the microtiter plates was filled with 100 µL 
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of the diluted seed culture. Control wells were prepared by filling wells in the microtiter plates 
with 100 µL of sterile biofilm growth media. Each plate was covered with a sterile thin film to 
reduce evaporation, a single hole was added for aeration in the center of each well using a 22-
gauge sterile needle. The microtiter plates containing Bacillus sp. were incubated at 37 oC in a 
humidified oven in static conditions for 32 h. While the microtiter plates containing P. 
fluorescens were incubated in a sterile chamber at 21 oC for 72 h and media was replenished 
every 24 h. Subsequently the plates are washed (Tecan Hydroflex Plate Washer) gently three 
times using wash buffer. 
3.4.3.2.4. Fixing Biofilm Growth 
This step is done to fix initial biofilm growth to be compared with the biofilm remaining in 
other wells following treatment. It is assumed that fixed biofilms are nonactive or dead. At the 
end of the treatment duration this process is repeated to treated wells and prior to biofilm 
quantification. Growth medium was removed, and each well was filled with 200µL methanol for 
20 min. Microtiter plates are then left to air dry completely at room temperature (Stepanović et 
al., 2000; Kwasny and Opperman, 2010). 
3.4.3.2.5. Enzymatic Treatments Preparation 
The protease treatments (Savinase, Protamex, Subtilisin A, and Trypsin) were prepared in 
sodium phosphate buffer (pH 8) at five concentrations (1, 5, 10, 15, and 30 U/mL), while the 
polysaccharide-degrading enzymes (Pectinex, Carezyme, Cellic-CTec2, Cellic-HTec2) were 
prepared in sodium acetate buffer (pH 4) at five concentrations 1, 5, 10, 15, and 30 U/mL for 
Carezyme, Cellic-Ctec2, and Cellic-HTec and 5, 15, 25, 50, and 75 U/mL for Pectinex. 
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The enzymatic activity of the different proteases was quantified before and after 
conducting the experiments using casein as substrate (Folin and Ciocalteu, 1927; Anson, 1938), 
no change was noticed in the enzymatic activity of the proteases (data not shown). The 
protease activity unit (U) is defined as the amount of enzyme required to hydrolyse casein in 
one minute, pH 7.5, 37oC, to produce color (Folin & Ciocalteau’s reagent) equivalent to 1 µmole 
of tyrosine (Folin and Ciocalteu, 1927; Anson, 1938).  
The activity of the polysaccharide degrading enzymes (Carezyme, Cellic-CTec2, and 
Cellic-HTec2) were quantified before and after conducting the experiments using cellulose as a 
substrate (Worthington, 1988), no change was noticed in the enzymatic activity of the tested 
enzymes (results not shown). The enzymes activity unit (U) is defined as the amount of the 
enzyme required at pH 5 and 37 oC, to liberate 1 µmole of glucose from cellulase in 1 h 
(Worthington, 1988). The list of enzymes used in this work are presented in Table 3–1. The 
activity unit (U) for Pectinex is defined as the amount of enzyme required to liberate 1 µmole of 
galacturonic acid from poly-galacturonic acid in 1 h at pH 4 and 25 oC.  
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Table 3–1. List of enzymes used and their optimum activity conditions. 
  
Enzyme  
Optimum Activity 
Range  Source 
Name  Type  pH  
Temp. 
(Co)    
                  
Protamex®  Protease  7.5 - 9.5  40 - 60  Sigma-Adrich Inc., Saint Louis, Mo, USA 
Subtilisin A  Protease  7.5 - 10  50 - 65  Sigma-Adrich Inc., Saint Louis, Mo, USA 
Trypsin  Protease  6.5 - 10  30 - 44  Sigma-Adrich Inc., Saint Louis, Mo, USA 
Savinase  Protease  8.0 - 11  55 - 75  Sigma-Adrich Inc., Saint Louis, Mo, USA 
         
Carezyme  Polysaccharide-degrading  4.0 - 5.5  35 - 60  Sigma-Adrich Inc., Saint Louis, Mo, USA 
Pectinex Ultra  Polysaccharide-degrading  3.5 - 6.0  30 - 60  Sigma-Adrich Inc., Saint Louis, Mo, USA 
Cellic CTec2  Polysaccharide-degrading  4.0 - 6.5  40 - 60  Novozymes A/S, Bagsværd, Denmark 
Cellic HTec2  Polysaccharide-degrading  4.0 - 6.0  60 - 75  Novozymes A/S, Bagsværd, Denmark 
                  
         
3.4.3.2.6. Applying Treatments 
After washing the microtiter plates with the buffer solution, the designated treatment was 
applied by dispensing 125 µL of enzymatic treatment solution into desired wells, that was 
followed by incubation at 21 oC for 24 h.  
3.4.3.2.7. Total Biofilm Quantification Using Crystal Violet Stain 
Biofilm formation was quantified using the crystal violet binding assay method. This method is 
commonly used to quantify biofilms (O’Toole, Kaplan and Kolter, 2000; Kolodkin-Gal et al., 
2010, 2012; Brandenburg et al., 2013; Zhang and Hu, 2013). To quantify biofilm formation in 
the microtiter plates, using a multichannel pipette, 150 µL of 0.1 % (W/V) crystal violet stain 
was dispensed into each well, this was followed by 60 min incubation (Stepanović et al., 2000; 
Kwasny and Opperman, 2010). The microtiter plate was washed 4 times by dispensing 200 µL 
DI-Water in drip mode and then aspirating using the Tecan Hydroflex plate washer without 
touching the bottom of the wells (previous testing proved that washing the plates 4 times 
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produce a washing waste liquid that is stain free). Microtiter plates were then air dried 
completely at room temperature. The crystal violet was then resolubilized by manually 
dispensing 200 µl 30% acetic acid using a multichannel pipet into each well (Stepanović et al., 
2000), the microtitet plate is then incubated static at room temperature for 20 min. Using a 
multichannel pipet, 100 µL from each well were transferred to clear polystyrene plates with the 
flat bottom for to be quantified via measuring absorbance at OD 570 nm (TECAN infinite M200 
Pro Plate reader).  
3.4.4. Results 
3.4.4.1.  Reproducibility of Biofilm Formation in Different Microtiter Plates 
Reproducibility of biofilm growth in the microtiter plates was evaluated first to validate 
comparisons between different treatments within the same microtiter plate (intra-plate) and 
between different microplates (inter-plate) prepared from the same batch. Biofilm growth for 
P. fluorescens was quantified in 96 wells per plate in three separate plats following the 
designated incubation time. A one-way ANOVA test was performed for inter-plate comparison 
of biofilm formation. The results showed no significant difference (p-value = 0.63) among the 
three plates. Reproducibility of P. fluorescens biofilm within the same plate was also assessed 
using one-way ANOVA, the results obtained showed no significant difference (p-value = 0.73) 
among the twelve columns (8 wells/column) within the same microtiter plate. Reproducibility 
testing for Bacillus sp. showed no significant difference for both inter-plate and intra-plate 
comparisons, for details please see Section 3.2.4.1 . 
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3.4.4.2. Biofilm Removal Using Proteases 
 
Figure 3-10. Bacillus sp. viable biofilm removal using proteases. Each enzyme was tested at 5 
concentrations ranging between 1 and 30 U/mL. For each enzyme tested, only the enzyme 
concentration resulting in the highest biofilm removal is plotted for comparison with other 
tested enzymes. Each column is an average of 8 replicates. Error bars represent 95% confidence 
intervals. 
The effect of enzyme concentration on biofilm removal was evaluated for four different 
enzymes. Savinase was the most effective protease in removing Bacillus sp. biofilms, as shown 
in Figure 3-10. That was followed by Protamex, Subtilisin A, and Trypsin respectively. The 
highest Bacillus sp. biofilms removal (68%) using proteases was achieved by Savinase (Figure 
3-10). 
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Figure 3-11. Pseudomonas fluorescens viable biofilm removal using proteases. Each enzyme was 
tested at 5 concentrations ranging between 1 and 30 U/mL. For each enzyme tested, only the 
enzyme concentration resulting in the highest biofilm removal is plotted for comparison with 
other tested enzymes. Each column is an average of 8 replicates. Error bars represent 95% 
confidence intervals.  
Savinase was the most effective protease in P. fluorescens biofilm removal presented in 
Figure 3-11, this was closely followed by Protamex, and then Subtilisin A, and Trypsin 
respectively. The highest P. fluorescens biofilm removal (84%) by proteases was achieved by 
Savinase (Figure 3-11). 
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3.4.4.3. Biofilm Removal Using Polysaccharides-degrading Enzymes 
 
Figure 3-12. Bacillus Sp. viable biofilm removal using polysaccharide-degrading enzymes. Each 
enzyme was tested at 5 concentrations ranging between 1 and 75 U/mL. For each enzyme 
tested, only the enzyme concentration resulting in the highest biofilm removal is plotted for 
comparison with other tested enzymes. Each column is an average of 8 replicates. Error bars 
represent 95% confidence intervals. 
The polysaccharide-degrading enzyme Pectinex was the most effective enzyme in 
removing biofilms formed by Bacillus sp. as presented in Figure 3-12 
, this was followed by Cellic-CTec2, Carezyme, and Cellic-HTec2 respectively (Figure 3-12). The 
highest Bacillus sp. biofilm removal (74%) using polysaccharide-degrading enzymes was 
achieved by Pectinex (Figure 3-12).  
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Figure 3-13. Pseudomonas fluoresces viable biofilm removal using polysaccharide-degrading 
enzymes. Each enzyme was tested at 5 concentrations ranging between 1 and 75 U/mL. For 
each enzyme tested, only the enzyme concentration resulting in the highest biofilm removal is 
plotted for comparison with other tested enzymes. Each column is an average of 8 replicates. 
Error bars represent 95% confidence intervals. 
Pectinex was the most effective polysaccharide degrading enzyme in removing P. 
fluorescens biofilms as presented in Figure 3-13, this was followed closely by Cellic-CTec2, and 
then Cellic-HTec2, and Carezyme. The highest biofilm removal (55%) of P. fluorescens biofilms 
using polysaccharide degrading enzymes was achieved by Pectinex (Figure 3-13). 
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3.4.5. Discussion 
The ability of different enzymatic treatments to remove biofilms formed by two 
different bacterial strains has been evaluated. The bacterial strains tested in this research are 
the gram-positive bacteria Bacillus sp. and the gram-negative bacteria P. fluorescens. Biofilms 
formed by Bacillus sp. are well characterised, which made it a model microorganism for biofilm 
studies (K. P. Lemon et al., 2008; Dervaux, Magniez and Libchaber, 2014). Biofilms formed by 
Bacillus sp. has been reported to be mainly composed of polysaccharides (Branda et al., 2001; 
Morikawa et al., 2006), while proteins are reported to be the main component of P. fluorescens 
biofilms (Molobela, Cloete and Beukes, 2010), this variation in their biofilms composition 
provides more different scenarios for testing the different enzymatic treatments. In addition, it 
has been reported previously that when compared with the biofilms formed by other disease 
causing gram-negative microorganisms (Pseudomonas aeruginosa, Staphylococcus aureus, and 
Staphylococcus epidermidis), biofilms formed by P. fluorescens has shown the highest 
resistance to enzymatic treatments (Johansen and Falholt, 1997).  
Biofilms formed by Bacillus sp. and P. fluorescens were effectively removed by both 
proteases and polysaccharide-degrading enzymes (Figure 3-10, Figure 3-11, Figure 3-12, and 
Figure 3-13) only at different removal efficiencies. In general, proteases were more effective in 
removing biofilms formed by P. fluorescens (84%) than biofilms formed by Bacillus sp. (68%) 
this can be seen by comparing  Figure 3-10 and Figure 3-11, while polysaccharide-degrading 
enzymes were more effective in removing biofilms formed by Bacillus sp. (74 %) than biofilms 
formed by P. fluorescens (55%), this can be seen by comparing Figure 3-12 and Figure 3-13.  A 
possible reason for this is the difference in the specific compositions of the biofilms formed by 
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the two species. Biofilms formed by P. fluorescens are mainly composed from proteins 
(Molobela, Cloete and Beukes, 2010), which makes it a more suitable substrate for proteases 
and hence more vulnerable to degradations by proteases, while biofilms formed by Bacillus sp. 
are mainly composed of polysaccharides (Branda et al., 2001; Morikawa et al., 2006), which is a 
more suitable substrate for the polysaccharide-degrading enzymes, and therefor biofilms 
formed by Bacillus sp. were more effectively removed by polysaccharide-degrading enzymes.      
Among the proteases tested in this research, results obtained indicate that Savinase and 
Protamex have the highest biofilm removals for biofilms formed by both Bacillus sp. (Figure 
3-10) and P. fluorescens (Figure 3-11), this was followed by Subtilisin A and Trypsin respectively. 
Possible reasons for that is the variation in the protein composition of the tested biofilms which 
made them less resistant to Savinase and Protamex (Augustin, Ali-Vehmas and Atroshi, 2004; 
Chaignon et al., 2007; Lequette et al., 2010; Molobela, Cloete and Beukes, 2010; Cordeiro, 
Hippius and Werner, 2011). In addition, unlike Subtilisin A and Trypsin, Protamex contains 
different enzymatic mixtures (bacillolysin, subtilisin, neutral proteases), which might give it an 
advantage facing the variations in the biofilm protein components (Garcia-Mora et al., 2014; 
Fernandes, 2016). Previous research has shown that Subtilisin A was effective at inhibiting 
initial biofilm attachment, and not as much effective at dismembering pre-existing biofilms (C. 
Leroy et al., 2008). The results obtained for Subtilisin A biofilm removal efficiency was similar to 
previous research findings by others (Vickery, Pajkos and Cossart, 2004; Cordeiro, Hippius and 
Werner, 2011). Previous research has also found Trypsin inefficient in removing biofilms formed 
by Staphylococcus epidermidis biofilms, in contrary, they found it efficient in removing biofilms 
formed by Staphylococcus aureus, this variation in efficiency was attributed to the difference in 
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the protein composition between the two bacterial strains (Chaignon et al., 2007).  The results 
obtained here suggests that Savinase was the most effective protease in removing biofilms 
formed by both species Bacillus sp. (68%) and P. fluorescenes (84%), this can be attributed to 
the broad substrate specificity and the superior stability that Savinase posses when compared 
to other proteases  (Betzel et al., 1992; Georgieva et al., 2001; Marcato-Romain et al., 2012; 
Garcia-Mora et al., 2014). Moreover, Savinase has been reported to possess bactericidal effects 
(Smith, Green and Mason, 2003), and it was suggested that Savinase targets proteins involved 
in bacterial adhesion in biofilm formation (C Leroy et al., 2008). Previous researchers have also 
reported Savinase to be the most effective enzyme in biofilm removal (C Leroy et al., 2008; 
Molobela, Cloete and Beukes, 2010; Marcato-Romain et al., 2012). 
The results obtained for the polysaccharide degrading enzymes (Figure 3-12 and Figure 
3-13) showed that Pectinex and Cellic-CTec2 had the highest removal efficiency for biofilm 
formed by Bacillus sp. and P. fluorescens. For Bacillus sp. (Figure 3-12) this was followed by 
Carezyme and Cellic-HTec2 respectively, while for P. fluorescens (Figure 3-13) this was followed 
by Cellic-HTec2 and Carezyme respectively. The higher biofilm removal results obtained for 
Pectinex and CellicCTec2 can be a results of specific substrate compatibility which made the 
polysaccharides in biofilms formed by Bacillus sp. and P. fluorescens more suitable substrates 
for enzymatic degradation by Pectinex and CellicCTec2 (Augustin, Ali-Vehmas and Atroshi, 
2004; Chaignon et al., 2007; Lequette et al., 2010; Molobela, Cloete and Beukes, 2010). 
Previous research reported that Cellulase (the main active enzyme in Carezyme, CellicCTec2 
and CellicHTec2) was successful in reducing initial attachment of biofilms formed by S. 
epidermidis, contrary results were obtained for Cellulase on biofilms formed by P. aeruginosa 
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(Cordeiro, Hippius and Werner, 2011). Another research reported that Cellulases obtained from 
two different sources partially inhibited biofilm by P. aeruginosa (Loiselle and Anderson, 2003). 
Results obtained (Figure 3-12 and Figure 3-13) shows that for the exopolysaccharide-degrading 
enzymes investigated in this research, Pectinex achieved the highest biofilm removal efficiency 
for biofilms formed by both Bacillus sp. (74%) and P. fluorescens (55%). The superiority of 
Pectinex removal efficiency over the other polysaccharide-degrading enzymes tested can be 
due the fact that Pectinex is a multicomponent enzymatic mixture that contains different 
enzymes including proteases (Protease, Pectinase, Arabanse, Cellulase, Hemicellulase, β-
glucanase, and Xylanase) (Johansen and Falholt, 1997; Olwoch et al., 2014), this wide diversity 
in its enzymatic components gives it a broad substrate specificity that in addition to the broad 
polysaccharide-degradation activity includes proteins degradation. Similar results for Pectinex 
were obtained by previous researchers (Johansen and Falholt, 1997).   
3.4.6. Conclusions 
 It could be concluded from the results presented here that the use of proteases and 
polysaccharide degrading enzymes was successful in the removal of pre-existing biofilms 
formed by Bacillus sp. and P. fluorescens. The proteases Savinase and Protamex, and the 
polysaccharide-degrading enzymes Pectinex and CellicCTec2, have shown the highest removal 
efficiency for pre-existing biofilm formed by Bacillus sp. and P. fluorescens. Proteases were 
more effective in removing biofilm formed by P. fluorescens, while polysaccharide-degrading 
enzymes were more effective in removing Bacillus sp. biofilm. Interestingly, the results 
obtained emphasise the complexity of the structural stability of the biofilm. The ability of 
polysaccharide degrading enzymes to remove a substantial amount of P. fluorescens biofilm 
145 
 
(which is mainly composed of proteins), and the ability of proteases to remove a substantial 
amount of Bacillus sp. biofilm (which is mainly composed from polysaccharides), reflects the 
complex interdependent relationship between polysaccharides and proteins in maintaining the 
stability and structural integrity of the biofilm formation. Future work should be directed 
toward optimizing biofilm removal using enzymatic treatments to achieve the highest efficiency 
in biofilm removal treatments that target a broader spectrum of biofilms. 
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3.5.1. Preface 
Section 3.5 presents the experimental work done to fulfill the specific objective 
previously presented in Section 1.3.2.4. Based on the results obtained in Section 3.5 the 
proteases Savinase and Protamex and the polysaccharide-degrading enzymes Pectinex and 
Cellic-Ctec2 showed the highest biofilm removal among the tested enzymes. Section 3.5 builds 
on the results previously obtained in Section 3.4 and further optimize biofilm removal using 
enzymatic treatments. The results of the optimization experiments showed that a treatment 
containing Savinase and Pectinex had the highest biofilm removal efficiency. The models 
developed were successful in predicting biofilm removal. 
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3.5.2. Introduction 
Biofilms are multicellular communities formed by bacterial aggregation on surfaces, 
bacterial cells within a biofilm are connected together and to the surface  by an extracellular 
matrix consisting mainly from polysaccharides and proteins (Costerton et al., 1987; Donlan, 
2002; Hall-Stoodley; Kolodkin-Gal et al., 2012). Distinctive characteristic of bacterial cells living 
in a biofilm community can be summarised by higher antibacterial resistance, the formation of 
free planktonic cells, UV light tolerance, the formation of bacterial spores, and an increased 
synthesis of extracellular matrix (Habash and Reid, 1999; O’Toole, Kaplan and Kolter, 2000; Hall-
Stoodley and Stoodley, 2002; Rowland and Voorheesville, 2003; Garrett, Bhakoo and Zhang, 
2008; Coleman et al., 2010; Vlamakis et al., 2013). Biofilm formation can be problimatic for the 
healthcare and industrial sectors (Barbeau et al., 1996; Barbeau, Bokum and Gauthier, 1998). 
Biofilm communities can harbour different undesirable pathogens, biofilm formation can cause 
clogging of pipes and tubes, in addition, biofilms can interfere with the mechanical properties 
of dental devices (Barbeau et al., 1996; Coleman et al., 2010; Vasickova et al., 2010). 
The use of chemical treatments to remove biofilms was found to be challenging 
(Ntsama-Essomba et al., 1997; Vickery, Pajkos and Cossart, 2004). Due to the physical barrier 
between the chemical treatments and the bacterial cells living within the biofilm, chemical 
treatments cannot access the bacterial cells (Gilbert and McBain, 2001). Lower diffusivity of 
chemical treatments through biofilms makes them highly resistant to disinfectants, biocides, 
and antibiotics. When compared to its free planktonic form, bacteria living in a biofilm 
formation was reported to be up to 1000-fold more resistant to chemical treatments (Gilbert 
and McBain, 2001). The composition of the extracellular matrix can vary depending on the 
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bacterial strain and other external factors ( such as gaseous levels, and nutrients) (Simões, 
Simões and Vieira, 2010). Biofilms composition includes carbohydrates, polysaccharides, 
glycoproteins, nucleic acids, amyloid proteins, phospholipids, lipids, nucleic acids (Branda et al., 
2005; Flemming and Wingender, 2010; Hobley et al., 2014) 
Enzymatic treatments have been recently suggested as anti-biofilm treatments, previous 
research has shown their ability in removing biofilm from industrial surfaces (Taraszkiewicz et 
al., 2013; Thallinger et al., 2013; Meireles et al., 2016). Enzymatic treatments have been 
described as more affordable, efficient, and eco-friendly alternative than the chemical 
treatments used in removing biofilms (Cordeiro, Hippius and Werner, 2011; Cortés, Bonilla and 
Sinisterra, 2011; Srey, Jahid and Ha, 2013). The use of enzymes in industry and for cleaning 
surfaces has been approved by regulatory agencies and no evidence of side effects has been 
reported (Schmidt, 2012; Meireles et al., 2016). 
Due to the substrate-specific nature of enzymes, it is vital to identify the components of 
the extracellular matrix prior to the selection of the enzymatic treatment (Molobela, Cloete and 
Beukes, 2010). Although there is variation in the constituents of biofilms the major two 
components remains to be proteins and polysaccharides (Stewart and William Costerton, 2001; 
Sutherland, 2001; Molobela, Cloete and Beukes, 2010), the specific enzymes that degrade these 
two major components of biofilm are proteases and polysaccharide-degrading enzymes, 
respectively (Jedrzejas, 2000; Jayani, Saxena and Gupta, 2005; C. Leroy et al., 2008). The ability 
of proteases and polysaccharide-degrading enzymes in removing biofilm have been 
investigated previously, the proteases Savinase and Protamex, and the polysaccharide-
degrading enzymes Pectinex and Cellic-CTec2, have shown the highest efficiency in removing 
159 
 
biofilms formed by Bacillus sp. and P. fluorescens, for more details please refer to Sections 
3.4.4.2 and 3.4.4.3. 
Bacillus species (Bacillus sp.) and Pseudomonas fluorescens (P. fluorescens)  are 
considered model microorganisms for biofilm related studies (K. P. Lemon et al., 2008; 
Rossignol et al., 2008). Bacillus sp. is a  non-pathogenic, gram-positive, biofilm forming bacteria, 
they can be found in abundance in both terrestrial and aquatic environments due to their 
ability to adapt to different environments (Grossman, 1995; Maglott et al., 2007; Earl, Losick 
and Kolter, 2008). It has been reported that the major structural component of biofilms formed 
by Bacillus sp. is polysaccharides (Branda et al., 2001; Morikawa et al., 2006). Pseudomonas 
fluorescens is a gram-negative, non-pathogenic, biofilm forming bacteria (Rossignol et al., 
2008). This bacterium is ubiquitous in the environment and in hospitals, it is characterised with 
high adaptation to different environments and its ability to resist a wide range of antibiotics 
and disinfectants (Spiers, Buckling and Rainey, 2000; Rossignol et al., 2008). Previous research 
reported that P. fluorescens produces biofilms that are mainly composed of proteins (Molobela, 
Cloete and Beukes, 2010). 
Taking into consideration the heterogeneity of biofilms compositions, and the substrate-
specific characteristic of enzymes makes it vital to use enzymatic mixtures to achieve a broader 
spectrum and higher efficiency of biofilm removal (Augustin, Ali-Vehmas and Atroshi, 2004; 
Torres et al., 2011). The use of enzymatic mixtures containing proteases and polysaccharide-
degrading enzymes is expected to achieve higher biofilm removal efficiency (Thallinger et al., 
2013). Previous researchers expected promising results from using enzymatic mixtures 
containing proteases and polysaccharide-degrading enzymes for biofilm removal in different 
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applications (Orgaz et al., 2006; Torres et al., 2011; Zanaroli et al., 2011). To the best knowledge 
of the authors, this is the first-of-kind optimization study on the use of proteases and 
polysaccharide-degrading enzymes mixtures for biofilm removal. 
Response surface methodology (RSM) is an effective mathematical and statistical tool 
used for analysis, modeling, and optimization of a complicated process that include several 
independent variables (factors) affecting a dependent variable (response) (Montgomery, 
Runger and Hubele, 2001; Mason, Gunst and Hess, 2003; Montgomery, 2008). The advantage of 
using this method is the reduction in the number of experiments required to optimize the  
desired response, this method have been utilized by many researchers for optimization studies 
in different fields (Sarchami and Rehmann, 2015; Barwal and Chaudhary, 2016; Sarchami, 
Johnson and Rehmann, 2016).   
The objective of this research is to optimize biofilm removal efficiency of pre-existing 
biofilms formed by Bacillus sp. and P. fluorescens by using enzymatic mixtures consisting of the 
proteases Savinase and Protamex, and the polysaccharide-degrading enzymes Pectinex and 
Cellic-CTec2. 
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3.5.3. Experimental Procedures 
3.5.3.1.  Materials 
3.5.3.1.1. 10X Tbase 
928 mL DI-Water,10 g Trisodium citrate (34 mM sodium citrate), 19.8 g (NH4)2SO4 (0.15M 
ammonium sulphate), 139.36 g K2HPO4 (0.8M potassium phosphate dibasic), 59.88 g KH2PO4 
(0.44M potassium phosphate monobasic), autoclaved for 20 min. 
3.5.3.1.2. Biofilm Growth Media for Pseudomonas fluorescens 
500 mL of DI-Water, 10 g peptone, 5 gm glycerol, 0.75 g K2HPO4, 0.75 g MgSO4.7H2O, 
autoclaved for 20 min. 
3.5.3.1.3. Biofilm Growth Media for Bacillus species 
 450 mL of DI-Water, 50 mL of 10X Tbase, 5 g tryptone, 2.5 g yeast extract, 5 g NaCl, 0.02 g D-
glucose), 0.006 g MgSO4, autoclaved for 20 min. 
3.5.3.1.4. Wash Buffer 
450 mL DI-Water, 50 mL of the 10X Tbase solution, 0.5 mL of 1M MgSO4, autoclaved for 20 min. 
3.5.3.1.5. Sodium Phosphate Buffer for Proteases (pH 8) 
500 mL of DI-Water, 12.7 g sodium phosphate dibasic heptahydrate, 0.37 g sodium phosphate 
monobasic monohydrate, autoclaved 20 min.  
3.5.3.1.6. Sodium Phosphate Buffer for Mixed Enzymes Treatments (pH 6) 
500 mL of DI-Water, 1.65 g sodium phosphate dibasic heptahydrate, 6.10 g sodium phosphate 
monobasic monohydrate, autoclaved for 20 min. 
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3.5.3.1.7. Sodium Acetate Buffer for Polysaccharide-degrading enzymes (pH 4) 
2.45 g sodium acetate trihydrate, 410 mL of 0.2 M acetic acid solution, bring final volume to 1 L, 
autoclaved for 20 min.  
3.5.3.1.8. Bacterial Strains 
The Bacillus species strain used is known commercially as Unizyme 20X CSB 20 NF SPORE 
was provided by Germiphene Inc. The Pseudomonas fluorescens strain used was obtained from 
DSMZ in Germany. It is known as Pseudomonas fluorescens Migula 1895 (DSM No. 50090, type 
strain). 
3.5.3.2. Methods 
3.5.3.2.1. Seed Culture Preparation  
3.5.3.2.1.1. Bacillus species 
One milliliter of the Bacillus sp. spore suspension was washed three times. The wash 
procedure was carried on via centrifuge at 10,000 rounds per minute for 1 min and then 
resuspended in 1 mL wash buffer using a vortex, the washed spores are then concentrated 
using the centrifuge (10,000 rpm, 1 minute) and then resuspended in 1 mL biofilm growth 
medium, half a milliliter of the washed resuspended spores were used to inoculate 20 mL of the 
growth medium using a 150 mL glass flask inside a 37 oC humidified incubator oven at 300 
rounds per min until optical density was between 1 and 1.6 at 600 nm (using DI-Water as 
blank). 
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3.5.3.2.1.2. Pseudomonas fluorescens 
The received P. fluorescens culture was revived in growth media until optical density was 
1.2 at 600 nm. Samples of 1 mL size were taken and preserved with 20% glycerol in -80oC 
freezer. At the start of each experiment, the frozen culture samples were revived in growth 
media, by adding 0.5 mL of thawed culture to 20 mL fresh growth media, at 21oC and 300 
rounds per minute, until optical density measured was between 1 and 1.6 at 600 nm (using DI-
Water as blank).  
3.5.3.2.2. Inoculating the Microtiter Plates and Biofilm Growth  
For each of the two bacterial strains, the prepared seed culture was diluted in a 1:100 ratio 
in the appropriate growth media. The wells in the microtiter plates were filled with 100 µL of 
the diluted seed culture. The control wells were prepared using 100 µL of sterile growth media. 
The plates were covered with a thin sterile film to reduce evaporation, a hole was poked in the 
center of the wells for aeration using a sterile 22-gauge needle. The Bacillus sp. microtiter 
plates were then incubated in a humidified oven at 37 oC in static conditions for 38 h. The P. 
fluorescens microtiter plates were incubated at 21 oC for 96 h, the growth media was 
replenished every 24 h. Subsequently at the end of the incubation time the plates were washed 
gently three times using wash buffer (Tecan Hydroflex Plate Washer). 
3.5.3.2.3. Fixing Biofilm Growth 
Fixed biofilms are assumed to be dead or nonviable. This procedure is done to preserve the 
biofilm that formed at a certain stage to be quantified later. This procedure is repeated twice 
during the experiment. First time is after initial biofilm growth and just before applying the 
enzymatic treatments, this is done to specific wells (8 wells) to be able to quantify initial biofilm 
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growth prior to the application of treatments. The second time is done after the end of the 
enzymatic treatment duration to the wells containing the enzymatic treatments and prior to 
final biofilm quantification. The procedure was done by washing the microtiter plates to 
remove growth medium, and filling each well with 200 µL methanol for 20 minutes at room 
temperature. The methanol is then removed using the Tecan Hydroflex Plate Washer and 
microtiter plates are left to air dry at room temperature (Stepanović et al., 2000; Kwasny and 
Opperman, 2010). 
3.5.3.2.4. Enzymatic Treatments Preparation 
The protease treatment containing Savinase and Protamex was prepared in sodium 
phosphate buffer (pH 8), while the polysaccharide-degrading enzymes treatment containing 
Pectinex and Cellic-CTec2 was prepared in sodium acetate buffer (pH 4). The mixed enzymatic 
treatment containing Savinase and Pectinex was prepared in three different buffers, sodium 
phosphate buffer (pH 8), sodium phosphate buffer (pH 6), and sodium acetate buffer (pH 4) as 
previously explained. 
The activities of the enzymes used were quantified before and after conducting the 
experiments (data not shown), no change was noticed in the enzymatic activity, for more 
details please refer to Section (3.4.3.2.5). The activity unit (U) of proteases (Savinase and 
Protamex) is defined as the required amount of enzyme to hydrolyse casein at pH 7.5, 37 oC, in 
1 minute, to produce color equivalent to 1 µmole of tyrosine (Folin and Ciocalteu, 1927; Anson, 
1938). The activity unit (U) for Pectinex is defined as the amount of enzyme required to liberate 
1 µmole of galacturonic acid from poly-galacturonic acid in 1 h at pH 4 and 25 oC. The activity 
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unit (U) for Cellic-CTec2 is defined as the amount of Cellic-CTec2 required at 37oC, and pH 5 to 
liberate 1 µmole of glucose from cellulase in 1 h (Worthington, 1988). 
3.5.3.2.5. Applying Treatments 
At the end of initial biofilm growth, the microtiter plates are washed with the wash buffer 
using Tecan Hydroflex Plate Washer. One column (8 wells) of each plate is fixed with methanol 
as explained previously. The designated enzymatic treatments were applied by dispensing 125 
µL of each enzymatic treatment into their designated wells. The microtiter plates for both 
bacterial strains were then incubated at 21 oC in a sterile chamber for 24 h.  
3.5.3.2.6. Total Biofilm Quantification Using Crystal Violet Stain 
Crystal violet binding assay is a widely used method for biofilm quantification (O’Toole, 
Kaplan and Kolter, 2000; Kolodkin-Gal et al., 2010, 2012; Brandenburg et al., 2013; Zhang and 
Hu, 2013). At the end of the treatment duration, microtiter plates are washed and fixed, and 
left to air dry completely, now the microtiter plates are ready for biofilm quantification. By 
using a manual multichannel pipette, each well was filled with 150 µL of 0.1 % (W/V) crystal 
violet stain, the plates are then incubated at the bench top and room temperature for 60 
minutes (Stepanović et al., 2000; Kwasny and Opperman, 2010). The non-binding crystal violet 
stain in the wells is then washed 4 times using Tecan Hydroflex plate washer by dispensing 200 
µL DI-Water in drip mode and aspirating without touching the bottom of the wells. The 
microtiter plates were left to air dry on the bench top at room temperature. The biofilm-
binding crystal violet was resolubilized by dispensing 200 µl of 30% acetic acid using a manual 
multichannel pipettor into each well (Stepanović et al., 2000), the microtiter plates are then 
incubated on bench top at room temperature for 20 min. Using a manual multichannel pipet, a 
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volume of 100 µL from each well was transferred to polystyrene plates with the flat clear 
bottom and absorbance is measured at 570 nm optical density using TECAN infinite M200 Pro 
Plate reader. 
3.5.3.2.7. Optimization of Biofilm Removal  
3.5.3.2.7.1 Biofilm Removal 
Biofilm removal experiments were conducted on pre-grown biofilms in 96-well 
microtiter plates using the different enzymatic treatments. Biofilm removal was calculated 
using Equation (1) below: 
 
                   (1) 
 
Where the initial biofilm is the biofilm formed in the wells before the treatments were 
applied, and the final biofilm is the biofilm remaining in the wells after the enzymatic 
treatment.   
3.5.3.2.7.2 Central Composite Design and Statistical Analysis 
A two-factor central composite design (CCD) was developed to find the optimal 
combination of enzymes concentrations for maximizing the biofilm removal efficiency using 
enzymatic treatments. This method has been widely used by researchers in optimization 
experiments in different fields of research (Kumari and Sarkar, 2014; Sarchami and Rehmann, 
2015; Barwal and Chaudhary, 2016; Sarchami, Johnson and Rehmann, 2016). The five un-coded 
values used for the different concentrations of each enzyme were as follows [high star point, 
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high central point, center point, low central point, low star point]: Savinase, Protamex, and 
Cellic concentrations (U/mL) [30.27, 28, 16, 4, 1.73]: Pectinex concentrations (U/mL) [97.1, 90, 
52.5, 15, 7.9]. 
For the optimization of the protease enzyme Savinase and the polysaccharide-degrading 
enzyme Pectinex, the pH, and microorganism type were both set as a categoric factors, the 
enzymatic combinations were tested at three pH values (4, 6, and 8), and two microorganisms 
(Bacillus sp. and P. fluorescens), these conditions result in a total of 6 blocks. The optimization 
of the two proteases Savinase and Protamex was performed at a single pH value of 8 (optimal 
pH for proteases), and microorganism type (Bacillus sp. and P. fluorescens) was set as categoric 
factor, these conditions result in a total of 2 blocks. The optimization of the polysaccharide-
degrading enzymes Pectinex and Cellic were performed at a single pH value of 4 (optimal pH for 
polysaccharide-degrading enzymes), and microorganism type (Bacillus sp. and P. fluorescens) 
was set as categoric factor, these conditions result in a total of 2 blocks. These conditions 
combined for all the different tested conditions result in a total number of 10 blocks.  
The software Design Expert 9.0.6.2 was used to develop the experimental central 
composite design. Each non-centre point (total of 8 points) was tested in 4 replicates, while 
centre points (total of 1 point) were tested in 9 replicates, a total of 41 runs for each block. All 
locations of testing conditions were randomized on the microtiter plate.  
Following the application of the different treatment combinations, the biofilm removal 
was calculated for the different treatments using Equation (1). The treatment conditions (block) 
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that resulted in the highest biofilm removal for each of Bacillus sp. and P. fluorescens was 
chosen for model fitting and analysis (total of 2 models one for each microorganism).  
The selection of the fitted model was determined using sequential model probability (p-
value), Lack-of-Fit probability (p-value), adjusted R2, and predicted R2. The second order model 
presented in Equation (2) was selected and fitted to the experimental data using linear 
regression analysis. 
 
     (2) 
 
Where: Y is the dependent variable (biofilm removal), C is a constant representing the 
regression coefficient, X is the independent variables (enzymes concentrations), and Ɛ is the 
unobserved random error.  
Design expert software 9.0.6.2 was used to analyse the experimental data obtained. 
Analysis of variance (ANOVA) was used to verify the significance of the models selected and the 
significance of each model term. The F-test with an alpha value of 0.05 was used to evaluate 
the significance. The adequacy of the models was verified using model adequate precision and 
predicted versus actual plots. Normal probability plots were used to evaluate the normal 
distribution of errors for the fitted models (normally distributed, and insignificant). 
Design Expert 9.0.6.2 was used for numerical optimization to find the optimal enzymes 
concentrations required to achieve the highest biofilm removal efficiency. The developed 
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model and enzymes optimization results were then validated by conducting experiments with 
values near the predicted optimal points. 
3.5.4. Results 
3.5.4.1. Central Composite Design (CCD) 
The enzymes used in this research are industrial mixtures that have shown high 
efficiency in biofilm removal for biofilms formed by Bacillus sp. and P. fluorescens (please see 
Sections 3.4.4.2 and 3.4.4.3). The optimal conditions for these enzymes as specified by the 
manufacturer are listed in Table 3–2.  
Table 3–2. List of Enzymes and Their Reported Optimum Conditions. 
 
Enzymes  Optimum Activity Range  Source 
Name  Type  pH  Temp. (
oC)    
                  
Protamex  Protease  7.5 - 9.5  40 - 60  Sigma-Aldrich Inc., USA 
Savinase  Protease  8.0 - 11  55 - 75  Sigma-Aldrich Inc., USA 
Pectinex  Polysaccharide-degrading  3.5 - 6.0  30 - 60  Sigma-Aldrich Inc., USA 
Cellic  Polysaccharide-degrading  4.0 - 6.5  40 - 60  Novozymes A/S, Denmark 
                  
         
 
Synergistic effects are expected when using mixtures of the enzymes presented in Table 
3–2, however conditions suitable for both proteases and polysaccharide-degrading can be 
outside of the optimum conditions of the individual enzymes, hence an overall optimization 
using mixtures of two enzymes in each tested block were conducted via a central composite 
design. The pH value and the microbial strain were treated as categoric factors, and the 
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enzymes concentrations were optimized, leading to 10 independent CCDs (blocks) as shown in 
Table 3–3. 
Table 3–3. List of Optimization Factors Used in CCDs. 
              
Optimized factors  Categoric Factors   Number  
Enzymes (U/mL)   pH Bacterial Strain   of Blocks 
        
Savinase & Pectinex  4, 6, 8 Bacillus sp. P. fluorescens  6 
        
Pectinex & Cellic  4 Bacillus sp. P. fluorescens  2 
        
Savinase & Protamex  8 Bacillus sp. P. fluorescens  2 
               
          Total Blocks   10 
        
 
After applying the different treatments for 24 hrs, biofilm removal was calculated using 
Equation (1). The data of the block that resulted in the highest biofilm removal for each of the 
two microbial strains (Bacillus sp. and P. fluorescens) are presented in Table 3–4 (similar data 
was collected for the 8 other blocks). It can be seen from the experimental results presented in 
Table 3–4 that the enzymatic treatment mixture containing Savinase and Pectinex resulted in 
the highest biofilm removal for both bacterial strains, only at two different pH values (6 and 8 
for Bacillus sp. and P. fluorescens, respectively).  The use of Savinase and Pectinex was 
successful in removing biofilms formed by Bacillus sp. and P. fluorescens within the range of 
tested input variables. When compared with biofilms formed by Bacillus sp., results obtained in 
Table 3–4 show that a higher biofilm removal was achieved for biofilms formed by P. 
fluorescens. 
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Table 3–4. Biofilm Removal Corresponding to Conditions (two blocks, one for each microbial 
strain) That Resulted in The Maximum Biofilm Removal for Bacillus sp. and P. fluorescens 
Determined for CCDs. Error values represent 95% confidence intervals. 
                    
Savinase Pectinex  Number of  pH  Biofilm Removal (%) 
U/mL U/mL   replicates   Bacillus sp. P. fluorescens   Bacillus sp. P. fluorescens 
          
1.7 52.5  4  6 8  48.7 ± 1.7 56.9 ± 4.1 
4 15  4  6 8  47.0 ± 3.4  61.0 ± 3.5 
4 90  4  6 8   53.0 ± 3.5 48.4 ± 4.1 
16.0 7.9  4  6 8  61.6 ± 1.3 76.8 ± 5.1 
16.0 52.5  9  6 8  66.2 ± 1.1 81.5 ± 2.9 
16.0 97.1  4  6 8  65.4 ± 2.0 65.5 ± 4.4 
28.0 15.0  4  6 8  63.4 ± 2.2 76.3 ± 2.5 
28.0 90.0  4  6 8  67.5 ± 1.0 77.9 ± 4.5 
30.3 52.5  4  6 8  65.2 ± 2.5 81.8 ± 2.5 
                    
          
 
The two treatment conditions (two blocks) presented in Table 3–4 were further used for model 
selection and optimization (for all the following work presented in this research). 
3.5.4.2. Models Selection, Fitting, and Statistical Analysis  
The data presented in Table 3–4 was fitted with the quadratic model presented in 
Equation (2), the fit summary of the tested models are presented in Table 3–5. Based on the 
results obtained for the sequential model sum of squares, the lack of fit test, adjusted R2 and 
predicted R2 for the fitted models, a quadratic model was found to best fit the data and was 
chosen for both Bacillus sp. and P. fluorescens (the data was also tested with linear and cubic 
models, it was found to best fit the quadratic model presented in Equation (2), data not shown 
for linear and quadratic models).  
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Table 3–5. Fitted Model Selection Summary 
  
Microbial Model Sequential Lack of Fit Adjusted Predicted 
Strain Order p-value p-value R2 R2 
       
Bacillus sp. Quadratic < 0.0001 0.6159 0.9186 0.8993 
      
P. fluorescens Quadratic < 0.0001 0.6266 0.8861 0.8642 
            
      
 
The results obtained from the ANOVA test for the response surface of the fitted 
quadratic models for Bacillus sp. and P. fluorescens are presented in Table 3–6 and Table 3–7, 
respectively. The results presented in Table 3–6 shows all the significant model parameters. The 
p-value obtained for the model suggests that it is highly significant, while the p-value for the 
Lack-of-Fit test suggest that it was insignificant, which is desired. Similar results were obtained 
in Table 3–7 for P. fluorescens. The results obtained for R2, Adjusted R2, and predicted R2 are 
presented in Table 3–6 and Table 3–7, R2 and Adjusted R2 values are close to 1.0 which 
indicates a high correlation between predicted and observed values, this shows that the models 
are excellent in explaining the relationship between response (biofilm removal) and the 
independent variables (enzymes concentrations) (Myers, Raymond H; Montgomery, Douglas C; 
Anderson-Cook, 2009).  From the results presented in Table 3–6 and Table 3–7 it can be seen 
that Savinase was the parameter with the highest influence on the biofilm removal for both 
microorganisms tested, the results showed that the interaction term (AB) was significant for the 
removal of biofilm formed by P. fluorescens and not significant for Bacillus sp. The results show 
that an optimal biofilm removal exist at a concentration that if exceeded the biofilm removal 
will be negatively affected.   
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Table 3–6. Analysis of variance table for response surface fitted quadratic model for Bacillus sp. 
viable biofilm removal. 
  
Source Sum of Degree of Mean F p-value Significant 
  Squares Freedom Square Value Prob > F   
       
Model 2207.58 4 551.89 91.27 < 0.0001 Yes 
A(Savinase) 1498.70 1 1498.70 309.30 < 0.0001 Yes 
B(Pectinex) 124.71 1 124.71 25.74 < 0.0001 Yes 
A^2 573.78 1 573.78 118.42 < 0.0001 Yes 
B^2 48.89 1 48.89 10.09 0.0031 Yes 
Residual 173.20 36 4.81    
Lack of Fit 12.73 4 3.18 0.63 0.6416 No 
Pure Error 160.47 32 5.01    
Cor Total 2380.78 40     
              
       
R2      0.93 
Adjusted R2      0.92 
Predicted R2     0.91 
Adequate Precision     25.0 
              
       
Final Equation in Terms of Actual Factors:    
𝐵𝑖𝑜𝑓𝑖𝑙𝑚 𝑅𝑒𝑚𝑜𝑣𝑎𝑙 (%) = 37.954 + 2.068𝐴 + 0.199𝐵 − 0.045𝐴2 − 0.001𝐵2  
              
       
The goodness of fit was statistically tested for the models and their associated 
parameters using the F-test for ANOVA, the results obtained are presented in Table 3–6 and 
Table 3–7. The models fitted to the biofilm removal of Bacillus sp. and P. fluorescens have an F-
value of 91.27 and 63.21, the probability of an F-value this large to occur due to noise is 0.01%.  
This indicates that the models are highly significant for the prediction of biofilm removal. The p-
values presented in Table 3–6 and Table 3–7 were used to evaluate the significance of the 
models’ parameters.  A p-value less than 0.05% is required for a model parameter to be 
considered significant (Berthouex and Brown, 1994). From the results presented in Table 3–6 
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and Table 3–7, it can be seen that all models’ parameters were found to be highly significant. 
An adequate precision value of 4 is required for the model to be considered adequate. The 
results obtained for adequate precision for the models in Table 3–6 and Table 3–7 are 22.67 
and 22.29, which indicates that both models are highly adequate.  The results presented in 
Table 3–6 and Table 3–7 indicates that the models selected are suitable for prediction of biofilm 
removal within the central composite design range. 
Table 3–7. Analysis of variance table for response surface fitted quadratic model for P. 
fluorescens viable biofilm removal. 
  
Source Sum of Degree of Mean F p-value Significant 
  Squares Freedom Square Value Prob > F   
       
Model 5224.25 5 1044.85 63.21 < 0.0001 Yes 
A(Savinase) 3243.76 1 3243.76 196.25 < 0.0001 Yes 
B(Pectinex) 347.87 1 347.87 21.05 < 0.0001 Yes 
AB 203.36 1 203.36 12.30 0.0013 Yes 
A2 959.45 1 959.45 58.05 < 0.0001 Yes 
B2 693.12 1 693.12 41.93 < 0.0001 Yes 
Residual 578.51 35 16.53   
 
Lack of Fit 30.28 3 10.09 0.59 0.63 No 
Pure Error 548.23 32 17.13   
 
Cor Total 5802.76 40    
 
              
       
R2      0.90 
Adjusted R2      0.89 
Predicted R2      0.86 
Adequate Precision     22.29 
              
       
Final Equation in Terms of Actual Factors:    
𝐵𝑖𝑜𝑓𝑖𝑙𝑚 𝑅𝑒𝑚𝑜𝑣𝑎𝑙 (%) = 49.479 + 2.369𝐴 + 0.314𝐵 + 0.008𝐴𝐵 − 0.059𝐴2 − 0.005𝐵2 
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The numerical relationship between the independent variables (enzymes 
concentrations) and the dependent variable (biofilm removal) was described using a second-
order polynomial quadratic equation. The quadratic equations developed in terms of actual 
factors (enzymes concentrations) for the response (biofilm removal) are presented Table 3–6 
and Table 3–7 for Bacillus sp. and P. fluorescens, respectively.  
 
Figure 3-14. Normal % Probability Versus Externally Studentized Residuals for Bacillus sp. (1.A) 
and P. fluorescens (2.A) and The Model Predicted Values Versus Actual Experimental Values for 
Bacillus sp. (1.B) and P. fluorescens (2.B). 
The results of the normal (%) probability plots of the external studentized residuals for 
the suggested models are presented in Figure 3-14 (1.A and 2.A, for Bacillus sp. and P. 
fluorescens respectively), It can be seen from the plots that the errors were generally 
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insignificant and normally distributed, which is desired. Residual analysis assures that the 
analytical data fits the statistical assumptions. The results of the predicted versus actual plots 
presented in Figure 3-14 (1.B and 2.B, for Bacillus sp. and P. fluorescens respectively) shows 
that the models were satisfactory in predicting real conditions. Good agreement can be seen 
between predicted and actual and no obvious dispersal can be noticed. Results obtained for 
predicted versus actual (Figure 3-14) suggests that the models were adequate in predicting real 
conditions. The diagnostic plots presented in Figure 3-14 can be used to evaluate how 
satisfactory are the models developed, which was found to be highly satisfactory.  
 
3.5.4.3. Response Surface Analysis and Numerical Optimization 
 Response surface plots provide a better visualization of the effect of each of the tested 
factors (enzymes concentration) on the measured response (Biofilm Removal) within the range 
of the tested factors. 
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Figure 3-15. Optimal Biofilm Removal for Bacillus sp. (A), and P. fluorescens (B). 
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The response surface plots of biofilm removal for Bacillus sp. and P. fluorescens are 
presented in Figure 3-15. It can be clearly seen from the plots that an optimum biofilm removal 
exists within the observed design space with respect to enzymes concentration for both Bacillus 
sp. and P. fluorescens. Increasing the enzymes concentrations close to midranges results in an 
increase in biofilm removal for both Bacillus sp. and P. fluorescens. While increasing the 
concentration of the enzyme beyond midrange results in a decrease in biofilm removal for both 
Bacillus sp. and P. fluorescens.   
Numerical optimization was conducted on the models developed for Biofilm removal for 
each bacterial strain. The results of the numerical optimization for the different treatment 
conditions tested (all 10 blocks) are presented in Table 3–8. The highest biofilm removal for 
Bacillus sp. (68.7%) was achieved by Savinase (22.6 U/mL) and Pectinex (70.9 U/mL) at a pH of 
6.  The highest biofilm removal for P. fluorescens (84.5%) was achieved by Savinase (23.7 U/mL) 
and Pectinex (48.8 U/mL) at a pH value of 8. The results presented in Table 3–8 suggest that, for 
both microorganisms tested in this research, generally a higher biofilm removal can be achieved 
at higher pH values, and when compared with Bacillus sp., a higher biofilm removal was 
achieved by most treatments for biofilms formed by P. fluorescens. 
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Table 3–8. Numerical Optimization Results of All Initial Treatment Conditions (10 blocks) for 
Biofilm Removal for Bacillus sp. and P. fluorescens. 
                      
Bacterial  pH  Enzymes  Optimal 
Species    Name  Conc.* (U/mL)   Biofilm 
      1 2   1 2  Removal (%) 
                      
           
Bacillus sp.   4   Savinase Pectinex   18.3 76.9   52.8 
P. fluorescens  4  Savinase Pectinex  18.1 65.2  82 
Bacillus sp.   6   Savinase Pectinex   19.6 63.8   68.1H 
P. fluorescens  6  Savinase Pectinex  14.1 57.3  79.3 
Bacillus sp.   8   Savinase Pectinex   23.3 62   50.6 
P. fluorescens  8  Savinase Pectinex  23.7 48.8  84.5
H 
Bacillus sp.   4   Pectinex Cellic-CTec2   59.1 19   67.3 
P. fluorescens  4  Pectinex Cellic-CTec2  57.6 14.2  55.8 
Bacillus sp.   8   Savinase Protamex   19.7 13.3   38.7 
P. fluorescens  8  Savinase Protamex  20.8 10.3  75.2 
                      
H represents the highest biofilm removal obtained for the specified bacterial strain 
* represents the enzyme concentration corresponding to the optimal biofilm removal 
 
The results presented in Table 3–8 shows the numerical optimization of all treatment 
conditions (10 blocks) tested at the beginning of this work. The results of the numerical 
optimization of all treatment conditions (10 blocks) reassures the proper selection of the 
treatment conditions (blocks) that resulted in the highest biofilm removal for each bacterial 
strain (presented in Table 3–4). The results of the treatment conditions containing both 
Savinase and Pectinex (6 blocks) presented in Table 3–8 showed that the pH value appears to 
be proportional to the optimal concentration of Savinase and inversely related to the optimal 
concentration of Pectinex. 
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3.5.4.4. Verification of Response Surface Models and Optimal Conditions 
The actual and predicted values of Bacillus sp. and P. fluorescens near optimal biofilm 
removal is presented in Table 3–9. The results of predicted and actual biofilm removal 
presented in Table 3–9 for Bacillus sp. and P. fluorescens was compared using the statistical T-
test at 95% confidence interval and no significant difference was found (data not shown). The 
results presented in Table 3–9 shows that the response surface models were successful in 
predicting optimal biofilm removal. 
Table 3–9. Models and Optimal Conditions Verification. Errors for biofilm removal represent 95% 
confidence intervals. 
              
Microorganism Factor 1 Factor 2 Factor 3  Biofilm Removal (%) 
 Savinase Pectinex pH  Predicted Actual 
Bacillus sp. 16 52.5 6  66.17±1.42 67.27±1.29 
P. fluorescens 16 52.5 8  81.44±2.62 80.09±3.25 
        
 
       
 
3.5.5. Discussion 
Treatments tested in this research were applied to pre-existing biofilms of both Bacillus 
sp. and P. fluorescens at room temperature (21oC) for 24 h to mimic actual conditions in 
treatment application. The enzymes used in this research are presented in Table 3–2, these 
enzymes were chosen due to their reported efficiency in the removal of biofilms formed by 
Bacillus sp. and P. fluorescens (please see Sections 3.4.4.2 and 3.4.4.3). The two microorganisms 
used to produce biofilms, Bacillus sp. and P. fluorescens, are chosen due to their different 
biofilm composition (please see Section 3.5.2); to represent more scenarios that might be 
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encountered in real conditions. The intention of this study is not to discuss the mechanism of 
biofilm removal using enzymes as this was covered in previous work (please see Section 3.4).  
Although researchers have previously recommended the use of different enzymatic mixtures 
for biofilm treatment ( Cordeiro, Hippius and Werner, 2011; Torres et al., 2011), to the best 
knowledge of the authors, this is the first attempt to optimize the use of proteases and 
polysaccharide-degrading enzymes in a mixed enzymatic treatment containing both enzymes 
types for biofilm removal.   
The experimental conditions and biofilm removal results presented in Table 3–4 are the 
actual values of the independent variables (concentrations of enzymes used, pH, and bacterial 
strain) and their measured responses (biofilm removal). All experimental conditions presented 
in Table 3–4 were chosen based on a central composite design. The aim of the central 
composite design was to present a simple empirical correlation between the concentrations of 
the two different enzymes used (two independent variables) and biofilm removal (the 
measured response).   As can be seen from Table 3–4 and Table 3–8 all tested enzymatic 
treatments were successful in removing biofilms formed by Bacillus sp. and P. fluorescens 
within the ranges of tested input values. This was expected as previous work conducted 
indicated that optimal biofilm removal existed within these ranges (please see Section 3.4.4). 
The experimental conditions (enzyme 1, enzyme 2, pH, and bacterial strain) presented in Table 
3–4 (and later confirmed in Table 3–8) that resulted in the highest biofilm removal for Bacillus 
sp. and P. fluorescens were selected for further analysis. 
 The generated actual datasets for the treatment condition that resulted in the highest 
biofilm removal (presented in Table 3–4) went through further analysis for model selection, 
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using the sequential model sum of squares, lack-of-fit test, predicted R2, adjusted R2 presented 
in Table 3–5 and were found to best fit the quadratic model presented in Equation (2). The p-
value under the sequential term in Table 3–5 represents the probability that the order terms 
are modelling the noise rather than the trend in the response (biofilm removal). The p-values 
obtained for the quadratic models of Bacillus sp. and P. fluorescens were less than 0.0001 for 
both bacterial strains, the probability that the order terms are modelling the noise rather than 
the trend in the response is less than 0.01%, which is highly desirable. The p-values obtained for 
the lack-of-fit test for Bacillus sp. and P. fluorescens were 0.62 and 0.63, the best model should 
have an insignificant lack-of-fit with the desired p-value higher than 0.10, the probability that 
this large lack of fit could occur due to noise is 61.59% and 62.66%, respectively. The obtained 
p-values for the lack-of-fit test shows that the selected models have highly insignificant lack-of-
fit, which is highly desirable. The selected quadratic models for Bacillus sp. and P. fluorescens 
have high R2 and adjusted R2 values (presented in Table 3–5), which is highly desirable. Based 
on the results presented in Table 3–5, a quadratic model was selected for both Bacillus sp. and 
P. fluorescens. The response surface representing the selected models is presented in Figure 
3-15 for Bacillus sp. and P. fluorescens.  
The selected quadratic models and their associated parameters for Bacillus sp. and P. 
fluorescens were analysed for their significance using their F-value and the results are 
presented in Table 3–6 and Table 3–7, respectively.  The models F-value for Bacillus sp. and P. 
fluorescens were found to be 91.27 and 63.21, there is less than 0.01% chance that F-values this 
large could be due to noise. The associated model p-value is the probability that the data used 
produced false effects, this value is desired to be less than 0.05 for the model to be significant, 
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results of model p-value obtained for Bacillus sp. and P. fluorescens were less than 0.0001 for 
both bacterial strains, which indicates that both models are highly significant. The significance 
of models’ parameters was determined using their associated p-values, a p-value less than 0.05 
is required for a model parameter to be considered significant, as can be seen from p-values 
presented in Table 3–6 and Table 3–7, all models parameters were found to be highly 
significant with p-values less than 0.0001. The results presented in Table 3–6 and Table 3–7 also 
suggest that all tested factors have a great effect on biofilm removal. 
The points presented in Figure 3-14 (1.A and 2.A) for the normal (%) probability of the 
external studentized residuals lay close to the straight line and between -2.0 and 2, which 
indicates that errors were insignificant and normally distributed (Mason, Gunst and Hess, 
2003). This assures that the analytical data presented fits the statistical assumptions made. 
Another important part of the model statistical analysis is the model adequacy check. Models 
adequacy was evaluated using actual versus predicted plots presented in Figure 3-14 (1.B and 
2.B), it can be seen that there is good agreement between actual and predicted values with no 
obvious dispersal, this indicates that the models are adequate. These results confirm the 
adequate precision results presented in Table 3–6 and Table 3–7. 
Bacillus sp. optimal biofilm removal was found to be 68.7% at pH of 6, and 
concentrations of 22.6 U/mL and 70.9 U/mL for Savinase and Pectinex respectively. Optimal 
biofilm removal for P. fluorescens was found to be 84.5% at pH of 8, and concentrations of 22.6 
U/mL and 70.9 U/mL for Savinase and Pectinex respectively. The response surface plots 
presented in Figure 3-15 shows that Savinase and Pectinase were effective in removing pre-
existing biofilms formed by Bacillus sp. and P. fluorescens. Generally, the enzymatic treatments 
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tested showed less biofilm removal (%) for Bacillus sp. and higher biofilm removal (%) for 
biofilms formed by P. fluorescens, possible explanation for that is the different composition of 
the biofilms formed by the two different bacterial strains (Morikawa et al., 2006; Molobela, 
Cloete and Beukes, 2010), moreover, biofilms formed by Bacillus sp. were more robust (thicker) 
when compared to biofilms formed by P. fluorescens (biofilm formation was measured 
indirectly using crystal violet stain).    
Previous studies that have separately used Pectinex and Savinase reported them to be 
successful in removing biofilms (Johansen and Falholt, 1997; C. Leroy et al., 2008; Molobela, 
Cloete and Beukes, 2010). Studies on optimization of enzymatic treatments for biofilm removal 
are very limited, to the best knowledge of the authors, this is the first study that optimizes the 
combined treatment of proteases and polysaccharide-degrading enzymes for removal of 
biofilms. Only one enzymatic optimization study was found by Johansen and Falholt 1997, the 
authors used two polysaccharide-degrading enzymes, Mutanase and Dextranase, for the 
removal of plaque. In their study, a plaque was formed on hydroxyapatite discs and the 
removal of the plaque was measured in terms of log reductions in colony forming units per disc 
(CFU/disc). The authors reported additive effect (log reduction from 108 to 106 CFU/disc) from 
combining both enzymes in one treatment rather than using them separately in treatments 
(Johansen and Falholt, 1997).  The authors also reported that Pectinex alone was able to reduce 
the cell count for biofilm formed by P. fluorescens one log reduction (2.5x10-7 to 2.4x10-6) using 
a concentration of 180 PSU mL-1 for 15 min at pH 7. A study by Leroy et al. 2008 investigated 
and compared the efficiency of different enzymes (four proteases, seven polysaccharide-
degrading, and one lipase) used as anti-biofilm agents against biofilms formed by marine 
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bacterial strain Pseudoalteromonas sp. D41. The biofilm was grown for 24 hrs in a 96-well 
microtiter plate using sterile seawater at 20 oC. Biofilm was quantified using fluorescent dye 
DAPI (4[prime]6-diamidino-2-phenylindole). Results obtained showed that Savinase had the 
highest efficiency in preventing and removing biofilms (up to 100% reduction in bacterial 
adhesion and 50% reduction of pre-existing biofilms after a 24 hrs treatment at a concentration 
of 1.7 mg mL-1). From their results, the authors concluded that depending on the enzymes used 
and their concentrations, enzymes could remove biofilms or inversely increase their formation 
(C Leroy et al., 2008). 
The validation of the response surface models and optimal conditions was done by 
performing and independent confirming experiment around the estimated optimal conditions, 
the results of the predicted and actual values of biofilm removal are presented in Table 3–9. 
The actual and predicted values presented in Table 3–9 were compared using the statistical T-
test at 95% confidence interval and no significant difference was found between them. This 
indicates that the proposed models can be used for the prediction of biofilm removal using 
Savinase and Pectinex. 
3.5.6. Conclusions 
In conclusion, synergetic effects can be noticed by combining the protease Savinase and 
the polysaccharide-degrading enzyme Pectinex. The enzymatic mixtures containing these two 
enzymes were more effective than treatments containing two enzymes from the same type 
(the proteases Savinase and Protamex, and the Polysaccharide-degrading Pectinex and Cellic). 
Identifying the optimal concentrations of enzymes for biofilm removal is vital not only from an 
economical point, the results presented suggests that increasing the enzyme concentration 
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beyond the optimal resulted in adverse effects on biofilm removal, this is hypothesised to be a 
result of the elevated amounts of sugars that are associated in the enzymatic mixtures 
preparations during their manufacturing process. The results suggest that the pH can have a 
high influence on the biofilm removal process, this is due to its influence on both the efficiency 
of the enzymes and its direct effect on biofilm formation. The use of a mixed (protease and 
polysaccharide-degrading) enzymatic treatment was successful in removing biofilms formed by 
Bacillus sp. and P. fluorescens. The models developed were successful in estimating real 
conditions for the removal of biofilm formed by Bacillus sp. and P. fluorescens using the 
enzymes mixture. The optimal conditions for the highest removal (68.1%) of biofilm formed by 
Bacillus sp. was achieved by Savinase and Pectinex at concentrations of 19.6 U/mL and 63.8 
U/mL, and a pH value of 6. The optimal conditions for the highest removal (84.5%) of biofilm 
formed by P. fluorescens was achieved by Savinase and Pectinex at concentrations of 23.7 U/mL 
and 48.8 U/mL, and a pH value of 8. Higher biofilm removal was achieved for pH values at or 
above neutral (pH 6-8).  
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Chapter 4 - Thesis Summary and Conclusions 
4.1 Preface 
Chapter 4 provides a summary of the experimental work performed in this thesis and 
the thesis’ general conclusions.  
4.2 Thesis Summary 
The control of biofilm formation is of high interest in medical and industrial areas. 
Consequently, biofilm control agents are of industrial and academic interest. Therefore, the 
goal of this thesis is to investigate the ability of potential treatments to control biofilm 
formation. 
4.2.1 Biofilm Control Using Norspermidine 
Studies that have previously investigated biofilm removal debated the effect of 
norspermidine on biofilm formation control. The effect of norspermidine on biofilm formation 
was of specific interest for this thesis. The results presented in this study suggest that 
norspermidine enhanced biofilm growth for active biofilm communities by 73%, while it caused 
disassembly for nonactive (dead) biofilm with 39% biofilm removal. This dual effect is possibly 
responsible for the apparent contradiction on the role of norspermidine in the previous 
literature. 
4.2.2 Biofilm Control Using D-amino Acids 
Amino acids have been described as self-produced triggers by bacteria at late stages of 
mature biofilm for biofilm disassembly. Varying results have been presented by previous 
researchers on the effects of D-amino acids on biofilm formation. Currently, the literature is 
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lacking for quantitative studies that investigate the effect of D-amino acids on biofilm 
formation. The four D-amino acids investigated in this research (D-tyrosine, D-tryptophan, D-
Methionine, and D-leucine) could inhibit biofilm growth for Bacillus sp. at concentrations as low 
as 5 µM for D-tyrosine and 5 mM for D-methionine, D-tryptophan, and D-leucine. The increase 
in the concentration of D-tyrosine (µM) and D-tryptophan (mM) between 10 and 20 had limited 
effects on the dispersal (31% and 28%, respectively) of Bacillus sp. pre-existing biofilms. The 
concentration of D-tyrosine and D-tryptophan applied was proportional to biofilm removal. D-
leucine and D-methionine did not show the ability to remove Bacillus sp. pre-existing biofilm for 
treatments concentrations up to 20 mM. D-amino acids mixture treatment consisting of 5 µM 
D-tyrosine and 5 mM of D-tryptophan, and D-leucine, and D-Methionine could inhibit biofilm 
formation. The increase of D-tryptophan (mM) and D-tyrosine (µM) concentration between 10 
and 20 in the D-amino acids mixture resulted in the dispersal (39%) of Bacillus sp. pre-existing 
biofilm. The results obtained for the D-amino acid mixture showed limited synergetic effects.  
4.2.3 Biofilm Control Using Enzymes 
Previous studies have presented promising results on the use of enzymatic treatments 
for biofilm removal. Previous studies have approached the problem without a comprehensive 
approach to the type of biofilm tested and selected enzymes. Current limitations on the use of 
enzymatic treatments for biofilm removal is due to the substrate-specific nature of enzymes 
which is met with biofilm composition of high complexity. In this thesis, a comprehensive 
approach was used in investigating the efficiency of two different enzyme types 
(polysaccharide-degrading and proteases) as biofilm control agents for the removal of two 
different composition biofilms formed by Bacillus species and Pseudomonas fluorescens. The 
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results obtained suggest that the proteases, Savinase had the highest biofilm removal 
capabilities when compared to other tested proteases. Savinase removed 68% and 84% of 
biofilm formed by Bacillus sp. and P. fluorescens respectively. The highest biofilm removal by 
polysaccharide-degrading enzymes was achieved by Pectinex. Pectinex removed 74% and 55% 
of biofilm formed by Bacillus sp. and P. fluorescens respectively. The results obtained suggest 
that an optimization of enzymatic treatment containing a mixture of enzymes can be beneficial 
for higher removal efficiency for biofilms with different compositions. 
4.2.4 Optimization of Biofilm Removal Using Enzymatic Treatments 
The use of enzymatic mixture treatments as biofilm control agents have been 
recommended by previous researchers. This is due to the promising results enzymes have 
shown when used for biofilm removal. The removal of biofilms formed by two different 
bacterial strains (different biofilm compositions), using enzymatic mixtures formed from 
polysaccharide-degrading enzymes and proteases was optimized using response surface 
analysis and central composite design. Ten central composite designs have been used to 
evaluate the effect of enzymes concentration and pH on the removal of biofilm formed by 
Bacillus sp. and P. fluorescens. The experimental data were fitted with a quadratic model. The 
model developed was successful in predicting the biofilm removal as a function of the 
concentrations of enzymes used. The quadratic model developed was verified by additional 
experiments, there was no significant difference between actual and predicted values of the 
biofilm removed. The results obtained in this thesis suggests that enzymatic treatments 
containing Savinase and Pectinex were the most effective for biofilm removal. The treatment 
containing Pectinex and Savinase at concentrations of 63.8 and 19.6 U/mL, respectively, 
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removed 68.1% of Bacillus sp. biofilm at pH 6, and at concentrations of 48.8 and 23.7 U/mL, 
respectively, removed 84.5% of P. fluorescens biofilm at pH 8. 
4.3 General Conclusions 
The main objective of this thesis was to investigate and develop treatments that can be 
used for biofilm control. The work presented in Section 3.2 highlights the importance of 
considering the biological activity of the tested biofilm. The results presented showed that 
active and nonactive biofilms responded differently to the treatment containing norspermidine. 
This different response was attributed to the competition between the biological process 
(biofilm growth) and the chemical interaction between norspermidine and the polysaccharides 
in the biofilm. When norspermidine was added to active biofilm, the biological process was 
dominant over the chemical interaction between norspermidine and the polysaccharides in the 
biofilm matrix and biofilm growth was enhanced. When the biofilm was nonactive (dead) the 
biological process ceased and the chemical interaction between norspermidine and the 
polysaccharide was dominant which resulted in biofilm removal.  
The results obtained in Section 3.3  suggests that the D-amino acids examined in this work can 
be used to inhibit the growth of Bacillus sp. pre-existing biofilm. The use of D-tyrosine and D-
tryptophan treatments did result in partial removal of pre-existing biofilm. The D-amino acid 
mixture did not show clear synergetic effects in the removal of pre-existing biofilm. Therefore, 
the use of D-amino acids can be utilized for inhibiting Bacillus sp. biofilm formation. Due to the 
lack of synergetic effects for the combined treatment, an optimization study for biofilm 
removal using D-amino acids mixtures was not recommended. 
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The results presented in Section 3.4 suggests that the use of proteases and 
polysaccharide-degrading enzymes was effective in the removal of biofilms formed by the two 
bacterial strains Bacillus sp. and P. fluorescens. The polysaccharide-degrading enzymes Cellic-
CTec2 and Pectinex, and the proteases Protamex and Savinase exhibited the highest biofilm 
removal efficiency for pre-existing biofilms formed by Bacillus sp. and P. fluorescens. Higher 
biofilm removal was achieved for biofilm formed by P. fluorescens using proteases., while for 
biofilm formed by Bacillus sp. the polysaccharide-degrading enzymes exhibited the highest 
biofilm removal efficiency. Remarkably, the results obtained in Section 3.4 highlight the 
interdependent relationship between the proteins and the polysaccharides in maintaining the 
structural integrity of the biofilm formation. The ability of the polysaccharide-degrading 
enzymes to remove a considerable amount of biofilm formed by P. fluorescens biofilm 
(composed mainly from proteins), and the ability to remove a significant amount of the biofilm 
formed by Bacillus sp. (composed mainly from polysaccharide) using proteases, emphasises the 
complex interdependent relation between proteins and polysaccharides in maintaining the 
integrity of the biofilm structure.  
From the results presented in Section 3.5 it could be stated that synergetic effects on 
biofilm removal were obtained after combining the protease Savinase and the polysaccharide-
degrading enzyme Pectinex in a mixed treatment. The treatment containing Savinase and 
Pectinex were more effective than treatments containing two proteases or two polysaccharide-
degrading enzymes. Recognizing the optimal concentrations of enzymes used for biofilm 
removal is critical. The results presented in Section 3.5 suggests that when the enzyme 
concentration exceeded the optimal concentration, adverse effects on biofilm removal were 
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obtained, it is hypothesised that this was a result of the increase in the concentration of sugars 
and other nutrients that are incorporated in the preparation process of enzymatic mixtures 
during the manufacturing process. The results obtained highlighted the effect of the pH on 
biofilm removal using enzymes. The pH affects the biofilm removal by affecting the efficiency of 
the enzymes used and through its direct effect on biofilm growth. The mixed enzymatic 
treatments were successful in removing biofilms formed by the two bacterial strains tested, 
Bacillus sp. and P. fluorescens. The quadratic models developed were successful in predicting 
actual conditions for removal of biofilms formed by P. fluorescens and Bacillus sp. using the 
enzymes mixtures. 
A suitable biofilm control agent is expected to enhance, inhibit, or eliminate biofilm 
formation on surfaces. The different treatments investigated in this thesis are norspermidine, 
D-amino acids, and enzymes. Based on the results presented in chapter 3 and using the 
evaluation procedure presented in Figure 1-2, it was concluded that the use of the treatments 
containing D-amino acids was found efficient for inhibiting biofilm formation, the ability of D-
amino acids to remove biofilm formation was found to be limited. The use of norspermidine 
was found to be effective in enhancing active biofilm formation which can be utilized in 
beneficial biofilm applications. The use of the treatment containing norspermidine enhanced 
the biofilm formation for active biofilm. Norspermidine showed limited ability in removing 
nonactive biofilm, this required a pre-treatment of the biofilm with methanol to inactivate the 
biofilm and this rendered the norspermidine treatment nonpractical for biofilm removal. In 
addition, the biofilm removed using norspermidine was limited. The use of enzymatic 
treatments was found to be the most efficient method investigated for biofilm removal. In 
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specific, the use of optimized enzymatic treatments containing the protease Savinase and the 
polysaccharide-degrading enzyme Pectinex were found to be the most effective treatment for 
the removal of biofilm. The developed models using the central composite designs and the 
response surface methodology were successful in predicting biofilm removal, no significant 
difference was found between predicted and actual values of biofilm removal. 
4.4 Future Recommendations 
The use of norspermidine and D-amino acids returned limited ability in removing pre-
existing biofilm formed by Bacillus sp. and P. fluorescens, therefore they are not recommended 
for the removal of pre-existing biofilm. Based on the resulted presented in this thesis, enzymes 
were the most effective treatment tested for the removal of pre-existing biofilm, therefore, it is 
recommended that future research on treatments for biofilm removal should be directed 
toward the use of enzymes. Future research should be directed toward developing a consistent 
and reproducible biofilm in flexible PVC tubes that are used in dental unit water lines (DUWLs) 
and other related applications under similar conditions found in DUWLs, this can help in 
producing results and comparisons that are statistically sound from biofilm removal 
experiments that are conducted on a biofilm that is more analogous to actual biofilm found in 
DUWLs. Enzymes are abundant and new enzymes emerge into the market constantly, it is 
recommended to continue testing new emerging enzymes for their ability to remove biofilm. 
Future research should be directed toward developing short duration treatments for cleaning 
DUWLS that can be used in between consecutive patients, this will help in reducing cross-
contamination.  
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Chapter 5 - Appendices 
5.1 Biofilm Production Protocol 
The biofilm used for testing the different treatments evaluated in this thesis was grown in 96-
well microtiter plates. Biofilm production and treatment testing that was used to evaluate the 
ability of different treatments to remove pre-existing biofilm is presented in the following eight 
steps: 
1- Preparing seed culture. 
2- Inoculation of microtiter plates. 
3- Washing initial biofilm in microtiter plates. 
4- Fixing initial biofilm formation. 
5- Applying Treatments. 
6- Washing final biofilm in microtiter plates. 
7- Fixing final biofilm formation. 
8- Quantification of biofilm formation using crystal violet stain. 
The aforementioned steps are explained in detail in subsections 5.1.1 – 5.1.8. These steps 
should be followed in the order they are mentioned. 
5.1.1 Prepare Bacterial Seed Culture 
1- Add 1 mL of bacterial suspension into a sterile microcentrifuge vial. 
2- Centrifuge the vial at 10,000 RPM for 60 seconds. 
3- Remove supernatant and add 1 mL wash buffer. 
4- Vortex the vial until the bacterial spores are completely dissolved 
5- Repeat steps 2-4 twice. 
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6- Add 1 milliliter of appropriate biofilm growth media to the vial and vortex. 
7- Using a 125-mL glass flask with a stir, half a milliliter of the washed bacterial spores are 
re-suspended in 20 mL growth media. 
8- The glass flask in then placed on the magnetic stirrer at 300 RPM and incubated at 
appropriate temp (37oC for Bacillus sp. And 21 oC for P. fluorescens) until optical 
density at 600 nm is between 1 and 1.6 when Milli-Q water is used as blank. 
 
5.1.2 Inoculation of Microtiter Plates with Bacterial Seed Culture 
1- A 200-mL glass petri dish with a flat bottom is filled with appropriate biofilm growth 
media and a stir bar. 
2- The prepared bacterial seed culture is then diluted in a 1:100 ratio in appropriate 
biofilm growth media. 
3- The petri dish is then placed on a magnetic stirrer at 300 rpm.  
4- 100 µL of sterile biofilm growth media are transferred into control wells in the 
microtiter plates. 
5- 100 µL from the petri dish are transferred into wells in the microtiter plates. 
6- Each microtiter plate is then covered with a sterile thin film (25 µm) to seal it and 
reduce evaporation. 
7- One hole is poked in the center of each well using a 22-gauge sterile needle (separate 
needles should be used for each of the inoculated wells and control wells to ensure no 
cross contamination will occur). 
8- The microtiter plates are then incubated at the appropriate conditions (37oC for Bacillus 
sp. and 21 oC for P. Fluorescens) and time (32 h for Bacillus sp. Abd 72 h for P. 
Fluorescens, biofilm growth media is replenished daily for P. Fluorescens only) for 
biofilm to form in the microtiter plate wells. 
 
5.1.3 Washing Initial Biofilm in Microtiter Plates with Wash Buffer 
After the incubation time is over and the biofilm has formed in the microtiter plate, the biofilm will be 
ready for washing. 
1- The thin film placed on the microplate is removed and then the microplate is placed in 
the Tecan Hydroflex Plate Washer. Each well in the plate is filled with 100 µL of wash 
buffer solution using the drip mode and then wash buffer is aspirated. 
2- Following that 150 µL of wash buffer solution is dispensed and aspirated same as the 
previous step, the process is repeated for a total of three times. 
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3- The microtiter plate is then gently flicked and the face of the microtiter plate is placed 
on a paper towel to release any excess liquid. 
 
5.1.4 Fixing Initial Biofilm Formation 
This step in performed to fix initial biofilm growth that will be compared with the biofilm 
remaining in other wells after applying treatment to them.  
1- 200 µL of methanol (99%) are dispensed into designated initial growth wells only. 
2- The microtiter plate is covered with aluminum foil to prevent evaporation for 20 min. 
3- The methanol is removed using the multichannel micropipette. 
 
5.1.5 Applying Treatments 
1- 125 µL of treatment solution are dispensed into desired wells. 
2- The microtiter plates are then covered with thin film. 
3- A single hole is poked in the center of each well using the 22-gauge sterile needle. 
4- The microtiter plates are then incubated at 21 oC for 24 h in sterile conditions. 
 
5.1.6 Washing Final Biofilm in Microtiter Plates With DI-Water 
After the treatment incubation time (24 h) is over the microtiter plate are ready for washing to remove 
exhausted media and loosely attached cells. 
1- The thin film placed on the microplate is removed and then the microplate is placed in 
the Tecan Hydroflex Plate Washer. Each well in the plate is filled with 100 µL of DI-
Water using the drip mode and then the DI-Water is aspirated. 
2- Following that 150 µL of DI-Water is dispensed and aspirated same as the previous step, 
the process is repeated for a total of three times. 
3- The microtiter plate is then gently flicked and the face of the microtiter plate is placed 
on a paper towel to release any excess liquid. 
 
5.1.7 Fixing Final Biofilm Formation 
This step in performed to fix the final biofilm formation that will be compared with the initial 
biofilm formation in the control wells.  
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1- 200 µL of methanol (99%) are dispensed into designated treated wells only. 
2- The microtiter plate is covered with aluminum foil to prevent evaporation for 20 min. 
3- The methanol is removed by aspiration using the Tecan Hydroflex Plate Washer. 
4- The microtiter plates are left to air dry completely on bench top. 
 
5.1.8 Quantification of Biofilm Formation Using Crystal Violet Stain 
 The crystal violet staining method is an indirect method for quantifying biofilm formation in microtiter 
plates. 
  
1- 150 µL of 0.1 % (W/V) crystal violet is dispensed into each well using the multichannel 
micropipette. 
2- The microtiter plate is covered to prevent evaporation and incubated at room 
temperature for 60 min. 
3- The microtiter plates are washed 4 times by dispensing 200 µL DI-Water in drip mode 
and aspirating using the Tecan Hydroflex plate washer. 
4- The microtiter plates are then left to air dry completely on bench top. 
5- The crystal violet is then resolubilized by dispensing 200 µl 30% acetic acid into each 
well. 
6- The microtiter plates are then covered and incubated without shaking at room 
temperature for 20 min. 
7- 100 µL from each well are transferred to new hard polystyrene plate with the clear flat 
bottom for quantification. 
8- Absorbance at OD 570 nm is measured using a TECAN infinite M200 Pro plate reader. 
The absorbance measured in proportional to the biofilm formed in the plates. 
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5.2 Raw Data Used in Section 3.4. 
The data used in creating the graphs presented in Section 3.4 is presented in Table A 
and Table B presented below.  
Table A.  The final biofilm formation following 24 h treatment duration of the tested 
proteases at different concentrations on biofilm formed by Bacillus sp. and P. fluorescens 
with 95% confidence intervals (n=8) (Raw data used in Section 3.4). 
                      
Enzyme   Bacillus sp.  P. fluorescens 
Name   Conc.  Abs. Unit   C.I.  Abs. Unit   C.I. 
   U/mL   570 nm   95%   570 nm   95% 
P
ro
ta
m
ex
 
 1  1.18  0.04  0.30  0.03 
 5  0.89  0.09  0.20  0.05 
 10  1.11  0.03  0.17  0.02 
 15  1.50  0.04  0.14  0.02 
 30  1.69  0.08  0.25  0.03 
 Initial Growth  1.89  0.07  0.81  0.05 
                      
Sa
vi
n
as
e 
 1  1.11  0.07  0.33  0.02 
 5  0.74  0.04  0.16  0.02 
 10  0.64  0.06  0.18  0.02 
 15  0.61  0.06  0.31  0.02 
 30  0.74  0.08  0.42  0.05 
 Initial Growth 
 1.89  0.05  0.98  0.07 
                      
Su
b
ti
lis
in
 A
 
 1  1.29  0.07  0.34  0.02 
 5  1.36  0.05  0.30  0.02 
 10  1.36  0.04  0.32  0.01 
 15  1.41  0.05  0.32  0.03 
 30  1.58  0.04  0.39  0.02 
 Initial Growth 
 1.76  0.07  0.76  0.04 
                      
Tr
yp
si
n
 
 1  1.46  0.08  0.42  0.01 
 5  1.55  0.08  0.37  0.01 
 10  1.60  0.13  0.41  0.01 
 15  1.61  0.13  0.45  0.04 
 30  1.59  0.09  0.52  0.02 
 Initial Growth 
 1.87  0.09  0.79  0.05 
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Table B.  The final biofilm formation following 24 h treatment duration of the tested 
polysaccharide degrading enzymes at different concentrations on biofilm formed by Bacillus 
sp. and P. fluorescens with 95% confidence intervals (n=8) (Raw data used in Section 3.4). 
                      
Enzyme   Bacillus sp.   P. fluorescens 
Name  Conc. 
 Abs. Unit  C.I.  Abs. Unit  C.I. 
   U/mL   570 nm   95%   570 nm   95% 
P
ec
ti
n
ex
 
 5  1.21  0.07  0.51  0.05 
 15  0.92  0.05  0.37  0.03 
 25  0.46  0.07  0.34  0.02 
 50  0.53  0.08  0.35  0.03 
 75  0.88  0.04  0.37  0.02 
 Initial Growth  1.81  0.12  0.76  0.05 
                      
C
el
lic
-C
Te
c2
  1  1.47  0.11  1.11  0.10 
 5  0.94  0.08  0.74  0.04 
 10  0.86  0.09  0.61  0.03 
 15  1.32  0.07  0.65  0.03 
 30  1.44  0.12  0.70  0.06 
 Initial Growth  1.98  0.07  1.29  0.05 
                      
C
ar
ez
ym
e 
 1  1.41  0.10  0.75  0.09 
 5  1.22  0.06  0.68  0.04 
 10  1.25  0.08  0.69  0.03 
 15  1.23  0.06  0.73  0.02 
 30  1.34  0.06  0.75  0.04 
 Initial Growth  1.74  0.10  0.87  0.05 
                      
C
el
lic
-H
Te
c2
  1  1.51  0.10  0.61  0.05 
 5  1.52  0.09  0.63  0.03 
 10  1.58  0.06  0.63  0.03 
 15  1.57  0.05  0.68  0.04 
 30  1.70  0.06  0.74  0.02 
 Initial Growth  1.97  0.09  0.94  0.06 
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